<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0223523421002439</prism:url><dc:identifier>doi:10.1016/j.ejmech.2021.113394</dc:identifier><eid>1-s2.0-S0223523421002439</eid><prism:doi>10.1016/j.ejmech.2021.113394</prism:doi><pii>S0223-5234(21)00243-9</pii><dc:title>Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2 </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>fla</pubtype><prism:issn>02235234</prism:issn><prism:volume>218</prism:volume><prism:startingPage>113394</prism:startingpage><prism:pageRange>113394</prism:pagerange><articleNumber>113394</articlenumber><dc:format>text/xml</dc:format><prism:coverDate>2021-06-05</prism:coverdate><prism:coverDisplayDate>5 June 2021</prism:coverdisplaydate><prism:copyright>© 2021 Elsevier Masson SAS. All rights reserved.</prism:copyright><prism:publisher>Elsevier Masson SAS.</prism:publisher><dc:creator>Xu, Pengfei</dc:creator><dc:creator>Shen, Pei</dc:creator><dc:creator>Wang, Hai</dc:creator><dc:creator>Qin, Lian</dc:creator><dc:creator>Ren, Jie</dc:creator><dc:creator>Sun, Qiushuang</dc:creator><dc:creator>Ge, Raoling</dc:creator><dc:creator>Bian, Jinlei</dc:creator><dc:creator>Zhong, Yi</dc:creator><dc:creator>Li, Zhiyu</dc:creator><dc:creator>Wang, JuBo</dc:creator><dc:creator>Qiu, Zhixia</dc:creator><dc:description>
                  Herein, we describe the design, synthesis, and structure−activity relationships of a series of imidazopyrrolopyridines derivatives that selectively inhibit Janus kinase 2 (JAK2). These screening cascades revealed that 6k was a preferred compound, with IC50 values of 10 nM for JAK2. Moreover, 6k was a selective JAK2 inhibitor with 19-fold, >30-fold and >30-fold selectivity over JAK1, JAK3 and TYK2 respectively. In cytokine-stimulated cell-based assays, 6k exhibited a higher JAK2 selectivity over JAK1 isoforms. Indeed, at a dose of 20 mg/kg compound 6k, pSTAT3 and pSTAT5 expression was reduced to levels comparable to those of control animals untreated with GM-CSF. Additionally, 6k showed a relatively good bioavailability (F = 38%), a suitable half-life time (T1/2 = 1.9 h), a satisfactory metabolic stability, suggesting that 6k might be a promising inhibitor of JAK2 for further development research for the treatment of MPNs.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>Kinase</dcterms:subject><dcterms:subject>Janus kinase 2 (JAK2)</dcterms:subject><dcterms:subject>Imidazopyrrolopyridine</dcterms:subject><dcterms:subject>Myeloproliferative neoplasms</dcterms:subject><dcterms:subject>Selectivity</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0223523421002439" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S0223523421002439" rel="scidir"/></link></coredata><objects><object ref="fx50" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="96" height="69" size="1407">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx50.jpg?httpAccept=%2A%2F%2A</object><object ref="fx19" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="70" height="69" size="1350">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx19.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="602" height="289" size="28282">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="71" size="1714">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx5.jpg?httpAccept=%2A%2F%2A</object><object ref="fx23" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1201">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx23.jpg?httpAccept=%2A%2F%2A</object><object ref="fx66" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="96" height="69" size="1384">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx66.jpg?httpAccept=%2A%2F%2A</object><object ref="fx40" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="45" height="77" size="1086">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx40.jpg?httpAccept=%2A%2F%2A</object><object ref="fx56" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="97" height="69" size="1472">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx56.jpg?httpAccept=%2A%2F%2A</object><object ref="fx48" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="156" height="123" size="3668">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx48.jpg?httpAccept=%2A%2F%2A</object><object ref="fx59" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="19" height="23" size="486">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx59.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="87" height="57" size="1536">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx2.jpg?httpAccept=%2A%2F%2A</object><object ref="fx51" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="79" height="83" size="1660">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx51.jpg?httpAccept=%2A%2F%2A</object><object ref="fx62" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="65" size="1316">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx62.jpg?httpAccept=%2A%2F%2A</object><object ref="fx36" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="35" height="66" size="886">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx36.jpg?httpAccept=%2A%2F%2A</object><object ref="fx54" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="96" height="69" size="1394">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx54.jpg?httpAccept=%2A%2F%2A</object><object ref="fx57" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1284">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx57.jpg?httpAccept=%2A%2F%2A</object><object ref="fx9" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="71" size="1721">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx9.jpg?httpAccept=%2A%2F%2A</object><object ref="fx35" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1206">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx35.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="646" height="345" size="70139">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="fx39" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1196">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx39.jpg?httpAccept=%2A%2F%2A</object><object ref="fx58" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="104" height="77" size="1466">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx58.jpg?httpAccept=%2A%2F%2A</object><object ref="fx3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="71" size="1714">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="646" height="261" size="45253">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx61" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="34" height="23" size="701">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx61.jpg?httpAccept=%2A%2F%2A</object><object ref="fx20" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="71" size="1698">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx20.jpg?httpAccept=%2A%2F%2A</object><object ref="fx26" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1285">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx26.jpg?httpAccept=%2A%2F%2A</object><object ref="fx34" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="85" size="1855">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx34.jpg?httpAccept=%2A%2F%2A</object><object ref="fx41" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1204">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx41.jpg?httpAccept=%2A%2F%2A</object><object ref="fx46" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="103" height="79" size="1462">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx46.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="602" height="546" size="49706">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc2.jpg?httpAccept=%2A%2F%2A</object><object ref="fx29" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1208">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx29.jpg?httpAccept=%2A%2F%2A</object><object ref="fx8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1287">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx8.jpg?httpAccept=%2A%2F%2A</object><object ref="fx14" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="46" height="55" size="1135">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx14.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="153" height="122" size="3509">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="646" height="729" size="128385">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="fx25" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="56" height="65" size="1028">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx25.jpg?httpAccept=%2A%2F%2A</object><object ref="fx18" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="46" height="54" size="1126">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx18.jpg?httpAccept=%2A%2F%2A</object><object ref="ga1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="500" height="124" size="24918">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-ga1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1283">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx4.jpg?httpAccept=%2A%2F%2A</object><object ref="fx13" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="111" height="69" size="1815">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx13.jpg?httpAccept=%2A%2F%2A</object><object ref="fx32" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="54" height="55" size="1405">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx32.jpg?httpAccept=%2A%2F%2A</object><object ref="fx15" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="66" height="65" size="1365">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx15.jpg?httpAccept=%2A%2F%2A</object><object ref="fx47" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="99" height="69" size="1537">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx47.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="580" height="171" size="18390">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="fx24" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="87" height="57" size="1548">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx24.jpg?httpAccept=%2A%2F%2A</object><object ref="fx17" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="58" height="69" size="1417">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx17.jpg?httpAccept=%2A%2F%2A</object><object ref="fx37" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1195">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx37.jpg?httpAccept=%2A%2F%2A</object><object ref="fx43" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1211">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx43.jpg?httpAccept=%2A%2F%2A</object><object ref="fx38" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="45" height="53" size="1109">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx38.jpg?httpAccept=%2A%2F%2A</object><object ref="fx31" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1192">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx31.jpg?httpAccept=%2A%2F%2A</object><object ref="fx64" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="91" height="22" size="1349">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx64.jpg?httpAccept=%2A%2F%2A</object><object ref="fx49" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1289">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx49.jpg?httpAccept=%2A%2F%2A</object><object ref="fx65" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="46" height="30" size="961">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx65.jpg?httpAccept=%2A%2F%2A</object><object ref="fx53" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1289">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx53.jpg?httpAccept=%2A%2F%2A</object><object ref="fx52" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="93" height="69" size="1421">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx52.jpg?httpAccept=%2A%2F%2A</object><object ref="fx45" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="92" height="69" size="1412">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx45.jpg?httpAccept=%2A%2F%2A</object><object ref="fx16" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="46" height="55" size="1132">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx16.jpg?httpAccept=%2A%2F%2A</object><object ref="fx30" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="59" height="55" size="1259">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx30.jpg?httpAccept=%2A%2F%2A</object><object ref="fx27" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1207">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx27.jpg?httpAccept=%2A%2F%2A</object><object ref="fx21" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="157" height="123" size="3689">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx21.jpg?httpAccept=%2A%2F%2A</object><object ref="fx12" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="87" height="57" size="1538">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx12.jpg?httpAccept=%2A%2F%2A</object><object ref="fx10" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="87" height="57" size="1536">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx10.jpg?httpAccept=%2A%2F%2A</object><object ref="fx28" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="65" height="55" size="1391">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx28.jpg?httpAccept=%2A%2F%2A</object><object ref="fx6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="46" height="55" size="1140">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx6.jpg?httpAccept=%2A%2F%2A</object><object ref="fx11" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="99" height="69" size="1762">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx11.jpg?httpAccept=%2A%2F%2A</object><object ref="fx42" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="50" height="75" size="1180">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx42.jpg?httpAccept=%2A%2F%2A</object><object ref="fx22" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="87" height="57" size="1550">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx22.jpg?httpAccept=%2A%2F%2A</object><object ref="fx60" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="96" height="69" size="1397">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx60.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="624" height="377" size="56317">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="fx7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="88" height="71" size="1714">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx7.jpg?httpAccept=%2A%2F%2A</object><object ref="fx44" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1205">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx44.jpg?httpAccept=%2A%2F%2A</object><object ref="fx55" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="60" height="55" size="1284">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx55.jpg?httpAccept=%2A%2F%2A</object><object ref="fx63" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="42" height="25" size="853">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx63.jpg?httpAccept=%2A%2F%2A</object><object ref="fx33" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="72" height="78" size="1197">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx33.jpg?httpAccept=%2A%2F%2A</object><object ref="fx50" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="1913">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx50.sml?httpAccept=%2A%2F%2A</object><object ref="fx19" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="167" height="164" size="2248">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx19.sml?httpAccept=%2A%2F%2A</object><object ref="sc1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="105" size="4093">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc1.sml?httpAccept=%2A%2F%2A</object><object ref="fx5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="164" size="2742">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx5.sml?httpAccept=%2A%2F%2A</object><object ref="fx23" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1512">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx23.sml?httpAccept=%2A%2F%2A</object><object ref="fx66" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="1928">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx66.sml?httpAccept=%2A%2F%2A</object><object ref="fx40" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="348" size="3470">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx40.sml?httpAccept=%2A%2F%2A</object><object ref="fx56" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="156" size="1928">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx56.sml?httpAccept=%2A%2F%2A</object><object ref="fx48" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="208" height="164" size="2723">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx48.sml?httpAccept=%2A%2F%2A</object><object ref="fx59" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="86" height="104" size="1270">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx59.sml?httpAccept=%2A%2F%2A</object><object ref="fx2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="2651">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx2.sml?httpAccept=%2A%2F%2A</object><object ref="fx51" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="156" height="164" size="2167">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx51.sml?httpAccept=%2A%2F%2A</object><object ref="fx62" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="161" size="2057">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx62.sml?httpAccept=%2A%2F%2A</object><object ref="fx36" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="156" height="293" size="2439">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx36.sml?httpAccept=%2A%2F%2A</object><object ref="fx54" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="1994">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx54.sml?httpAccept=%2A%2F%2A</object><object ref="fx57" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="177" height="164" size="2521">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx57.sml?httpAccept=%2A%2F%2A</object><object ref="fx9" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="164" size="2699">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx9.sml?httpAccept=%2A%2F%2A</object><object ref="fx35" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1494">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx35.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="117" size="7981">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="fx39" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1538">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx39.sml?httpAccept=%2A%2F%2A</object><object ref="fx58" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="163" size="1793">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx58.sml?httpAccept=%2A%2F%2A</object><object ref="fx3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="164" size="2797">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx3.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="89" size="5434">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="fx61" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="153" height="104" size="2183">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx61.sml?httpAccept=%2A%2F%2A</object><object ref="fx20" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="164" size="2677">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx20.sml?httpAccept=%2A%2F%2A</object><object ref="fx26" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="177" height="164" size="2547">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx26.sml?httpAccept=%2A%2F%2A</object><object ref="fx34" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="169" height="163" size="2139">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx34.sml?httpAccept=%2A%2F%2A</object><object ref="fx41" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1535">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx41.sml?httpAccept=%2A%2F%2A</object><object ref="fx46" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="214" height="164" size="1798">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx46.sml?httpAccept=%2A%2F%2A</object><object ref="sc2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="181" height="164" size="5178">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc2.sml?httpAccept=%2A%2F%2A</object><object ref="fx29" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1547">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx29.sml?httpAccept=%2A%2F%2A</object><object ref="fx8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="177" height="164" size="2573">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx8.sml?httpAccept=%2A%2F%2A</object><object ref="fx14" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="204" height="242" size="3660">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx14.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="205" height="164" size="2573">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="145" height="164" size="8290">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="fx25" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="140" height="163" size="1674">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx25.sml?httpAccept=%2A%2F%2A</object><object ref="fx18" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="204" height="241" size="3802">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx18.sml?httpAccept=%2A%2F%2A</object><object ref="ga1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="54" size="4182">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-ga1.sml?httpAccept=%2A%2F%2A</object><object ref="fx4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="177" height="164" size="2532">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx4.sml?httpAccept=%2A%2F%2A</object><object ref="fx13" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="137" size="2328">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx13.sml?httpAccept=%2A%2F%2A</object><object ref="fx32" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="161" height="164" size="2765">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx32.sml?httpAccept=%2A%2F%2A</object><object ref="fx15" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="167" height="164" size="2098">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx15.sml?httpAccept=%2A%2F%2A</object><object ref="fx47" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="153" size="1891">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx47.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="65" size="4693">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="fx24" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="2717">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx24.sml?httpAccept=%2A%2F%2A</object><object ref="fx17" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="138" height="164" size="2291">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx17.sml?httpAccept=%2A%2F%2A</object><object ref="fx37" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1493">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx37.sml?httpAccept=%2A%2F%2A</object><object ref="fx43" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1528">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx43.sml?httpAccept=%2A%2F%2A</object><object ref="fx38" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="241" size="3591">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx38.sml?httpAccept=%2A%2F%2A</object><object ref="fx31" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1513">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx31.sml?httpAccept=%2A%2F%2A</object><object ref="fx64" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="53" size="1783">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx64.sml?httpAccept=%2A%2F%2A</object><object ref="fx49" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="178" height="164" size="2614">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx49.sml?httpAccept=%2A%2F%2A</object><object ref="fx65" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="204" height="135" size="2797">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx65.sml?httpAccept=%2A%2F%2A</object><object ref="fx53" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="178" height="164" size="2662">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx53.sml?httpAccept=%2A%2F%2A</object><object ref="fx52" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="163" size="2017">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx52.sml?httpAccept=%2A%2F%2A</object><object ref="fx45" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="164" size="1974">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx45.sml?httpAccept=%2A%2F%2A</object><object ref="fx16" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="204" height="242" size="3809">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx16.sml?httpAccept=%2A%2F%2A</object><object ref="fx30" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="177" height="164" size="2610">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx30.sml?httpAccept=%2A%2F%2A</object><object ref="fx27" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1484">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx27.sml?httpAccept=%2A%2F%2A</object><object ref="fx21" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="208" height="163" size="2680">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx21.sml?httpAccept=%2A%2F%2A</object><object ref="fx12" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="2736">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx12.sml?httpAccept=%2A%2F%2A</object><object ref="fx10" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="2647">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx10.sml?httpAccept=%2A%2F%2A</object><object ref="fx28" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="195" height="164" size="2935">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx28.sml?httpAccept=%2A%2F%2A</object><object ref="fx6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="204" height="242" size="3755">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx6.sml?httpAccept=%2A%2F%2A</object><object ref="fx11" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="153" size="2710">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx11.sml?httpAccept=%2A%2F%2A</object><object ref="fx42" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="108" height="163" size="1686">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx42.sml?httpAccept=%2A%2F%2A</object><object ref="fx22" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="144" size="2692">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx22.sml?httpAccept=%2A%2F%2A</object><object ref="fx60" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="158" size="1922">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx60.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="132" size="7401">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="fx7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="203" height="164" size="2692">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx7.sml?httpAccept=%2A%2F%2A</object><object ref="fx44" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1524">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx44.sml?httpAccept=%2A%2F%2A</object><object ref="fx55" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="178" height="164" size="2589">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx55.sml?httpAccept=%2A%2F%2A</object><object ref="fx63" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="188" height="114" size="2535">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx63.sml?httpAccept=%2A%2F%2A</object><object ref="fx33" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="151" height="164" size="1486">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx33.sml?httpAccept=%2A%2F%2A</object><object ref="fx50" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="426" height="308" size="9005">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx50_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx19" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="313" height="307" size="8679">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx19_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2666" height="1282" size="206994">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="393" height="317" size="11721">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx23" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7639">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx23_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx66" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="426" height="308" size="9020">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx66_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx40" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="203" height="348" size="6541">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx40_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx56" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="432" height="308" size="8900">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx56_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx48" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="694" height="546" size="25570">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx48_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx59" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="86" height="104" size="1835">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx59_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="256" size="10210">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx51" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="350" height="368" size="10700">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx51_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx62" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="392" height="289" size="8126">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx62_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx36" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="156" height="293" size="4428">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx36_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx54" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="426" height="308" size="8930">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx54_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx57" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="246" size="7826">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx57_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx9" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="393" height="317" size="11702">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx9_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx35" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="350" size="7692">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx35_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2862" height="1528" size="586831">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx39" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7770">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx39_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx58" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="462" height="343" size="9596">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx58_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="393" height="317" size="11742">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2862" height="1158" size="378073">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx61" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="153" height="104" size="3097">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx61_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx20" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="392" height="316" size="11779">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx20_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx26" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="246" size="7766">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx26_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx34" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="393" height="380" size="12739">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx34_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx41" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7794">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx41_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx46" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="459" height="351" size="9690">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx46_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2666" height="2418" size="374580">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-sc2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx29" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="350" size="7834">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx29_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx8" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="246" size="7752">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx14" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="204" height="242" size="6757">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx14_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="680" height="544" size="23461">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2862" height="3228" size="1065096">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx25" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="248" height="289" size="6004">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx25_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx18" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="204" height="241" size="6736">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx18_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="ga1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2213" height="547" size="184216">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-ga1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="246" size="7760">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx13" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="495" height="309" size="12818">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx13_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx32" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="240" height="244" size="8256">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx32_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx15" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="293" height="288" size="7812">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx15_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx47" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="441" height="308" size="9185">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx47_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2568" height="758" size="181151">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx24" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="256" size="10301">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx24_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx17" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="259" height="308" size="8869">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx17_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx37" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="350" size="7780">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx37_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx43" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="350" size="7734">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx43_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx38" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="203" height="241" size="6718">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx38_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx31" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7746">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx31_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx64" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="405" height="98" size="7112">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx64_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx49" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="245" size="7720">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx49_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx65" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="204" height="135" size="4944">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx65_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx53" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="245" size="7826">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx53_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx52" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="413" height="308" size="8738">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx52_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx45" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="411" height="308" size="8571">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx45_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx16" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="204" height="242" size="6813">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx16_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx30" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="265" height="245" size="7352">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx30_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx27" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7714">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx27_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx21" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="696" height="547" size="25101">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx21_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx12" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="256" size="10286">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx12_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx10" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="255" size="10195">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx10_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx28" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="290" height="244" size="8469">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx28_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="204" height="242" size="6834">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx11" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="441" height="309" size="12080">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx11_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx42" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="224" height="338" size="7603">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx42_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx22" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="255" size="10305">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx22_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx60" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="426" height="308" size="8985">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx60_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2764" height="1670" size="392662">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx7" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="393" height="317" size="11687">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx44" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="350" size="7692">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx44_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx55" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="266" height="245" size="7738">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx55_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx63" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="188" height="114" size="4913">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx63_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx33" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="323" height="351" size="7774">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-fx33_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="6519126">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-mmc1.docx?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="1162505">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002439-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85103603205</scopus-id><scopus-eid>2-s2.0-85103603205</scopus-eid><pubmed-id>33813153</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/85103603205" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20210326">2021-03-26</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20210326">2021-03-26</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20210401">2021-04-01</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20210401">2021-04-01</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2021-05-02T12:43:18</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0223523421002439</xocs:eid>
      <xocs:pii-formatted>S0223-5234(21)00243-9</xocs:pii-formatted>
      <xocs:pii-unformatted>S0223523421002439</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2021.113394</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523421X00074</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20210517">2021-05-17T08:02:50.798552Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20210605</xocs:date-search-begin>
      <xocs:year-nav>2021</xocs:year-nav>
      <xocs:indexeddate epoch="1616774843">2021-03-26T16:07:23.660371Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articlenumber articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast grantnumber grantsponsor grantsponsorid highlightsabst otherkwds primabst ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>218</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>218</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 218</xocs:vol-iss-suppl-text>
      <xocs:sort-order>21</xocs:sort-order>
      <xocs:first-fp>113394</xocs:first-fp>
      <xocs:article-number>113394</xocs:article-number>
      <xocs:pages>
         <xocs:first-page>113394</xocs:first-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20210605</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>5 June 2021</xocs:cover-date-text>
      <xocs:cover-date-start>2021-06-05</xocs:cover-date-start>
      <xocs:cover-date-year>2021</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Full papers</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2021 Elsevier Masson SAS. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>DISCOVERYIMIDAZOPYRROLOPYRIDINESDERIVATIVESNOVELSELECTIVEINHIBITORSJAK2</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>XU</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>P</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results and discussion</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Design and biochemical activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biological evaluation</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>ADME and physicochemical properties of inhibitors</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cellular activity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>In vivo pharmacokinetics</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>In vivo pharmacodynamics</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Experimental</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry and chemical methods</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>Tert</ce:italic>-butyl 3-(cyanomethylene) azetidine-1-carboxylate (<ce:bold>11</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b] pyridine (<ce:bold>13</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-Chloro-5-nitro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b] pyridine (<ce:bold>14</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>Tert</ce:italic>-butyl 3-(cyanomethyl)-3-(4-((5-nitro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)amino)-1H-pyrazol-1-yl)azetidine-1-carboxylate (<ce:bold>15</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>Tert</ce:italic>-butyl 3-(4-((5-amino-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)amino)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate (<ce:bold>16</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>1H-pyrazol-4-amine (<ce:bold>18</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.7</xocs:item-toc-label>
                  <xocs:item-toc-section-title>5-Nitro-1-(phenylsulfonyl)-N-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b] pyridin-4-amine (<ce:bold>19</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.8</xocs:item-toc-label>
                  <xocs:item-toc-section-title>1-(Phenylsulfonyl)-N4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-4,5-diamine (<ce:bold>20</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.9</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Ethylsulfonyl)-3-(4-(2-(5-(hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.10</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Ethylsulfonyl)-3-(4-(2-(5-methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.11</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Ethylsulfonyl)-3-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.12</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Ethylsulfonyl)-3-(4-(2-(5-methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.13</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(3-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)-1-(propylsulfonyl)azetidin-3-yl)acetonitrile (<ce:bold>2a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.14</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Butylsulfonyl)-3-(4-(2-(5-(hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>3a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.15</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(Thiophen-2-yl)-1-(1-(1-((trifluoromethyl)sulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>2c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.16</xocs:item-toc-label>
                  <xocs:item-toc-section-title>1,1,1-Trifluoro-N-(2-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)ethyl)methanesulfonamide (<ce:bold>3c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.17</xocs:item-toc-label>
                  <xocs:item-toc-section-title>N-(2-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)ethyl)propane-1-sulfonamide (<ce:bold>4c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.18</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(1-(Ethylsulfonyl)-3-(4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1e</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.19</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.20</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)acetonitrile (<ce:bold>6a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.21</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(5-Methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.22</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(3-Hydroxyphenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.23</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.24</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(2-Chlorophenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5e</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.25</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(4-(Methylsulfonyl)phenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5f</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.26</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(Trifluoromethyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5g</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.27</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(Thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5h</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.28</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(Thiazol-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5i</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.29</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(2-(Thiazol-5-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5j</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.30</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5k</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.31</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6k</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.32</xocs:item-toc-label>
                  <xocs:item-toc-section-title>5-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)pentanenitrile (<ce:bold>7k</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.33</xocs:item-toc-label>
                  <xocs:item-toc-section-title>1-(1-(4,4,4-Trifluorobutyl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>8k</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.34</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-(5-Methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.35</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-(2-Aminothiazol-5-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>7b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.36</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.37</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-(5-Methylthiophen-2-yl)-1-(1-(4,4,4-trifluorobutyl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>7d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.38</xocs:item-toc-label>
                  <xocs:item-toc-section-title>5-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)pentanenitrile (<ce:bold>8d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.39</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-Methylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.40</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-Cyclopropylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.41</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-Cyclobutylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.42</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-(2-Cyclopentylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biologic assays</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Enzyme assay</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cellular assays</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Microsomal metabolism</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>JAK2-STAT pathway assay</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Pharmacokinetic in rats</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Pharmacodynamics in mice</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>DANIEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>2391</xocs:ref-first-fp>
            <xocs:ref-last-lp>2406</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>LEGARE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1995</xocs:ref-pub-year>
            <xocs:ref-first-fp>283</xocs:ref-first-fp>
            <xocs:ref-last-lp>292</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>MONALI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>264</xocs:ref-first-fp>
            <xocs:ref-last-lp>271</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>VESNA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>614</xocs:ref-first-fp>
            <xocs:ref-last-lp>618</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>EMILY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>312</xocs:ref-first-fp>
            <xocs:ref-last-lp>318</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>WILLIAM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>4638</xocs:ref-first-fp>
            <xocs:ref-last-lp>4658</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7">
            <xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>798</xocs:ref-first-fp>
            <xocs:ref-last-lp>809</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>LIM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>7334</xocs:ref-first-fp>
            <xocs:ref-last-lp>7349</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>PERNER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>854</xocs:ref-first-fp>
            <xocs:ref-last-lp>872</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>MASCARENHAS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>3008</xocs:ref-first-fp>
            <xocs:ref-last-lp>3014</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>HANNAH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>1719</xocs:ref-first-fp>
            <xocs:ref-last-lp>1725</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>WAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>850</xocs:ref-first-fp>
            <xocs:ref-last-lp>855</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>HART</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>845</xocs:ref-first-fp>
            <xocs:ref-last-lp>849</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>ZAK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>4764</xocs:ref-first-fp>
            <xocs:ref-last-lp>4785</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>JAMES</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>5023</xocs:ref-first-fp>
            <xocs:ref-last-lp>5038</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>IOANNIDIS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>262</xocs:ref-first-fp>
            <xocs:ref-last-lp>276</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>SWAPNA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2020</xocs:ref-pub-year>
            <xocs:ref-first-fp>278</xocs:ref-first-fp>
            <xocs:ref-last-lp>285</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>ZAK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>6176</xocs:ref-first-fp>
            <xocs:ref-last-lp>6193</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>KULAGOWSKI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>5901</xocs:ref-first-fp>
            <xocs:ref-last-lp>5921</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>7596</xocs:ref-first-fp>
            <xocs:ref-last-lp>7602</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>RITZEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>641</xocs:ref-first-fp>
            <xocs:ref-last-lp>646</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>YANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>8233</xocs:ref-first-fp>
            <xocs:ref-last-lp>8262</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>SHUBHASREE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>521</xocs:ref-first-fp>
            <xocs:ref-last-lp>546</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>XUX2021X113394</xocs:refkey3>
         <xocs:refkey4ai>XUX2021X113394XP</xocs:refkey4ai>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-embargo-opening-date>2023-04-01T00:00:00.000Z</xocs:or-embargo-opening-date>
      </xocs:open-research>
      <xocs:self-archiving>
         <xocs:sa-start-date>2023-04-01T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2021 Elsevier Masson SAS. All rights reserved.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:funding-list has-funding-info="1">
         <xocs:funding-addon-generated-timestamp>2021-03-24T01:31:10.731Z</xocs:funding-addon-generated-timestamp>
         <xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/eoas</xocs:funding-addon-type>
         <xocs:funding>
            <xocs:funding-agency-acronym>NSFC</xocs:funding-agency-acronym>
            <xocs:funding-agency>National Natural Science Foundation of China</xocs:funding-agency>
            <xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100001809</xocs:funding-agency-id>
            <xocs:funding-agency-country>http://sws.geonames.org/1814991</xocs:funding-agency-country>
         </xocs:funding>
      </xocs:funding-list>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(21)00243-9</xocs:pii-formatted>
         <xocs:pii-unformatted>S0223523421002439</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0223523421002439</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2021.113394</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2021-05-17T08:02:50.798552Z</xocs:timestamp>
         <xocs:cover-date-start>2021-06-05</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/MAIN/application/pdf/9e3ce70f4916908cb55b2be268bc293a/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>3448226</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>18</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0223523421002439-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/PREVIEW/image/png/0279b9719d4ec070cd2a95effde887af/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>62643</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx50.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx50/DOWNSAMPLED/image/jpeg/f7d9f23e82bae53fb21aacb9bac57429/fx50.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx50</xocs:file-basename>
               <xocs:filename>fx50.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1407</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>96</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx19.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx19/DOWNSAMPLED/image/jpeg/69c13610a14f9af00564d41652254a85/fx19.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1350</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>70</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc1/DOWNSAMPLED/image/jpeg/9be0499272ab545897e6a93847f5f785/sc1.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>28282</xocs:filesize>
               <xocs:pixel-height>289</xocs:pixel-height>
               <xocs:pixel-width>602</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx5/DOWNSAMPLED/image/jpeg/1a244f1cc5275cdea9f6dc698ceed76a/fx5.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1714</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx23.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx23/DOWNSAMPLED/image/jpeg/131eeaed22597bf1f013afcb2b908e57/fx23.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1201</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx66.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx66/DOWNSAMPLED/image/jpeg/8f9ce7825996caedb89775c08ff5e9ac/fx66.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx66</xocs:file-basename>
               <xocs:filename>fx66.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1384</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>96</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx40.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx40/DOWNSAMPLED/image/jpeg/b0f18ecadd292d69220ee929a57ee180/fx40.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx40</xocs:file-basename>
               <xocs:filename>fx40.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1086</xocs:filesize>
               <xocs:pixel-height>77</xocs:pixel-height>
               <xocs:pixel-width>45</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx56.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx56/DOWNSAMPLED/image/jpeg/8efdc52524dcd8e14efad372de4dba15/fx56.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx56</xocs:file-basename>
               <xocs:filename>fx56.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1472</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>97</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx48.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx48/DOWNSAMPLED/image/jpeg/6e9ff2fe6c08f86ec019d424ecdb311c/fx48.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx48</xocs:file-basename>
               <xocs:filename>fx48.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3668</xocs:filesize>
               <xocs:pixel-height>123</xocs:pixel-height>
               <xocs:pixel-width>156</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx59.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx59/DOWNSAMPLED/image/jpeg/20fa87587ab288570332e56768392d45/fx59.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx59</xocs:file-basename>
               <xocs:filename>fx59.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>486</xocs:filesize>
               <xocs:pixel-height>23</xocs:pixel-height>
               <xocs:pixel-width>19</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx2/DOWNSAMPLED/image/jpeg/53c6dbb3dee15041aec879d90c512e1d/fx2.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1536</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>87</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx51.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx51/DOWNSAMPLED/image/jpeg/4c872c03bb9ec1b3b6e033db1c23215c/fx51.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx51</xocs:file-basename>
               <xocs:filename>fx51.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1660</xocs:filesize>
               <xocs:pixel-height>83</xocs:pixel-height>
               <xocs:pixel-width>79</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx62.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx62/DOWNSAMPLED/image/jpeg/701728abb501de12cc1c3b09a88f4000/fx62.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx62</xocs:file-basename>
               <xocs:filename>fx62.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1316</xocs:filesize>
               <xocs:pixel-height>65</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx36.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx36/DOWNSAMPLED/image/jpeg/f65572dde24895f7f092f5ff8484731f/fx36.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx36</xocs:file-basename>
               <xocs:filename>fx36.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>886</xocs:filesize>
               <xocs:pixel-height>66</xocs:pixel-height>
               <xocs:pixel-width>35</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx54.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx54/DOWNSAMPLED/image/jpeg/0a81d8ed5c7e9f94cb5dd1fddeab8149/fx54.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx54</xocs:file-basename>
               <xocs:filename>fx54.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1394</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>96</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx57.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx57/DOWNSAMPLED/image/jpeg/3cef1132e81d8add380c8d4e7a9a4b4a/fx57.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx57</xocs:file-basename>
               <xocs:filename>fx57.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1284</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx9.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx9/DOWNSAMPLED/image/jpeg/93a6adb05f463eb7b8eb86ac2b6b7f51/fx9.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1721</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx35.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx35/DOWNSAMPLED/image/jpeg/1c45a87bbaf49340f602e2ee65753b1d/fx35.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1206</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr2/DOWNSAMPLED/image/jpeg/14dac476df7a1da720d41b197a957569/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>70139</xocs:filesize>
               <xocs:pixel-height>345</xocs:pixel-height>
               <xocs:pixel-width>646</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx39.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx39/DOWNSAMPLED/image/jpeg/e7099df943ba370c36fc08bb768894f7/fx39.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx39</xocs:file-basename>
               <xocs:filename>fx39.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1196</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx58.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx58/DOWNSAMPLED/image/jpeg/23fabc7ce48fac0098c1933b4323a5dd/fx58.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx58</xocs:file-basename>
               <xocs:filename>fx58.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1466</xocs:filesize>
               <xocs:pixel-height>77</xocs:pixel-height>
               <xocs:pixel-width>104</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx3/DOWNSAMPLED/image/jpeg/41df266c369347a44a3d9f96f52014b6/fx3.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1714</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr1/DOWNSAMPLED/image/jpeg/dcda5de9d1777489ab465508ae4c58e6/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>45253</xocs:filesize>
               <xocs:pixel-height>261</xocs:pixel-height>
               <xocs:pixel-width>646</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx61.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx61/DOWNSAMPLED/image/jpeg/9ad049f28b1458cccbd2ac7535eb0b67/fx61.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx61</xocs:file-basename>
               <xocs:filename>fx61.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>701</xocs:filesize>
               <xocs:pixel-height>23</xocs:pixel-height>
               <xocs:pixel-width>34</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx20.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx20/DOWNSAMPLED/image/jpeg/8070d3fdb74b6ffe3016b22e75a35cf3/fx20.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1698</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx26.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx26/DOWNSAMPLED/image/jpeg/346d4e055982eab5aeb8af4e8b80d171/fx26.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1285</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx34.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx34/DOWNSAMPLED/image/jpeg/0cae252d9363377fcf0161582427b779/fx34.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1855</xocs:filesize>
               <xocs:pixel-height>85</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx41.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx41/DOWNSAMPLED/image/jpeg/deca091922c0dcb0294da786126f4b72/fx41.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx41</xocs:file-basename>
               <xocs:filename>fx41.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1204</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx46.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx46/DOWNSAMPLED/image/jpeg/ca89a1b7c1489e9eb7d8b57b03901825/fx46.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx46</xocs:file-basename>
               <xocs:filename>fx46.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1462</xocs:filesize>
               <xocs:pixel-height>79</xocs:pixel-height>
               <xocs:pixel-width>103</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc2/DOWNSAMPLED/image/jpeg/477dd30310f73342f5fb5a54f08ebb7b/sc2.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>49706</xocs:filesize>
               <xocs:pixel-height>546</xocs:pixel-height>
               <xocs:pixel-width>602</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx29.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx29/DOWNSAMPLED/image/jpeg/9cca9998ce3bf1d53da31b39f5b40fe3/fx29.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1208</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx8/DOWNSAMPLED/image/jpeg/867bacee9b089985a3fb265e04003e23/fx8.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1287</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx14.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx14/DOWNSAMPLED/image/jpeg/4f699dd565d669f62105713246fcd6f9/fx14.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1135</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx1/DOWNSAMPLED/image/jpeg/86774d0af68da46c1558d5755eb7b3c0/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3509</xocs:filesize>
               <xocs:pixel-height>122</xocs:pixel-height>
               <xocs:pixel-width>153</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr3/DOWNSAMPLED/image/jpeg/d99eecf8e552698c8172e096dbaa4989/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>128385</xocs:filesize>
               <xocs:pixel-height>729</xocs:pixel-height>
               <xocs:pixel-width>646</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx25.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx25/DOWNSAMPLED/image/jpeg/2650ef5a995b69de74ebdd7df468071f/fx25.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1028</xocs:filesize>
               <xocs:pixel-height>65</xocs:pixel-height>
               <xocs:pixel-width>56</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx18.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx18/DOWNSAMPLED/image/jpeg/68060808be47b1d4e4616dd7df012ab1/fx18.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1126</xocs:filesize>
               <xocs:pixel-height>54</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-ga1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/ga1/DOWNSAMPLED/image/jpeg/765e78a108f7558897c017ffb417c073/ga1.jpg</xocs:ucs-locator>
               <xocs:file-basename>ga1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>ga1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>24918</xocs:filesize>
               <xocs:pixel-height>124</xocs:pixel-height>
               <xocs:pixel-width>500</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx4/DOWNSAMPLED/image/jpeg/142c594ba7f80d3012845c468f9b2a34/fx4.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1283</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx13.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx13/DOWNSAMPLED/image/jpeg/5d7debf8945dfadd53eb71e94ecbad17/fx13.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1815</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>111</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx32.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx32/DOWNSAMPLED/image/jpeg/d9cd3e2936fe3578d0cf6eac8530765c/fx32.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1405</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>54</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx15.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx15/DOWNSAMPLED/image/jpeg/90a0190c6e4dae87be2a99dbd4d856d2/fx15.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1365</xocs:filesize>
               <xocs:pixel-height>65</xocs:pixel-height>
               <xocs:pixel-width>66</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx47.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx47/DOWNSAMPLED/image/jpeg/a567eef6eff9b35e0e2507f34d00b80a/fx47.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx47</xocs:file-basename>
               <xocs:filename>fx47.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1537</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>99</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr4/DOWNSAMPLED/image/jpeg/48388b40cf51400fbf9c3b5de8c1b872/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>18390</xocs:filesize>
               <xocs:pixel-height>171</xocs:pixel-height>
               <xocs:pixel-width>580</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx24.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx24/DOWNSAMPLED/image/jpeg/3769bf5ae416ad8f7f26bb178b54b992/fx24.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1548</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>87</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx17.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx17/DOWNSAMPLED/image/jpeg/57b02538e87cc7ef2069f7abe99afc73/fx17.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1417</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>58</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx37.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx37/DOWNSAMPLED/image/jpeg/dd986c64652df0ee584ea2fa42404d37/fx37.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx37</xocs:file-basename>
               <xocs:filename>fx37.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1195</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx43.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx43/DOWNSAMPLED/image/jpeg/98af9f0755ec5bef3770627b144449fc/fx43.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx43</xocs:file-basename>
               <xocs:filename>fx43.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1211</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx38.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx38/DOWNSAMPLED/image/jpeg/971bf61ef1a25b8550412473ca5bed49/fx38.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx38</xocs:file-basename>
               <xocs:filename>fx38.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1109</xocs:filesize>
               <xocs:pixel-height>53</xocs:pixel-height>
               <xocs:pixel-width>45</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx31.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx31/DOWNSAMPLED/image/jpeg/795e4d01e5a9c3544c117d0a85838154/fx31.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1192</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx64.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx64/DOWNSAMPLED/image/jpeg/3968f0a085e8107062428ca337facdc2/fx64.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx64</xocs:file-basename>
               <xocs:filename>fx64.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1349</xocs:filesize>
               <xocs:pixel-height>22</xocs:pixel-height>
               <xocs:pixel-width>91</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx49.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx49/DOWNSAMPLED/image/jpeg/35ec85a9562ea3bcfbc781a79e4ecd1c/fx49.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx49</xocs:file-basename>
               <xocs:filename>fx49.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1289</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx65.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx65/DOWNSAMPLED/image/jpeg/f8c57c7d4c4458155aab3a76f6efce6f/fx65.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx65</xocs:file-basename>
               <xocs:filename>fx65.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>961</xocs:filesize>
               <xocs:pixel-height>30</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx53.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx53/DOWNSAMPLED/image/jpeg/6e9cbcff5e1f161780c2d77fec6892bb/fx53.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx53</xocs:file-basename>
               <xocs:filename>fx53.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1289</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx52.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx52/DOWNSAMPLED/image/jpeg/341f472ab3aa3af205f39c6360b247a5/fx52.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx52</xocs:file-basename>
               <xocs:filename>fx52.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1421</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>93</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx45.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx45/DOWNSAMPLED/image/jpeg/787cabe6ab350131562f0953c41d7ab0/fx45.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx45</xocs:file-basename>
               <xocs:filename>fx45.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1412</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>92</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx16.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx16/DOWNSAMPLED/image/jpeg/432cf3f4daef0f29d85e58ffda3bc98c/fx16.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1132</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx30.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx30/DOWNSAMPLED/image/jpeg/b6466279653d97f967adb1f6c3750a4b/fx30.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1259</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>59</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx27.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx27/DOWNSAMPLED/image/jpeg/c90e96573bbb4b4695dc3aa62952d3f2/fx27.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1207</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx21.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx21/DOWNSAMPLED/image/jpeg/e0d447f20c16da98d4d6d895b9fd485d/fx21.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3689</xocs:filesize>
               <xocs:pixel-height>123</xocs:pixel-height>
               <xocs:pixel-width>157</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx12.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx12/DOWNSAMPLED/image/jpeg/fc17f975b405c12e56022a5ab17adaee/fx12.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1538</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>87</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx10.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx10/DOWNSAMPLED/image/jpeg/10a2d7f6774a4ccf263ceac12d38aa94/fx10.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1536</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>87</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx28.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx28/DOWNSAMPLED/image/jpeg/70ffe97a551c6240e7c6039c9d900bda/fx28.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1391</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>65</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx6/DOWNSAMPLED/image/jpeg/bbd527fa5bcea277974904878143b08e/fx6.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1140</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>46</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx11.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx11/DOWNSAMPLED/image/jpeg/7683e540b058dc24a57de1fc4bb6d5b8/fx11.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1762</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>99</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx42.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx42/DOWNSAMPLED/image/jpeg/9ff51d08b208d777fbbea20c3c3ce3ac/fx42.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx42</xocs:file-basename>
               <xocs:filename>fx42.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1180</xocs:filesize>
               <xocs:pixel-height>75</xocs:pixel-height>
               <xocs:pixel-width>50</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx22.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx22/DOWNSAMPLED/image/jpeg/0c270b768aa672a72ff40ae8e8126bc9/fx22.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1550</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>87</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx60.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx60/DOWNSAMPLED/image/jpeg/ad630ad73dca52cb10f95ec84029df08/fx60.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx60</xocs:file-basename>
               <xocs:filename>fx60.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1397</xocs:filesize>
               <xocs:pixel-height>69</xocs:pixel-height>
               <xocs:pixel-width>96</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr5/DOWNSAMPLED/image/jpeg/25cc0921bca3804d96e399593d146a16/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>56317</xocs:filesize>
               <xocs:pixel-height>377</xocs:pixel-height>
               <xocs:pixel-width>624</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx7/DOWNSAMPLED/image/jpeg/daff22be077991d99cc2631d97611ab8/fx7.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1714</xocs:filesize>
               <xocs:pixel-height>71</xocs:pixel-height>
               <xocs:pixel-width>88</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx44.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx44/DOWNSAMPLED/image/jpeg/30b4f923deea2da972d2138dc32687f5/fx44.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx44</xocs:file-basename>
               <xocs:filename>fx44.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1205</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx55.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx55/DOWNSAMPLED/image/jpeg/e4dfc039a3ab535fe3d970cb659fff47/fx55.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx55</xocs:file-basename>
               <xocs:filename>fx55.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1284</xocs:filesize>
               <xocs:pixel-height>55</xocs:pixel-height>
               <xocs:pixel-width>60</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx63.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx63/DOWNSAMPLED/image/jpeg/8f011b3949399d5ff66375a1a470afea/fx63.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx63</xocs:file-basename>
               <xocs:filename>fx63.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>853</xocs:filesize>
               <xocs:pixel-height>25</xocs:pixel-height>
               <xocs:pixel-width>42</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx33.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx33/DOWNSAMPLED/image/jpeg/544be12d77ace22d5b7531ebafc9a129/fx33.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1197</xocs:filesize>
               <xocs:pixel-height>78</xocs:pixel-height>
               <xocs:pixel-width>72</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx50.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx50/THUMBNAIL/image/gif/d55ec5c900c3b5432403640131b0c977/fx50.sml</xocs:ucs-locator>
               <xocs:file-basename>fx50</xocs:file-basename>
               <xocs:filename>fx50.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1913</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx19.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx19/THUMBNAIL/image/gif/20aa6102f3ae65f53444064d355217d0/fx19.sml</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2248</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>167</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc1/THUMBNAIL/image/gif/caf0c6e880a9875c23fc46235d2adaa4/sc1.sml</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4093</xocs:filesize>
               <xocs:pixel-height>105</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx5/THUMBNAIL/image/gif/8fcea37cf84dee17618bbfdedce75d70/fx5.sml</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2742</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx23.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx23/THUMBNAIL/image/gif/e1031c2dcb2183dc255d0a8be803fb95/fx23.sml</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1512</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx66.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx66/THUMBNAIL/image/gif/15615ee7f835969f046c3b40bd304ce4/fx66.sml</xocs:ucs-locator>
               <xocs:file-basename>fx66</xocs:file-basename>
               <xocs:filename>fx66.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1928</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx40.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx40/THUMBNAIL/image/gif/487ef1a8ecf36f129883c66be09f7e12/fx40.sml</xocs:ucs-locator>
               <xocs:file-basename>fx40</xocs:file-basename>
               <xocs:filename>fx40.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3470</xocs:filesize>
               <xocs:pixel-height>348</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx56.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx56/THUMBNAIL/image/gif/aef4465a1e00c8e826e6a937dd75d212/fx56.sml</xocs:ucs-locator>
               <xocs:file-basename>fx56</xocs:file-basename>
               <xocs:filename>fx56.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1928</xocs:filesize>
               <xocs:pixel-height>156</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx48.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx48/THUMBNAIL/image/gif/31de33e79f05f9257e183831710d439c/fx48.sml</xocs:ucs-locator>
               <xocs:file-basename>fx48</xocs:file-basename>
               <xocs:filename>fx48.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2723</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>208</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx59.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx59/THUMBNAIL/image/gif/703e2014b4fa90448cc50c973524bf9a/fx59.sml</xocs:ucs-locator>
               <xocs:file-basename>fx59</xocs:file-basename>
               <xocs:filename>fx59.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1270</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>86</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx2/THUMBNAIL/image/gif/683ad3810f88f8cc8f3dde90537418aa/fx2.sml</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2651</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx51.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx51/THUMBNAIL/image/gif/aa7a409759700e1f1a9da54d05f863f6/fx51.sml</xocs:ucs-locator>
               <xocs:file-basename>fx51</xocs:file-basename>
               <xocs:filename>fx51.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2167</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>156</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx62.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx62/THUMBNAIL/image/gif/d2dcda574615e618014d33f7bb596657/fx62.sml</xocs:ucs-locator>
               <xocs:file-basename>fx62</xocs:file-basename>
               <xocs:filename>fx62.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2057</xocs:filesize>
               <xocs:pixel-height>161</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx36.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx36/THUMBNAIL/image/gif/962a48422fdfa24e95e4342e6c0f3787/fx36.sml</xocs:ucs-locator>
               <xocs:file-basename>fx36</xocs:file-basename>
               <xocs:filename>fx36.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2439</xocs:filesize>
               <xocs:pixel-height>293</xocs:pixel-height>
               <xocs:pixel-width>156</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx54.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx54/THUMBNAIL/image/gif/f236e1d6b066b31ea8041cb93eb6e6b6/fx54.sml</xocs:ucs-locator>
               <xocs:file-basename>fx54</xocs:file-basename>
               <xocs:filename>fx54.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1994</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx57.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx57/THUMBNAIL/image/gif/756a75313cf73b4bd347c13d5a00ff48/fx57.sml</xocs:ucs-locator>
               <xocs:file-basename>fx57</xocs:file-basename>
               <xocs:filename>fx57.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2521</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx9.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx9/THUMBNAIL/image/gif/94099f5fc67e08c5f10b94c6a1c2cd09/fx9.sml</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2699</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx35.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx35/THUMBNAIL/image/gif/9eb2429844c5c53186ea06d14c08a25c/fx35.sml</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1494</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr2/THUMBNAIL/image/gif/e913c7224a85f33bc63fee0202910503/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7981</xocs:filesize>
               <xocs:pixel-height>117</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx39.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx39/THUMBNAIL/image/gif/b725a1674681f43af5ca2b924cd58693/fx39.sml</xocs:ucs-locator>
               <xocs:file-basename>fx39</xocs:file-basename>
               <xocs:filename>fx39.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1538</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx58.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx58/THUMBNAIL/image/gif/df49931ab5dbb74af3b9c63bc0013bd6/fx58.sml</xocs:ucs-locator>
               <xocs:file-basename>fx58</xocs:file-basename>
               <xocs:filename>fx58.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1793</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx3/THUMBNAIL/image/gif/12f73704777a3901f0d91d01af078ea7/fx3.sml</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2797</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr1/THUMBNAIL/image/gif/6393d1145c39ecb7aed6bfa8ac8c9f16/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5434</xocs:filesize>
               <xocs:pixel-height>89</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx61.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx61/THUMBNAIL/image/gif/444b625f2eb860325196ac4508737a7c/fx61.sml</xocs:ucs-locator>
               <xocs:file-basename>fx61</xocs:file-basename>
               <xocs:filename>fx61.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2183</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>153</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx20.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx20/THUMBNAIL/image/gif/e6ea1d8c32d1662556e7e654c85b7b93/fx20.sml</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2677</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx26.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx26/THUMBNAIL/image/gif/13810607a36df205d924d12efd600066/fx26.sml</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2547</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx34.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx34/THUMBNAIL/image/gif/d4beaa596650480eaab045a18a8223da/fx34.sml</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2139</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>169</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx41.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx41/THUMBNAIL/image/gif/d4d0add3c574a697c36042004a6b8dfb/fx41.sml</xocs:ucs-locator>
               <xocs:file-basename>fx41</xocs:file-basename>
               <xocs:filename>fx41.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1535</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx46.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx46/THUMBNAIL/image/gif/0eca40ec170d5da0988b037d01ffd7ba/fx46.sml</xocs:ucs-locator>
               <xocs:file-basename>fx46</xocs:file-basename>
               <xocs:filename>fx46.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1798</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>214</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc2/THUMBNAIL/image/gif/a1a98047b5d308ce5053ce0327ce5a5c/sc2.sml</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5178</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>181</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx29.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx29/THUMBNAIL/image/gif/21b43acf8bd1c5bef0b9afbac7b2ac69/fx29.sml</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1547</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx8/THUMBNAIL/image/gif/a710b6800de41b0a2b95909de5afc2d6/fx8.sml</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2573</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx14.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx14/THUMBNAIL/image/gif/22200daf6aaf0238dc64f7d8af1c4cf0/fx14.sml</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3660</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx1/THUMBNAIL/image/gif/eaf81287cea45f984d9a8b64f3837825/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2573</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>205</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr3/THUMBNAIL/image/gif/0dee7dbe967489e7b116e59f413568a5/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8290</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>145</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx25.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx25/THUMBNAIL/image/gif/7d67859015ecf15d0b0a6b9ba1093dad/fx25.sml</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1674</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>140</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx18.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx18/THUMBNAIL/image/gif/2bc18d6bd628e7239b9a39349bbd9be2/fx18.sml</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3802</xocs:filesize>
               <xocs:pixel-height>241</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-ga1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/ga1/THUMBNAIL/image/gif/5f291b90215257d9976862bbb9cdfcda/ga1.sml</xocs:ucs-locator>
               <xocs:file-basename>ga1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>ga1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4182</xocs:filesize>
               <xocs:pixel-height>54</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx4/THUMBNAIL/image/gif/e1aa513f9dcd592a4dc18e548aa3ccaf/fx4.sml</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2532</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx13.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx13/THUMBNAIL/image/gif/897352a4e09179cea9cb788a0ec58f07/fx13.sml</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2328</xocs:filesize>
               <xocs:pixel-height>137</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx32.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx32/THUMBNAIL/image/gif/dd5446026d71c80d3ef7fd4c3a8b6247/fx32.sml</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2765</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>161</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx15.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx15/THUMBNAIL/image/gif/a012c9b335eb538644c9a3034ef8a2f1/fx15.sml</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2098</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>167</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx47.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx47/THUMBNAIL/image/gif/7d1a560b8b6f21278b499d53742bfbcd/fx47.sml</xocs:ucs-locator>
               <xocs:file-basename>fx47</xocs:file-basename>
               <xocs:filename>fx47.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1891</xocs:filesize>
               <xocs:pixel-height>153</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr4/THUMBNAIL/image/gif/d41b917425c5fb1914b9c3f8addb4a4d/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>4693</xocs:filesize>
               <xocs:pixel-height>65</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx24.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx24/THUMBNAIL/image/gif/2c077b4cad54d5b6ba579f6ccf5c219a/fx24.sml</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2717</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx17.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx17/THUMBNAIL/image/gif/39c259f3137446206bb6f2b27794bfc8/fx17.sml</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2291</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>138</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx37.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx37/THUMBNAIL/image/gif/5624fb2cbb57a9f71a08f6b5dd789c78/fx37.sml</xocs:ucs-locator>
               <xocs:file-basename>fx37</xocs:file-basename>
               <xocs:filename>fx37.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1493</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx43.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx43/THUMBNAIL/image/gif/be41c1b3136f91809e799358d642b57c/fx43.sml</xocs:ucs-locator>
               <xocs:file-basename>fx43</xocs:file-basename>
               <xocs:filename>fx43.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1528</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx38.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx38/THUMBNAIL/image/gif/3f69a2ffdcf22a9d1c2ad269e66cf695/fx38.sml</xocs:ucs-locator>
               <xocs:file-basename>fx38</xocs:file-basename>
               <xocs:filename>fx38.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3591</xocs:filesize>
               <xocs:pixel-height>241</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx31.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx31/THUMBNAIL/image/gif/7d4086bc2a5fe31f05f8cbac278d2f13/fx31.sml</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1513</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx64.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx64/THUMBNAIL/image/gif/2758647115168d49143b4fa48ff70319/fx64.sml</xocs:ucs-locator>
               <xocs:file-basename>fx64</xocs:file-basename>
               <xocs:filename>fx64.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1783</xocs:filesize>
               <xocs:pixel-height>53</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx49.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx49/THUMBNAIL/image/gif/39292d1d7d42c17b47718e96a6b1801e/fx49.sml</xocs:ucs-locator>
               <xocs:file-basename>fx49</xocs:file-basename>
               <xocs:filename>fx49.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2614</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx65.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx65/THUMBNAIL/image/gif/359f7f92f5cfa649442a880f7a488b94/fx65.sml</xocs:ucs-locator>
               <xocs:file-basename>fx65</xocs:file-basename>
               <xocs:filename>fx65.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2797</xocs:filesize>
               <xocs:pixel-height>135</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx53.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx53/THUMBNAIL/image/gif/505cbfceee5c2dc35367c86d58628b6d/fx53.sml</xocs:ucs-locator>
               <xocs:file-basename>fx53</xocs:file-basename>
               <xocs:filename>fx53.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2662</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx52.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx52/THUMBNAIL/image/gif/7400bcdefe62d8e21176d1eed149bcfa/fx52.sml</xocs:ucs-locator>
               <xocs:file-basename>fx52</xocs:file-basename>
               <xocs:filename>fx52.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2017</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx45.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx45/THUMBNAIL/image/gif/2ea44fd569c7c83f272805b10fdaed5c/fx45.sml</xocs:ucs-locator>
               <xocs:file-basename>fx45</xocs:file-basename>
               <xocs:filename>fx45.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1974</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx16.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx16/THUMBNAIL/image/gif/090eeda0e6ab0b059d1d39bb803af430/fx16.sml</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3809</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx30.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx30/THUMBNAIL/image/gif/93968083f149b65de923b20ba46f07e4/fx30.sml</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2610</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>177</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx27.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx27/THUMBNAIL/image/gif/89a11546629644b2d611568061dfb0f4/fx27.sml</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1484</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx21.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx21/THUMBNAIL/image/gif/f460ebc7e3957e10e91734c6f2b2235d/fx21.sml</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2680</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>208</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx12.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx12/THUMBNAIL/image/gif/322387c9d8d5b0490321e226d7d7b5ad/fx12.sml</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2736</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx10.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx10/THUMBNAIL/image/gif/cc0d861f5973834f857934dc181c32cc/fx10.sml</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2647</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx28.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx28/THUMBNAIL/image/gif/62cb270e97fcda9637d9f9899ebf4c89/fx28.sml</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2935</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>195</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx6/THUMBNAIL/image/gif/4889a8716007b4e5416e8abff070e3b9/fx6.sml</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>3755</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx11.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx11/THUMBNAIL/image/gif/8249007689ddedb8fc44b2d4f22c8054/fx11.sml</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2710</xocs:filesize>
               <xocs:pixel-height>153</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx42.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx42/THUMBNAIL/image/gif/ab79671534a968470bbe896aa35134cf/fx42.sml</xocs:ucs-locator>
               <xocs:file-basename>fx42</xocs:file-basename>
               <xocs:filename>fx42.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1686</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>108</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx22.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx22/THUMBNAIL/image/gif/e0434330f7a76879ac73fae8b0307ecd/fx22.sml</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2692</xocs:filesize>
               <xocs:pixel-height>144</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx60.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx60/THUMBNAIL/image/gif/0b0628dea16dd691efc770b701d8c979/fx60.sml</xocs:ucs-locator>
               <xocs:file-basename>fx60</xocs:file-basename>
               <xocs:filename>fx60.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1922</xocs:filesize>
               <xocs:pixel-height>158</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr5/THUMBNAIL/image/gif/fa88bc65c300e81c5f0a162b2c29b676/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7401</xocs:filesize>
               <xocs:pixel-height>132</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx7/THUMBNAIL/image/gif/3701f38ee8f6272551ba2c05a7f525cf/fx7.sml</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2692</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx44.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx44/THUMBNAIL/image/gif/d6c38e566c9e6558f5d69665ba616131/fx44.sml</xocs:ucs-locator>
               <xocs:file-basename>fx44</xocs:file-basename>
               <xocs:filename>fx44.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1524</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx55.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx55/THUMBNAIL/image/gif/5a18b4ad772aac581030248e24d1c6a4/fx55.sml</xocs:ucs-locator>
               <xocs:file-basename>fx55</xocs:file-basename>
               <xocs:filename>fx55.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2589</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>178</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx63.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx63/THUMBNAIL/image/gif/eceac0b93276e50194a0c60cb34bdb39/fx63.sml</xocs:ucs-locator>
               <xocs:file-basename>fx63</xocs:file-basename>
               <xocs:filename>fx63.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>2535</xocs:filesize>
               <xocs:pixel-height>114</xocs:pixel-height>
               <xocs:pixel-width>188</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx33.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx33/THUMBNAIL/image/gif/3f3d6367593c6321ec7570ff476e0aab/fx33.sml</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>1486</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>151</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx50_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx50/HIGHRES/image/jpeg/6987ff45c2faa8c1cc0a484aff2b64ae/fx50_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx50</xocs:file-basename>
               <xocs:filename>fx50_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9005</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>426</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx19_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx19/HIGHRES/image/jpeg/1db2457f7da96a4beb89c8d7177b8d40/fx19_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx19</xocs:file-basename>
               <xocs:filename>fx19_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8679</xocs:filesize>
               <xocs:pixel-height>307</xocs:pixel-height>
               <xocs:pixel-width>313</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc1/HIGHRES/image/jpeg/4e5db814c3b3f762b6b97c98edcdeb1c/sc1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>206994</xocs:filesize>
               <xocs:pixel-height>1282</xocs:pixel-height>
               <xocs:pixel-width>2666</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx5/HIGHRES/image/jpeg/6683fcddff50ecc65fbc6a60c604456e/fx5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx5</xocs:file-basename>
               <xocs:filename>fx5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11721</xocs:filesize>
               <xocs:pixel-height>317</xocs:pixel-height>
               <xocs:pixel-width>393</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx23_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx23/HIGHRES/image/jpeg/11c89d57affbc870877f0630e80b2171/fx23_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx23</xocs:file-basename>
               <xocs:filename>fx23_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7639</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx66_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx66/HIGHRES/image/jpeg/46383c0ffac15e39c861405a2c86d8fd/fx66_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx66</xocs:file-basename>
               <xocs:filename>fx66_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9020</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>426</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx40_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx40/HIGHRES/image/jpeg/2aa1309671b965be5103d9adfe2b4aad/fx40_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx40</xocs:file-basename>
               <xocs:filename>fx40_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6541</xocs:filesize>
               <xocs:pixel-height>348</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx56_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx56/HIGHRES/image/jpeg/4788808be8eb1d7784a71c5f76f77420/fx56_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx56</xocs:file-basename>
               <xocs:filename>fx56_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8900</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>432</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx48_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx48/HIGHRES/image/jpeg/db84f1e01f6865f660844cb304260ad1/fx48_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx48</xocs:file-basename>
               <xocs:filename>fx48_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>25570</xocs:filesize>
               <xocs:pixel-height>546</xocs:pixel-height>
               <xocs:pixel-width>694</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx59_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx59/HIGHRES/image/jpeg/df01b99de539d79386bef3f03d18652f/fx59_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx59</xocs:file-basename>
               <xocs:filename>fx59_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1835</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>86</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx2/HIGHRES/image/jpeg/fff6a89b2e359f558c59a2e6021e2781/fx2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10210</xocs:filesize>
               <xocs:pixel-height>256</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx51_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx51/HIGHRES/image/jpeg/2003ad480476723320ba9ea11af72e09/fx51_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx51</xocs:file-basename>
               <xocs:filename>fx51_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10700</xocs:filesize>
               <xocs:pixel-height>368</xocs:pixel-height>
               <xocs:pixel-width>350</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx62_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx62/HIGHRES/image/jpeg/ca3ade5e8b55d0f2fab364b272b54e02/fx62_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx62</xocs:file-basename>
               <xocs:filename>fx62_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8126</xocs:filesize>
               <xocs:pixel-height>289</xocs:pixel-height>
               <xocs:pixel-width>392</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx36_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx36/HIGHRES/image/jpeg/40a77eea413b58333af66e2fd766e5c8/fx36_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx36</xocs:file-basename>
               <xocs:filename>fx36_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4428</xocs:filesize>
               <xocs:pixel-height>293</xocs:pixel-height>
               <xocs:pixel-width>156</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx54_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx54/HIGHRES/image/jpeg/5a7c794d0e48f1646d3ed7a7e06636c7/fx54_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx54</xocs:file-basename>
               <xocs:filename>fx54_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8930</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>426</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx57_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx57/HIGHRES/image/jpeg/3e71e2a959e822b7078040795e199031/fx57_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx57</xocs:file-basename>
               <xocs:filename>fx57_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7826</xocs:filesize>
               <xocs:pixel-height>246</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx9_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx9/HIGHRES/image/jpeg/b4903865eb45dffdc57a5445698ab45d/fx9_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx9</xocs:file-basename>
               <xocs:filename>fx9_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11702</xocs:filesize>
               <xocs:pixel-height>317</xocs:pixel-height>
               <xocs:pixel-width>393</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx35_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx35/HIGHRES/image/jpeg/30356f75d95f22ae284e951aeb3f9897/fx35_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx35</xocs:file-basename>
               <xocs:filename>fx35_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7692</xocs:filesize>
               <xocs:pixel-height>350</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr2/HIGHRES/image/jpeg/5fd0147708b141d029400ec40b7da80c/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>586831</xocs:filesize>
               <xocs:pixel-height>1528</xocs:pixel-height>
               <xocs:pixel-width>2862</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx39_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx39/HIGHRES/image/jpeg/a0dc45006dac7a62d2db6b1e7c939883/fx39_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx39</xocs:file-basename>
               <xocs:filename>fx39_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7770</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx58_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx58/HIGHRES/image/jpeg/4178c8adf86c873d9cb1defe4036d7c5/fx58_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx58</xocs:file-basename>
               <xocs:filename>fx58_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9596</xocs:filesize>
               <xocs:pixel-height>343</xocs:pixel-height>
               <xocs:pixel-width>462</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx3/HIGHRES/image/jpeg/4dd7c33443341cc3df9b8832c6d39c47/fx3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx3</xocs:file-basename>
               <xocs:filename>fx3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11742</xocs:filesize>
               <xocs:pixel-height>317</xocs:pixel-height>
               <xocs:pixel-width>393</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr1/HIGHRES/image/jpeg/29009784729dff953594d5ddc42472bf/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>378073</xocs:filesize>
               <xocs:pixel-height>1158</xocs:pixel-height>
               <xocs:pixel-width>2862</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx61_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx61/HIGHRES/image/jpeg/6a8fe19c46e3c4b51eb20966065c486d/fx61_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx61</xocs:file-basename>
               <xocs:filename>fx61_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>3097</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>153</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx20_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx20/HIGHRES/image/jpeg/5dad825a71d2fed47bbb3c6149937795/fx20_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx20</xocs:file-basename>
               <xocs:filename>fx20_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11779</xocs:filesize>
               <xocs:pixel-height>316</xocs:pixel-height>
               <xocs:pixel-width>392</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx26_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx26/HIGHRES/image/jpeg/3a1830a3de9eec01b8c2487b7260abf6/fx26_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx26</xocs:file-basename>
               <xocs:filename>fx26_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7766</xocs:filesize>
               <xocs:pixel-height>246</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx34_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx34/HIGHRES/image/jpeg/46250623404f36fa04ca8428eb243002/fx34_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx34</xocs:file-basename>
               <xocs:filename>fx34_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>12739</xocs:filesize>
               <xocs:pixel-height>380</xocs:pixel-height>
               <xocs:pixel-width>393</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx41_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx41/HIGHRES/image/jpeg/be10b0e1c804fec559d577da2b712a0d/fx41_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx41</xocs:file-basename>
               <xocs:filename>fx41_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7794</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx46_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx46/HIGHRES/image/jpeg/01071e31a885945c7b29e64595663aa6/fx46_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx46</xocs:file-basename>
               <xocs:filename>fx46_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9690</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>459</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-sc2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/sc2/HIGHRES/image/jpeg/7bbcd669a91fc858a3d950628fd7a057/sc2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>374580</xocs:filesize>
               <xocs:pixel-height>2418</xocs:pixel-height>
               <xocs:pixel-width>2666</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx29_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx29/HIGHRES/image/jpeg/899a8b507dbefc27c5c7d21b347a3d83/fx29_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx29</xocs:file-basename>
               <xocs:filename>fx29_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7834</xocs:filesize>
               <xocs:pixel-height>350</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx8_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx8/HIGHRES/image/jpeg/fb17c3b7d936f60ef8398f8d22e73655/fx8_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx8</xocs:file-basename>
               <xocs:filename>fx8_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7752</xocs:filesize>
               <xocs:pixel-height>246</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx14_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx14/HIGHRES/image/jpeg/704668e9c415d83e59d5bef86c07c2d7/fx14_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx14</xocs:file-basename>
               <xocs:filename>fx14_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6757</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx1/HIGHRES/image/jpeg/b7d53c65bce5ee69ef95b75c886568e9/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>23461</xocs:filesize>
               <xocs:pixel-height>544</xocs:pixel-height>
               <xocs:pixel-width>680</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr3/HIGHRES/image/jpeg/40c23d3b9e2ec15bd1c26b79169e4cdd/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1065096</xocs:filesize>
               <xocs:pixel-height>3228</xocs:pixel-height>
               <xocs:pixel-width>2862</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx25_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx25/HIGHRES/image/jpeg/3575a192c94b14a06b780272119f3f86/fx25_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx25</xocs:file-basename>
               <xocs:filename>fx25_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6004</xocs:filesize>
               <xocs:pixel-height>289</xocs:pixel-height>
               <xocs:pixel-width>248</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx18_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx18/HIGHRES/image/jpeg/d7e320fa2a0896378c645419a9f58352/fx18_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx18</xocs:file-basename>
               <xocs:filename>fx18_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6736</xocs:filesize>
               <xocs:pixel-height>241</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-ga1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/ga1/HIGHRES/image/jpeg/fb5cb1364955a96037fe093a748293ea/ga1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>ga1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>ga1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>184216</xocs:filesize>
               <xocs:pixel-height>547</xocs:pixel-height>
               <xocs:pixel-width>2213</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx4/HIGHRES/image/jpeg/f29dc61a16109ec100715799745441c4/fx4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx4</xocs:file-basename>
               <xocs:filename>fx4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7760</xocs:filesize>
               <xocs:pixel-height>246</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx13_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx13/HIGHRES/image/jpeg/e9ece6879fe3174532f0ed1acd127f42/fx13_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx13</xocs:file-basename>
               <xocs:filename>fx13_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>12818</xocs:filesize>
               <xocs:pixel-height>309</xocs:pixel-height>
               <xocs:pixel-width>495</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx32_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx32/HIGHRES/image/jpeg/5825f9e79cf2897c7837b1bd63db9e44/fx32_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx32</xocs:file-basename>
               <xocs:filename>fx32_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8256</xocs:filesize>
               <xocs:pixel-height>244</xocs:pixel-height>
               <xocs:pixel-width>240</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx15_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx15/HIGHRES/image/jpeg/fd8ad2283cf5d6a9c77ab6459258c122/fx15_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx15</xocs:file-basename>
               <xocs:filename>fx15_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7812</xocs:filesize>
               <xocs:pixel-height>288</xocs:pixel-height>
               <xocs:pixel-width>293</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx47_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx47/HIGHRES/image/jpeg/3e84cd5362b3abea98818b6a94125d71/fx47_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx47</xocs:file-basename>
               <xocs:filename>fx47_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>9185</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>441</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr4/HIGHRES/image/jpeg/b1618d66f43ade6bf6cffd4607ad483e/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>181151</xocs:filesize>
               <xocs:pixel-height>758</xocs:pixel-height>
               <xocs:pixel-width>2568</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx24_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx24/HIGHRES/image/jpeg/a794c8ed2ed12f92ccecd9800e6be68f/fx24_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx24</xocs:file-basename>
               <xocs:filename>fx24_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10301</xocs:filesize>
               <xocs:pixel-height>256</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx17_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx17/HIGHRES/image/jpeg/0695be10ab41fcf9b989d509db91da71/fx17_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx17</xocs:file-basename>
               <xocs:filename>fx17_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8869</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>259</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx37_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx37/HIGHRES/image/jpeg/f128e6b0574db911e60e1d10aa0d21d9/fx37_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx37</xocs:file-basename>
               <xocs:filename>fx37_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7780</xocs:filesize>
               <xocs:pixel-height>350</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx43_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx43/HIGHRES/image/jpeg/cf718c742e4825ed513f059955604140/fx43_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx43</xocs:file-basename>
               <xocs:filename>fx43_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7734</xocs:filesize>
               <xocs:pixel-height>350</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx38_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx38/HIGHRES/image/jpeg/6197f53daffb6bd15667601e13ce70b6/fx38_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx38</xocs:file-basename>
               <xocs:filename>fx38_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6718</xocs:filesize>
               <xocs:pixel-height>241</xocs:pixel-height>
               <xocs:pixel-width>203</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx31_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx31/HIGHRES/image/jpeg/209c985ff675a8a17629e3acdec4d334/fx31_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx31</xocs:file-basename>
               <xocs:filename>fx31_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7746</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx64_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx64/HIGHRES/image/jpeg/0201e125756cc1e8d364e3cebbffd048/fx64_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx64</xocs:file-basename>
               <xocs:filename>fx64_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7112</xocs:filesize>
               <xocs:pixel-height>98</xocs:pixel-height>
               <xocs:pixel-width>405</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx49_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx49/HIGHRES/image/jpeg/bbb43936490bd39de11c4f40ccb8bc1b/fx49_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx49</xocs:file-basename>
               <xocs:filename>fx49_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7720</xocs:filesize>
               <xocs:pixel-height>245</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx65_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx65/HIGHRES/image/jpeg/83603a7b4bf6bde00129b092c13b65b8/fx65_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx65</xocs:file-basename>
               <xocs:filename>fx65_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4944</xocs:filesize>
               <xocs:pixel-height>135</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx53_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx53/HIGHRES/image/jpeg/65c345c09efb9b443de0965950c54719/fx53_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx53</xocs:file-basename>
               <xocs:filename>fx53_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7826</xocs:filesize>
               <xocs:pixel-height>245</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx52_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx52/HIGHRES/image/jpeg/23f2be7abe559d1eb6c14d4de2752d5d/fx52_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx52</xocs:file-basename>
               <xocs:filename>fx52_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8738</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>413</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx45_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx45/HIGHRES/image/jpeg/97c0e360f02f22bf9646398b44501a1b/fx45_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx45</xocs:file-basename>
               <xocs:filename>fx45_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8571</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>411</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx16_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx16/HIGHRES/image/jpeg/b2eb21a4759a4e5c9843c89bec96d05f/fx16_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx16</xocs:file-basename>
               <xocs:filename>fx16_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6813</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx30_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx30/HIGHRES/image/jpeg/a7346a2af7e8867bd46bba573edc3f53/fx30_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx30</xocs:file-basename>
               <xocs:filename>fx30_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7352</xocs:filesize>
               <xocs:pixel-height>245</xocs:pixel-height>
               <xocs:pixel-width>265</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx27_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx27/HIGHRES/image/jpeg/0f03aea888668acc1deac45a35472b73/fx27_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx27</xocs:file-basename>
               <xocs:filename>fx27_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7714</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx21_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx21/HIGHRES/image/jpeg/c184983d1b385491254accec75e190a7/fx21_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx21</xocs:file-basename>
               <xocs:filename>fx21_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>25101</xocs:filesize>
               <xocs:pixel-height>547</xocs:pixel-height>
               <xocs:pixel-width>696</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx12_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx12/HIGHRES/image/jpeg/d356e1c474bfc34222e40eac4245f4b3/fx12_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx12</xocs:file-basename>
               <xocs:filename>fx12_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10286</xocs:filesize>
               <xocs:pixel-height>256</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx10_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx10/HIGHRES/image/jpeg/509a3fa71a3e8129d78b0c44f45b092e/fx10_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx10</xocs:file-basename>
               <xocs:filename>fx10_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10195</xocs:filesize>
               <xocs:pixel-height>255</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx28_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx28/HIGHRES/image/jpeg/9e825a5bcc6debbaa52348c7dfada33a/fx28_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx28</xocs:file-basename>
               <xocs:filename>fx28_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8469</xocs:filesize>
               <xocs:pixel-height>244</xocs:pixel-height>
               <xocs:pixel-width>290</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx6/HIGHRES/image/jpeg/a3760deb4973906aef04788ad882e0e4/fx6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx6</xocs:file-basename>
               <xocs:filename>fx6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>6834</xocs:filesize>
               <xocs:pixel-height>242</xocs:pixel-height>
               <xocs:pixel-width>204</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx11_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx11/HIGHRES/image/jpeg/f2f57d732041449b7090512dbc1e3f44/fx11_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx11</xocs:file-basename>
               <xocs:filename>fx11_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>12080</xocs:filesize>
               <xocs:pixel-height>309</xocs:pixel-height>
               <xocs:pixel-width>441</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx42_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx42/HIGHRES/image/jpeg/0990bd0ee7b0a5c7fb9b3da16e7a43ae/fx42_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx42</xocs:file-basename>
               <xocs:filename>fx42_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7603</xocs:filesize>
               <xocs:pixel-height>338</xocs:pixel-height>
               <xocs:pixel-width>224</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx22_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx22/HIGHRES/image/jpeg/71e66020c75326305ff73d0dbb9b2eed/fx22_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx22</xocs:file-basename>
               <xocs:filename>fx22_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>10305</xocs:filesize>
               <xocs:pixel-height>255</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx60_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx60/HIGHRES/image/jpeg/ae777df2d9ba4889afa495b4d18c547c/fx60_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx60</xocs:file-basename>
               <xocs:filename>fx60_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>8985</xocs:filesize>
               <xocs:pixel-height>308</xocs:pixel-height>
               <xocs:pixel-width>426</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/gr5/HIGHRES/image/jpeg/5a5a6a2b53abcd339ef0bffda2317084/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>392662</xocs:filesize>
               <xocs:pixel-height>1670</xocs:pixel-height>
               <xocs:pixel-width>2764</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx7_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx7/HIGHRES/image/jpeg/e093500d9a30dc888137367fe372cee3/fx7_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx7</xocs:file-basename>
               <xocs:filename>fx7_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>11687</xocs:filesize>
               <xocs:pixel-height>317</xocs:pixel-height>
               <xocs:pixel-width>393</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx44_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx44/HIGHRES/image/jpeg/599ae8cfcb7fc9ddd29070adb42f74dd/fx44_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx44</xocs:file-basename>
               <xocs:filename>fx44_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7692</xocs:filesize>
               <xocs:pixel-height>350</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx55_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx55/HIGHRES/image/jpeg/efe69780a2e2fedbe9c7c7d460f84494/fx55_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx55</xocs:file-basename>
               <xocs:filename>fx55_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7738</xocs:filesize>
               <xocs:pixel-height>245</xocs:pixel-height>
               <xocs:pixel-width>266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx63_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx63/HIGHRES/image/jpeg/0a751d83789b758f7519cb5d2311a7da/fx63_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx63</xocs:file-basename>
               <xocs:filename>fx63_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>4913</xocs:filesize>
               <xocs:pixel-height>114</xocs:pixel-height>
               <xocs:pixel-width>188</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-fx33_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/fx33/HIGHRES/image/jpeg/c3a5d2555f8a7cd9877edb16d34b70d0/fx33_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx33</xocs:file-basename>
               <xocs:filename>fx33_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>7774</xocs:filesize>
               <xocs:pixel-height>351</xocs:pixel-height>
               <xocs:pixel-width>323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-mmc1.docx</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523421002439/mmc1/MAIN/application/vnd.openxmlformats-officedocument.wordprocessingml.document/a4900c089a78828ff445a46bb1dad471/mmc1.docx</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.docx</xocs:filename>
               <xocs:extension>docx</xocs:extension>
               <xocs:filesize>6519126</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523421002439-am.pdf</xocs:attachment-eid>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:filesize>1162505</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10N34WHKMSJ/MAIN/application/pdf/7106457f951b01e4e9687d484c5d2473/am.pdf</xocs:ucs-locator>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.6" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>113394</aid>
            <ce:article-number>113394</ce:article-number>
            <ce:pii>S0223-5234(21)00243-9</ce:pii>
            <ce:doi>10.1016/j.ejmech.2021.113394</ce:doi>
            <ce:copyright type="full-transfer" year="2021">Elsevier Masson SAS</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cap0010">
                  <ce:simple-para id="fspara0010" view="all">Structures of representative JAK2 inhibitors.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0020" role="short">Fig. 1</ce:alt-text>
               <ce:link locator="gr1" xlink:href="pii:S0223523421002439/gr1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0015" view="all">Design strategy for the target compounds.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0025" role="short">Fig. 2</ce:alt-text>
               <ce:link locator="gr2" xlink:href="pii:S0223523421002439/gr2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0020" view="all">Docking of compound <ce:bold>1a</ce:bold> with JAK2 (A: PDB code <ce:inter-ref id="intref0015" xlink:href="pdb:2XA4" xlink:type="simple">2XA4</ce:inter-ref>). Docking of compound <ce:bold>5k</ce:bold> and <ce:bold>6k</ce:bold> with JAK2 (B: PDB code <ce:inter-ref id="intref0020" xlink:href="pdb:2XA4" xlink:type="simple">2XA4</ce:inter-ref>). Docking of compound <ce:bold>6k</ce:bold> with JAK1 (C: PDB code <ce:inter-ref id="intref0025" xlink:href="pdb:4IVB" xlink:type="simple">4IVB</ce:inter-ref>). Docking of compound <ce:bold>5d</ce:bold> and <ce:bold>5h</ce:bold> with JAK2 (D: PDB code <ce:inter-ref id="intref0030" xlink:href="pdb:2XA4" xlink:type="simple">2XA4</ce:inter-ref>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0030" role="short">Fig. 3</ce:alt-text>
               <ce:link locator="gr3" xlink:href="pii:S0223523421002439/gr3" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig. 4</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0025" view="all">Western blot analysis of the effects of <ce:bold>Baricitinib</ce:bold> and compound <ce:bold>6k</ce:bold> on the phosphorylation of STAT5 in TF1 cells.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0035" role="short">Fig. 4</ce:alt-text>
               <ce:link locator="gr4" xlink:href="pii:S0223523421002439/gr4" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig. 5</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0030" view="all">Design and results of an GM-CSF induced pSTAT3 and pSTAT5 PD study of compound <ce:bold>6k</ce:bold> in the mouse; Measured 30 min after dosing of GM-CSF; Four animals were used in each of the control and dosing arms.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0040" role="short">Fig. 5</ce:alt-text>
               <ce:link locator="gr5" xlink:href="pii:S0223523421002439/gr5" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="sch1">
               <ce:label>Scheme 1</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0035" view="all">Synthesis of JAK2 inhibitors. Reagents and conditions: (a) 2-Diethoxyphosphorylacetonitrile, NaH, 0 °C, THF; (b) 4-Nitropyrazole, DBU, 20 °C, MeCN; (c) H<ce:inf loc="post">2</ce:inf>, Pd/C 20 °C, MeOH; (d) Benzenesulfonyl chloride, TEA, 0 °C, DCM; (e) Tetramethylammonium nitrate, trifluoroacetic anhydride, 20 °C, DCM; (f) K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, reflux, THF; (g) H<ce:inf loc="post">2</ce:inf>, Pd/C 20 °C, MeOH; (h) aldehyde, Na<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">5</ce:inf>, 90 °C, DMF or (EtO)<ce:inf loc="post">3</ce:inf>CH, p-TsOH (cat.), reflux, PhMe; (i) CF<ce:inf loc="post">3</ce:inf>COOH, 30 °C, DCM; (j) Corresponding sulfonyl chloride, K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, reflux, THF; (k) NaOH solution, 20 °C, THF/MeOH. Bs = Benzenesulfonyl.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0045" role="short">Scheme 1</ce:alt-text>
               <ce:link locator="sc1" xlink:href="pii:S0223523421002439/sc1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:figure id="sch2">
               <ce:label>Scheme 2</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0040" view="all">Synthesis of JAK2 inhibitors. Reagents and conditions: (a) H<ce:inf loc="post">2</ce:inf>, Pd/C 20 °C, MeOH; (b) K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, reflux, THF; (c) H<ce:inf loc="post">2</ce:inf>, Pd/C 20 °C, MeOH; (d) aldehyde, Na<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">5</ce:inf>, 90 °C, DMF or (EtO)<ce:inf loc="post">3</ce:inf>CH, <ce:italic>p</ce:italic>-TsOH (cat.), reflux, PhMe; (e) Corresponding Bromide, K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, 80 °C, DMF; (f) NaOH solution, 20 °C, THF/MeOH; (g) 1-Boc-3-Iodoazetidine, K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, 90 °C, DMF; (h) 2-Bromoethylamine Hydrobromide, NaH, 25 °C, DMF; (i) Corresponding sulfonyl chloride, K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, reflux, THF; (j) NaOH solution, 20 °C, THF/MeOH; (k) CF<ce:inf loc="post">3</ce:inf>COOH, 30 °C, DCM; (l) Trifluoromethanesulfonyl chloride, DIPEA, 20 °C, THF; (m) NaOH solution, 20 °C, THF/MeOH. Bs = Benzenesulfonyl.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0050" role="short">Scheme 2</ce:alt-text>
               <ce:link locator="sc2" xlink:href="pii:S0223523421002439/sc2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl1" rowsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="tspara0010" view="all">Structures and in vitro biological activities of compounds <ce:bold>1a-1e</ce:bold>, <ce:bold>2a-3a</ce:bold>, <ce:bold>2c-4c</ce:bold>.<ce:sup loc="post">a</ce:sup>..</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0055" role="short">Table 1</ce:alt-text>
               <ce:link locator="fx1" xlink:href="pii:S0223523421002439/fx1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
               <tgroup cols="5">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compd</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">1</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK1 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx2" xlink:href="pii:S0223523421002439/fx2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0060" role="short">Image 2</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx3" xlink:href="pii:S0223523421002439/fx3" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0065" role="short">Image 3</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">19 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>400 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx4" xlink:href="pii:S0223523421002439/fx4" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0070" role="short">Image 4</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx5" xlink:href="pii:S0223523421002439/fx5" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0075" role="short">Image 5</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">27 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">246 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx6" xlink:href="pii:S0223523421002439/fx6" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0080" role="short">Image 6</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx7" xlink:href="pii:S0223523421002439/fx7" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0085" role="short">Image 7</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">19 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx8" xlink:href="pii:S0223523421002439/fx8" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0090" role="short">Image 8</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx9" xlink:href="pii:S0223523421002439/fx9" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0095" role="short">Image 9</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">37 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>400 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx10" xlink:href="pii:S0223523421002439/fx10" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0100" role="short">Image 10</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx11" xlink:href="pii:S0223523421002439/fx11" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0105" role="short">Image 11</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">34 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>3a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx12" xlink:href="pii:S0223523421002439/fx12" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0110" role="short">Image 12</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx13" xlink:href="pii:S0223523421002439/fx13" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0115" role="short">Image 13</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">30 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>2c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx14" xlink:href="pii:S0223523421002439/fx14" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0120" role="short">Image 14</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx15" xlink:href="pii:S0223523421002439/fx15" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0125" role="short">Image 15</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">25.1%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">24.1%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>3c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx16" xlink:href="pii:S0223523421002439/fx16" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0130" role="short">Image 16</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx17" xlink:href="pii:S0223523421002439/fx17" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0135" role="short">Image 17</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.3%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>4c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx18" xlink:href="pii:S0223523421002439/fx18" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0140" role="short">Image 18</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx19" xlink:href="pii:S0223523421002439/fx19" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0145" role="short">Image 19</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.2%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx20" xlink:href="pii:S0223523421002439/fx20" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0150" role="short">Image 20</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">65.8%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="tspara0015" view="all">
                     <ce:sup loc="post">a</ce:sup> IC<ce:inf loc="post">50</ce:inf> values or inhibition rates % are a mean of two individual determinations.</ce:simple-para>
                  <ce:simple-para id="tspara0020" view="all">
                     <ce:sup loc="post">b</ce:sup> n.d. = value not determined.</ce:simple-para>
               </ce:legend>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl2" rowsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="cap0050">
                  <ce:simple-para id="tspara0025" view="all">Structures and in vitro biological activities of compounds <ce:bold>5a-5k</ce:bold>, <ce:bold>6a</ce:bold>, <ce:bold>6k-8k</ce:bold>.<ce:sup loc="post">a</ce:sup>..</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0155" role="short">Table 2</ce:alt-text>
               <ce:link locator="fx21" xlink:href="pii:S0223523421002439/fx21" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
               <tgroup cols="5">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compd</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">1</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK1 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx22" xlink:href="pii:S0223523421002439/fx22" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0160" role="short">Image 22</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx23" xlink:href="pii:S0223523421002439/fx23" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0165" role="short">Image 23</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">43 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>400 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx24" xlink:href="pii:S0223523421002439/fx24" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0170" role="short">Image 24</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx25" xlink:href="pii:S0223523421002439/fx25" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0175" role="short">Image 25</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">267 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx26" xlink:href="pii:S0223523421002439/fx26" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0180" role="short">Image 26</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx27" xlink:href="pii:S0223523421002439/fx27" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0185" role="short">Image 27</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">26 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>400 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx28" xlink:href="pii:S0223523421002439/fx28" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0190" role="short">Image 28</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx29" xlink:href="pii:S0223523421002439/fx29" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0195" role="short">Image 29</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">26 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx30" xlink:href="pii:S0223523421002439/fx30" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0200" role="short">Image 30</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx31" xlink:href="pii:S0223523421002439/fx31" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0205" role="short">Image 31</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">28 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.6%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx32" xlink:href="pii:S0223523421002439/fx32" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0210" role="short">Image 32</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx33" xlink:href="pii:S0223523421002439/fx33" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0215" role="short">Image 33</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">151 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5f</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx34" xlink:href="pii:S0223523421002439/fx34" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0220" role="short">Image 34</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx35" xlink:href="pii:S0223523421002439/fx35" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0225" role="short">Image 35</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">61 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5g</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx36" xlink:href="pii:S0223523421002439/fx36" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0230" role="short">Image 36</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx37" xlink:href="pii:S0223523421002439/fx37" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0235" role="short">Image 37</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">65 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx38" xlink:href="pii:S0223523421002439/fx38" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0240" role="short">Image 38</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx39" xlink:href="pii:S0223523421002439/fx39" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0245" role="short">Image 39</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">17 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">254 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5i</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx40" xlink:href="pii:S0223523421002439/fx40" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0250" role="short">Image 40</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx41" xlink:href="pii:S0223523421002439/fx41" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0255" role="short">Image 41</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">39.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5j</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx42" xlink:href="pii:S0223523421002439/fx42" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0260" role="short">Image 42</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx43" xlink:href="pii:S0223523421002439/fx43" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0265" role="short">Image 43</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">36.6%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx44" xlink:href="pii:S0223523421002439/fx44" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0270" role="short">Image 44</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">15 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">94 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx45" xlink:href="pii:S0223523421002439/fx45" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0275" role="short">Image 45</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">185 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx46" xlink:href="pii:S0223523421002439/fx46" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0280" role="short">Image 46</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">45.9%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx47" xlink:href="pii:S0223523421002439/fx47" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0285" role="short">Image 47</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">53 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">154 nM</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="tspara0030" view="all">
                     <ce:sup loc="post">a</ce:sup> IC<ce:inf loc="post">50</ce:inf> values or inhibition rates % are a mean of two individual determinations.</ce:simple-para>
                  <ce:simple-para id="tspara0035" view="all">
                     <ce:sup loc="post">b</ce:sup> n.d. = value not determined.</ce:simple-para>
               </ce:legend>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl3" rowsep="0">
               <ce:label>Table 3</ce:label>
               <ce:caption id="cap0055">
                  <ce:simple-para id="tspara0040" view="all">Structures and in vitro biological activities of compounds <ce:bold>6b-7b</ce:bold>, <ce:bold>6d-8d</ce:bold>, <ce:bold>9a-9d</ce:bold>.<ce:sup loc="post">a</ce:sup>..</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0290" role="short">Table 3</ce:alt-text>
               <ce:link locator="fx48" xlink:href="pii:S0223523421002439/fx48" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
               <tgroup cols="5">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compd</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">1</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK1 IC<inf loc="post">50</inf> or (Inhibition%/30 nM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx49" xlink:href="pii:S0223523421002439/fx49" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0295" role="short">Image 49</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx50" xlink:href="pii:S0223523421002439/fx50" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0300" role="short">Image 50</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">14 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12.6%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx51" xlink:href="pii:S0223523421002439/fx51" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0305" role="short">Image 51</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx52" xlink:href="pii:S0223523421002439/fx52" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0310" role="short">Image 52</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">29.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx53" xlink:href="pii:S0223523421002439/fx53" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0315" role="short">Image 53</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx54" xlink:href="pii:S0223523421002439/fx54" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0320" role="short">Image 54</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">251 nM</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx55" xlink:href="pii:S0223523421002439/fx55" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0325" role="short">Image 55</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx56" xlink:href="pii:S0223523421002439/fx56" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0330" role="short">Image 56</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">21.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx57" xlink:href="pii:S0223523421002439/fx57" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0335" role="short">Image 57</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx58" xlink:href="pii:S0223523421002439/fx58" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0340" role="short">Image 58</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">37.8%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx59" xlink:href="pii:S0223523421002439/fx59" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0345" role="short">Image 59</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx60" xlink:href="pii:S0223523421002439/fx60" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0350" role="short">Image 60</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">51.4%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx61" xlink:href="pii:S0223523421002439/fx61" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0355" role="short">Image 61</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx62" xlink:href="pii:S0223523421002439/fx62" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0360" role="short">Image 62</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">61.8%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx63" xlink:href="pii:S0223523421002439/fx63" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0365" role="short">Image 63</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx64" xlink:href="pii:S0223523421002439/fx64" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0370" role="short">Image 64</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">18 nM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">15.2%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx65" xlink:href="pii:S0223523421002439/fx65" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0375" role="short">Image 65</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <inline-figure baseline="0.0">
                              <link locator="fx66" xlink:href="pii:S0223523421002439/fx66" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></link>
                              <alt-text id="alttext0380" role="short">Image 66</alt-text>
                           </inline-figure>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">22.3%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="tspara0045" view="all">
                     <ce:sup loc="post">a</ce:sup> IC<ce:inf loc="post">50</ce:inf> values or inhibition rates % are a mean of two individual determinations.</ce:simple-para>
                  <ce:simple-para id="tspara0050" view="all">
                     <ce:sup loc="post">b</ce:sup> n.d. = value not determined.</ce:simple-para>
               </ce:legend>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl4" rowsep="0">
               <ce:label>Table 4</ce:label>
               <ce:caption id="cap0060">
                  <ce:simple-para id="tspara0055" view="all">Physicochemical properties and metabolic stability of preferred compounds.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0385" role="short">Table 4</ce:alt-text>
               <tgroup cols="7">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <colspec colname="col6" colnum="6"/></colspec>
                  <colspec colname="col7" colnum="7"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compd</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">log D<inf loc="post">
                              <italic>7.2</italic>
                           </inf>
                           <cross-ref id="crosref0325" refid="tbl4fna">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">tPSA<cross-ref id="crosref0330" refid="tbl4fnb">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Aqueous solubility (ug/mL)<cross-ref id="crosref0335" refid="tbl4fnc">
                              <sup loc="post">c</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CL (mL/min/kg)<cross-ref id="crosref0340" refid="tbl4fnd">
                              <sup loc="post">d</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">T<inf loc="post">1/2</inf> (min)<cross-ref id="crosref0345" refid="tbl4fnd">
                              <sup loc="post">d</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Stability (%) (2h)<cross-ref id="crosref0350" refid="tbl4fnd">
                              <sup loc="post">d</sup>
                           </cross-ref>
                        </entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.95</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">146.22</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.<cross-ref id="crosref0355" refid="tbl4fne">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.95</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">116.76</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.98</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">45</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">27.72</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.43</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.98</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">79.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">23.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">29.34</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">42.52</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">13.02</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">79.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">194.36</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.88</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">433.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">80.83</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">88.61</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">34.29</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">40.5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">30.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.85</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.42</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">79.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.31</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">69.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">18.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.94</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.63</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">79.38</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">77.03</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">25.74</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">48.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">17.99</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Baricitinib</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.24</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">113.52</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">16.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">96.12</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl4fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0010" view="all">Measured log of distribution coefficient between octanol and aqueous pH 7.2 buffer.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl4fnb">
                  <ce:label>b</ce:label>
                  <ce:note-para id="ntpara0015" view="all">Topological polar surface area predicted by Chemdraw 12.0.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl4fnc">
                  <ce:label>c</ce:label>
                  <ce:note-para id="ntpara0020" view="all">Solubility of solid powder in aqueous buffer determined by HPLC.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl4fnd">
                  <ce:label>d</ce:label>
                  <ce:note-para id="ntpara0025" view="all">In vitro stability in cryopreserved rat liver microsome.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl4fne">
                  <ce:label>e</ce:label>
                  <ce:note-para id="ntpara0030" view="all">n. d. = value not determined.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl5" rowsep="0">
               <ce:label>Table 5</ce:label>
               <ce:caption id="cap0065">
                  <ce:simple-para id="tspara0060" view="all">In vitro profiles of preferred compounds.<ce:sup loc="post">a</ce:sup>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0390" role="short">Table 5</ce:alt-text>
               <tgroup cols="7">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <colspec colname="col6" colnum="6"/></colspec>
                  <colspec colname="col7" colnum="7"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" role="rowgroup">Compd</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col5" namest="col2" role="colgroup">Enzymes IC<inf loc="post">50</inf> (nM) or (Inhibition%/30 nM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col7" namest="col6" role="colgroup">Cytokine signaling IC<inf loc="post">50</inf> (μM) in THP-1 or TF1 cells</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">TYK2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">IL-4 JAK1/JAK3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">GM-CSF JAK2/JAK2</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>400</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.<sup loc="post">b</sup>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>1c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.696</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>5h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">254</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">17</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">160</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.306</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">185</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.269</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12.6%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.56</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.397</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>6d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">251</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">280</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">>300</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.43</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.321</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>9c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">15.2%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">18</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">n.d.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.494</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Baricitinib</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">787</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">61</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.562</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.470</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="tspara0065" view="all">
                     <ce:sup loc="post">a</ce:sup> IC<ce:inf loc="post">50</ce:inf> values or inhibition rates % are a mean of two individual determinations.</ce:simple-para>
                  <ce:simple-para id="tspara0070" view="all">
                     <ce:sup loc="post">b</ce:sup> n.d. = value not determined.</ce:simple-para>
               </ce:legend>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" colsep="0" frame="topbot" id="tbl6" rowsep="0">
               <ce:label>Table 6</ce:label>
               <ce:caption id="cap0070">
                  <ce:simple-para id="tspara0075" view="all">Rat pharmacokinetic profile of compound 6k and baricitinib.<ce:cross-ref id="crosref0360" refid="tbl6fna">
                        <ce:sup loc="post">a</ce:sup>
                     </ce:cross-ref>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text id="alttext0395" role="short">Table 6</ce:alt-text>
               <tgroup cols="6">
                  <colspec colname="col1" colnum="1"/></colspec>
                  <colspec colname="col2" colnum="2"/></colspec>
                  <colspec colname="col3" colnum="3"/></colspec>
                  <colspec colname="col4" colnum="4"/></colspec>
                  <colspec colname="col5" colnum="5"/></colspec>
                  <colspec colname="col6" colnum="6"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2" role="rowgroup"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col4" namest="col2" role="colgroup">Compound 6k</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col6" namest="col5" role="colgroup">Baricitinib</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col6" namest="col2" role="colgroup">dose (mg/kg)</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5 (IV)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">20 (PO)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" nameend="col5" namest="col4" role="colgroup">1 (IV)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5 (PO)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>T</italic>
                           <inf loc="post">max</inf> (h)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.42</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.00</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>C</italic>
                           <inf loc="post">max</inf> (μg/L)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">885.62</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">659.15</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>AUC</italic> (μg<inf loc="post">∗</inf>h/L)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1004.64</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1507.67</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">1586.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3608.48</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">CL (L/h/kg)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">14.61</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">0.63</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.39</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>V</italic>
                           <inf loc="post">ss</inf> (L/kg)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">38.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">1.80</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.88</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>T</italic>
                           <inf loc="post">1/2</inf> (h)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.90</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">1.96</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.43</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>MRT</italic> (h)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">0.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">1.34</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.36</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" role="rowhead">
                           <italic>F</italic> (%)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">37.52</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left" nameend="col5" namest="col4" role="colgroup">/</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">45.48</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl6fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0035" view="all">IV vehicle: 70/20/10 Normal Saline/PEG400/DMSO. PO vehicle: 70/20/10 Normal Saline/PEG400/DMSO; Three animals were used in each of the control and dosing arms.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
         </ce:floats>
         <head>
            <ce:title id="title0010">Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" author-id="S0223523421002439-1334468d133ea9f048a3b7c8de81ea10">
                  <ce:given-name>Pengfei</ce:given-name>
                  <ce:surname>Xu</ce:surname>
                  <ce:cross-ref id="crosref0010" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au2" author-id="S0223523421002439-73bbf5c5e0df57fe9606bfbcd4e0523c">
                  <ce:given-name>Pei</ce:given-name>
                  <ce:surname>Shen</ce:surname>
                  <ce:cross-ref id="crosref0015" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au3" author-id="S0223523421002439-f1aad03d0ffbe143a00501e3785ae41b">
                  <ce:given-name>Hai</ce:given-name>
                  <ce:surname>Wang</ce:surname>
                  <ce:cross-ref id="crosref0020" refid="aff4">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au4" author-id="S0223523421002439-f74eab80e63269aae7bcd8664a51c794">
                  <ce:given-name>Lian</ce:given-name>
                  <ce:surname>Qin</ce:surname>
                  <ce:cross-ref id="crosref0025" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au5" author-id="S0223523421002439-98cd6ef271f46d20605ed850fb9740c4">
                  <ce:given-name>Jie</ce:given-name>
                  <ce:surname>Ren</ce:surname>
                  <ce:cross-ref id="crosref0030" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au6" author-id="S0223523421002439-023c1328e207f25b2540efb19ed6857c">
                  <ce:given-name>Qiushuang</ce:given-name>
                  <ce:surname>Sun</ce:surname>
                  <ce:cross-ref id="crosref0035" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au7" author-id="S0223523421002439-66949ec4a2ef5f3418dd9cc1ad1489fb">
                  <ce:given-name>Raoling</ce:given-name>
                  <ce:surname>Ge</ce:surname>
                  <ce:cross-ref id="crosref0040" refid="aff3">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au8" author-id="S0223523421002439-98c85e40316dc74abd31c358b6257d98">
                  <ce:given-name>Jinlei</ce:given-name>
                  <ce:surname>Bian</ce:surname>
                  <ce:cross-ref id="crosref0045" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0050" refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au9" author-id="S0223523421002439-604c3b17d393575106ec71ec368b625c">
                  <ce:given-name>Yi</ce:given-name>
                  <ce:surname>Zhong</ce:surname>
                  <ce:cross-ref id="crosref0055" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0060" refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au10" author-id="S0223523421002439-4ab2a82e356c267d1143c7cc4b0d3d75">
                  <ce:given-name>Zhiyu</ce:given-name>
                  <ce:surname>Li</ce:surname>
                  <ce:cross-ref id="crosref0065" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0070" refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0075" refid="cor1">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au11" author-id="S0223523421002439-07c1d891bc34ee21f0fd2e73da68fe47">
                  <ce:given-name>JuBo</ce:given-name>
                  <ce:surname>Wang</ce:surname>
                  <ce:cross-ref id="crosref0080" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0085" refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0090" refid="cor3">
                     <ce:sup loc="post">∗∗∗</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au12" author-id="S0223523421002439-e9b4fa0d700cd5a185fb0195ca4467ee">
                  <ce:given-name>Zhixia</ce:given-name>
                  <ce:surname>Qiu</ce:surname>
                  <ce:cross-ref id="crosref0095" refid="aff1">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0100" refid="aff2">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref id="crosref0105" refid="cor2">
                     <ce:sup loc="post">∗∗</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:affiliation id="aff1" affiliation-id="S0223523421002439-c3fd7adf63bd0d71e2b8235a554fa4bf">
                  <ce:label>a</ce:label>
                  <ce:textfn>Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Medicinal Chemistry</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tongjiaxiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>PR China</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="srct0010">Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="aff2" affiliation-id="S0223523421002439-b88dc79baea99642b6ddb6e44422d5a9">
                  <ce:label>b</ce:label>
                  <ce:textfn>Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Jiangsu Key Laboratory of Drug Design and Optimization</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>21009</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="srct0015">Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="aff3" affiliation-id="S0223523421002439-973bf6c6afc738b15beb585f78435417">
                  <ce:label>c</ce:label>
                  <ce:textfn>Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, 650000, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Institute of Medical Biology</sa:organization>
                     <sa:organization>Chinese Academy of Medical Sciences</sa:organization>
                     <sa:city>Kunming</sa:city>
                     <sa:postal-code>650000</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="srct0020">Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, 650000, China</ce:source-text>
               </ce:affiliation>
               <ce:affiliation id="aff4" affiliation-id="S0223523421002439-ebc6d8645ea616f2037c82f71748c8f5">
                  <ce:label>d</ce:label>
                  <ce:textfn>Changzhou Siyao Pharmaceutical Co. Ltd. No.567, Zhongwu Avenue, Changzhou, Jiangsu, 213018, China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Changzhou Siyao Pharmaceutical Co. Ltd. No.567</sa:organization>
                     <sa:address-line>Zhongwu Avenue</sa:address-line>
                     <sa:city>Changzhou</sa:city>
                     <sa:state>Jiangsu</sa:state>
                     <sa:postal-code>213018</sa:postal-code>
                     <sa:country>China</sa:country>
                  </sa:affiliation>
                  <ce:source-text id="srct0025">Changzhou Siyao Pharmaceutical Co. Ltd. No.567, Zhongwu Avenue, Changzhou, Jiangsu, 213018, China</ce:source-text>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author. Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Medicinal Chemistry</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tongjiaxiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>PR China</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
               <ce:correspondence id="cor2">
                  <ce:label>∗∗</ce:label>
                  <ce:text>Corresponding author. Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Medicinal Chemistry</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tongjiaxiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>PR China</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
               <ce:correspondence id="cor3">
                  <ce:label>∗∗∗</ce:label>
                  <ce:text>Corresponding author. Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Department of Medicinal Chemistry</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tongjiaxiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>PR China</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="26" month="1" year="2021"/></ce:date-received>
            <ce:date-revised day="15" month="3" year="2021"/></ce:date-revised>
            <ce:date-accepted day="15" month="3" year="2021"/></ce:date-accepted>
            <ce:abstract id="abs0010" xml:lang="en" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">Herein, we describe the design, synthesis, and structure−activity relationships of a series of imidazopyrrolopyridines derivatives that selectively inhibit Janus kinase 2 (JAK2). These screening cascades revealed that <ce:bold>6k</ce:bold> was a preferred compound, with IC<ce:inf loc="post">50</ce:inf> values of 10 nM for JAK2. Moreover, <ce:bold>6k</ce:bold> was a selective JAK2 inhibitor with 19-fold, >30-fold and >30-fold selectivity over JAK1, JAK3 and TYK2 respectively. In cytokine-stimulated cell-based assays, <ce:bold>6k</ce:bold> exhibited a higher JAK2 selectivity over JAK1 isoforms. Indeed, at a dose of 20 mg/kg compound <ce:bold>6k</ce:bold>, pSTAT3 and pSTAT5 expression was reduced to levels comparable to those of control animals untreated with GM-CSF. Additionally, <ce:bold>6k</ce:bold> showed a relatively good bioavailability (F = 38%), a suitable half-life time (T<ce:inf loc="post">1/2</ce:inf> = 1.9 h), a satisfactory metabolic stability, suggesting that <ce:bold>6k</ce:bold> might be a promising inhibitor of JAK2 for further development research for the treatment of MPNs.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:alt-text id="alttext0010" role="short">Image 1</ce:alt-text>
                           <ce:link locator="ga1" xlink:href="pii:S0223523421002439/ga1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords id="kwrds0010" xml:lang="en" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>Kinase</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Janus kinase 2 (JAK2)</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>Imidazopyrrolopyridine</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0025">
                  <ce:text>Myeloproliferative neoplasms</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0030">
                  <ce:text>Selectivity</ce:text>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords class="abr" id="kwrds0015" xml:lang="en" view="all">
               <ce:section-title id="sectitle0030">Abbreviations</ce:section-title>
               <ce:keyword id="kwrd0035">
                  <ce:text>JAKs</ce:text>
                  <ce:keyword id="kwrd0040">
                     <ce:text>Janus kinases</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0045">
                  <ce:text>JAK2</ce:text>
                  <ce:keyword id="kwrd0050">
                     <ce:text>Janus kinase 2</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0055">
                  <ce:text>JAK1</ce:text>
                  <ce:keyword id="kwrd0060">
                     <ce:text>Janus kinase 1</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0065">
                  <ce:text>SARs</ce:text>
                  <ce:keyword id="kwrd0070">
                     <ce:text>structure activity relationships</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0075">
                  <ce:text>MDS</ce:text>
                  <ce:keyword id="kwrd0080">
                     <ce:text>Myelodysplastic Syndrome</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0085">
                  <ce:text>MM</ce:text>
                  <ce:keyword id="kwrd0090">
                     <ce:text>Multiple Myeloma</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0095">
                  <ce:text>JAK-STAT</ce:text>
                  <ce:keyword id="kwrd0100">
                     <ce:text>JAK-Signal Transducer and Activator of Transcription</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0105">
                  <ce:text>FLT3</ce:text>
                  <ce:keyword id="kwrd0110">
                     <ce:text>Fms-like tyrosine kinase 3</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0115">
                  <ce:text>MF</ce:text>
                  <ce:keyword id="kwrd0120">
                     <ce:text>myelofibrosis</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0125">
                  <ce:text>MPNs</ce:text>
                  <ce:keyword id="kwrd0130">
                     <ce:text>myeloproliferative neoplasms</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0135">
                  <ce:text>DMF <ce:italic>N</ce:italic>
                  </ce:text>
                  <ce:keyword id="kwrd0140">
                     <ce:text>
                        <ce:italic>N</ce:italic>-Dimethylformamide</ce:text>
                  </ce:keyword>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0035">Introduction</ce:section-title>
                  <ce:para id="p0030" view="all">Hematologic malignancies which mainly include Leukemia, Lymphoma, Myelodysplastic Syndrome (MDS), and Multiple Myeloma (MM) are a group of diseases caused by disorders of the hematopoietic system [<ce:cross-ref id="crosref0110" refid="bib1">1</ce:cross-ref>]. MDS are a group of heterogeneous myeloid clonal diseases that originate from hematopoietic stem cells. They are characterized by abnormal differentiation and development of myeloid cells, manifested as ineffective hematopoiesis, refractory blood cell reduction, and hematopoietic functional failure [<ce:cross-ref id="crosref0115" refid="bib2">2</ce:cross-ref>]. Scientists have conducted an in-depth research of the pathogenesis of hematologic malignancies and thus found that certain genetic mutations including mutations in the JAK2 gene lead to signal transduction disorders in different tissues and cells which may resulted in the causing of these diseases [<ce:cross-ref id="crosref0120" refid="bib3">3</ce:cross-ref>,<ce:cross-ref id="crosref0125" refid="bib4">4</ce:cross-ref>]. Therefore, a variety of kinase inhibitors targeted JAK2 have been developed such as <ce:bold>Ruxolitinib</ce:bold>, <ce:bold>Fedratinib</ce:bold>, <ce:bold>Pacritinib</ce:bold>, and <ce:bold>BMS-911543</ce:bold> based on the pathogenesis of such diseases [<ce:cross-ref id="crosref0130" refid="bib5">5</ce:cross-ref>,<ce:cross-ref id="crosref0135" refid="bib6">6</ce:cross-ref>].</ce:para>
                  <ce:para id="p0035" view="all">Janus kinase 2 (JAK2) is an intracellular non-receptor tyrosine kinase that belongs to the JAK family kinases (JAK1, JAK2, JAK3 and TYK2). The JAK-signal transducer and activator of transcription (JAK - STAT) pathway mediates signaling by cytokines, which controls the survival, proliferation and differentiation of a variety of cells [<ce:cross-ref id="crosref0140" refid="bib7">7</ce:cross-ref>]. JAK2 phosphorylation, downstream STAT phosphorylation and activation of gene transcription ultimately results in increased proliferation, differentiation, and survival of erythroid and myeloid cells [<ce:cross-ref id="crosref0145" refid="bib8">8</ce:cross-ref>]. JAK2 was proven to be critical for the growth and progression of hematologic malignancies especially for myeloproliferative neoplasms among the four JAK subtypes [<ce:cross-ref id="crosref0150" refid="bib9">9</ce:cross-ref>]. Currently, a number of pan-JAK and selective JAK inhibitors have been discovered (<ce:cross-ref id="crosref0155" refid="fig1">Fig. 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/></ce:float-anchor>). JAK1/2 inhibitor <ce:bold>Ruxolitinib</ce:bold> and JAK2/FLT3 inhibitor <ce:bold>Fedratinib</ce:bold> were successively approved by FDA for the treatment of myelofibrosis (MF) and polycythemia vera [<ce:cross-ref id="crosref0160" refid="bib10">10</ce:cross-ref>,<ce:cross-ref id="crosref0165" refid="bib11">11</ce:cross-ref>]. Another JAK2 inhibitor, <ce:bold>BMS-911543</ce:bold>, is currently in phase II clinical tial [<ce:cross-ref id="crosref0170" refid="bib12">12</ce:cross-ref>].</ce:para>
                  <ce:para id="p0040" view="all">The approval of the JAK2 inhibitors <ce:bold>Ruxolitinib</ce:bold> and <ce:bold>Fedratinib</ce:bold> for the treatment of myeloproliferative neoplasms (MPNs) reinforced the feasibility of targeting the JAK family specifically. However, the high level of sequence conservation in the kinase domains of the JAK family is a key challenge for the design of selective JAK2 inhibitors [<ce:cross-ref id="crosref0175" refid="bib13">13</ce:cross-ref>]. Our recent research work discovered the compound <ce:bold>1a</ce:bold>, an imidazopyrrolopyridines derivative, as a potent selective JAK2 inhibitor with IC<ce:inf loc="post">50</ce:inf> for JAK1 and JAK2 are >400 nM and 19 nM respectively but less potent in cellular activity. We supposed that the poor cell activity was due to the high polarity of this molecule. In addition, the overall molecular weight of this compound is relatively high which led to low ligand efficiency. As a result, we explored the compound groups that affect the activity of JAK2 kinase in detail to obtain these imidazopyrrolopyridines analogues as potent JAK2 inhibitors in this work.</ce:para>
               </ce:section>
               <ce:section id="sec2" role="results" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0040">Results and discussion</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0045">Design and biochemical activity</ce:section-title>
                     <ce:para id="p0045" view="all">Based on the structure comparison between the approved JAK inhibitor <ce:bold>Baricitinib</ce:bold> and a reported JAK inhibitor <ce:bold>Compound 31</ce:bold>, we designed a novel series of JAK inhibitors as shown in <ce:cross-ref id="crosref0180" refid="fig2">Fig. 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/></ce:float-anchor>. <ce:bold>Compound 31</ce:bold> has excellent biological activities against JAKs, both in vitro and in vivo [<ce:cross-ref id="crosref0185" refid="bib14">14</ce:cross-ref>]. Meanwhile, <ce:bold>Baricitinib</ce:bold> is a highly potent JAK2 inhibitor. According to the combination principle of structural fragments, we designed imidazopyrrolopyridines derivative <ce:bold>1a</ce:bold> which exhibited highly and excellent biological activity against JAK2. Besides, docking study revealed that the furimethylene hydroxy could form hydrogen bonding with Asp939 in JAK2 while there was no interaction for the group of 1-(ethylsulfonyl)azetidine acetonitrile. Additionally, structure−activity relationship (SAR) studies showed that the removal of 1-(ethylsulfonyl)azetidine in these analogues did not influence their JAK inhibition significantly. As a result, a series of 1-(1H-pyrazol-4-yl)- imidazopyrrolopyridines derivatives were synthesized to explore the SAR between groups and the biological activities for JAK2.</ce:para>
                     <ce:para id="p0050" view="all">The imidazopyrrolopyridines derivatives were screened for their in vitro kinase inhibitory activities toward JAK1 and JAK2 for IC<ce:inf loc="post">50</ce:inf> or inhibition at 30 nM. <ce:bold>Baricitinib</ce:bold> (an approved JAK inhibitor; IC<ce:inf loc="post">50</ce:inf> for JAK1 and JAK2 were 4.0 nM and 6.6 nM respectively) were used as positive controls [<ce:cross-ref id="crosref0190" refid="bib15">15</ce:cross-ref>]. All the inhibition or IC<ce:inf loc="post">50</ce:inf> results were shown in <ce:cross-refs id="crosrefs0010" refid="tbl1 tbl2 tbl3">Table 1−3</ce:cross-refs>
                        <ce:float-anchor refid="tbl1"/></ce:float-anchor>
                        <ce:float-anchor refid="tbl2"/></ce:float-anchor>
                        <ce:float-anchor refid="tbl3"/></ce:float-anchor>. SAR studies began with variation of the imidazole C-2 group or the removal of the cyanoethyl as shown in <ce:cross-ref id="crosref0195" refid="tbl1">Table 1</ce:cross-ref>. The modification of R<ce:inf loc="post">1</ce:inf> group such as methylthiophene, thiophene or methylfuran did not influence their JAK2 inhibition and JAK1 selectivity significantly. At the same time, the extension of terminal alkyl chain resulted in compounds <ce:bold>2a</ce:bold> and <ce:bold>3a</ce:bold> reduced their JAK2 inhibition slightly. Compound <ce:bold>1a</ce:bold> was docked into the ATP binding pocket of JAK2 using MOE 2020.01 in order to investigate the binding mode of it in JAK2 (<ce:cross-ref id="crosref0200" refid="fig3">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/></ce:float-anchor>, <ce:bold>A</ce:bold>) [<ce:cross-ref id="crosref0205" refid="bib16">16</ce:cross-ref>]. The result shown in <ce:cross-ref id="crosref0210" refid="fig3">Fig. 3</ce:cross-ref> suggested that the −NH and = N moieties of azaindole in compound <ce:bold>1a</ce:bold> could form hydrogen bonds with GLU930 and LEU932. These hydrogen interactions were the crucial part for the protein kinase inhibition. There seemed to be no interaction between the cyanoethyl and the JAK2 kinase from this docking results. As a result, the next step of modifications focused on the removal of the cyanoethyl to simplify molecules of these analogues. However, deletion of the cyanoethyl lead to reduced JAK2 inhibition significantly such as compound <ce:bold>2c</ce:bold>, <ce:bold>3c</ce:bold> and <ce:bold>4c</ce:bold>. The bring back of the cyanoethyl resulted in the restoration of JAK2 activity indicated that the cyano group on pyrazole ring contributed much more to JAK2 inhibition that needed to be maintained.</ce:para>
                     <ce:para id="p0055" view="all">After confirming the importance of the cyano group, these derivatives were simplified through the deletion of the part of azetidine and the compound <ce:bold>5a</ce:bold> was synthesized with IC<ce:inf loc="post">50</ce:inf> (43 nM) for JAK2. When the propionitrile was replaced by acetonitrile to afford the compound <ce:bold>6a</ce:bold>, the kinase inhibition activity was further reduced which indicated that a suitable length of side chain connecting cyano was favorable for the activity against JAK2 kinase. Propionitrile was preserved and different R<ce:inf loc="post">1</ce:inf> substituted groups were explored during our initial screen. Results in <ce:cross-ref id="crosref0215" refid="tbl2">Table 2</ce:cross-ref> showed that compounds <ce:bold>5b-5k</ce:bold> exhibited moderate inhibitory activities against JAK2 except for compound <ce:bold>5e</ce:bold> with the IC<ce:inf loc="post">50</ce:inf> (151 nM), <ce:bold>5f</ce:bold> with the IC<ce:inf loc="post">50</ce:inf> (61 nM) and <ce:bold>5g</ce:bold> with the IC<ce:inf loc="post">50</ce:inf> (65 nM) against JAK2. To further simplify the structure of the molecules, the R<ce:inf loc="post">1</ce:inf> groups were removed totally which delivered the compound <ce:bold>5k</ce:bold>. This molecule (M. W = 277.28) gained remarkable inhibition activity against JAK2 (IC<ce:inf loc="post">50</ce:inf> = 15 nM) although the selectivity against JAK1 (IC<ce:inf loc="post">50</ce:inf> = 94 nM) was reduced to some extent. Replaced propionitrile by butylcyanide afforded the compound <ce:bold>6k</ce:bold> and the inhibition activity against JAK2 was further improved. However, when the length of this sidechain was extended or substituted by trifluoromethyl such as compound <ce:bold>7k</ce:bold> and <ce:bold>8k</ce:bold>, the inhibitory activity of JAK2 kinase decreased immediately which indicated that butylcyanide was the most suitable sidechain of these analogues.</ce:para>
                     <ce:para id="p0060" view="all">
                        <ce:bold>5k</ce:bold> and <ce:bold>6k</ce:bold> was docked into the ATP binding pocket of JAK2 in order to investigate the binding mode of them in JAK2 (<ce:cross-ref id="crosref0220" refid="fig3">Fig. 3</ce:cross-ref>, <ce:bold>B</ce:bold>). The results suggested that the −NH and = N moieties of azaindole in compound <ce:bold>5k</ce:bold> and <ce:bold>6k</ce:bold> could form hydrogen bonds with GLU930 and LEU932 which were the crucial part for the protein kinase inhibition. Additionally, the cyano group of these two compounds form additional hydrogen bonds with LYS882 that could explain the observed good inhibition activity for JAK2 kinase of these compounds. At the same time, the most potent compound <ce:bold>6k</ce:bold> was docked into the ATP binding pocket of JAK1 in order to investigate the reason for its poor JAK1 inhibition. The result exhibited in <ce:cross-ref id="crosref0225" refid="fig3">Fig. 3</ce:cross-ref>, <ce:bold>C</ce:bold> indicated that there was no interaction between the cyano group and the amino acid residues of JAK1 kinase which may contribute to low JAK1 inhibition of this compound. Besides, <ce:bold>5d</ce:bold> and <ce:bold>5h</ce:bold> were docked into the ATP binding pocket of JAK2 to explore influences of the R<ce:inf loc="post">1</ce:inf> substituted groups. As showed in <ce:cross-ref id="crosref0230" refid="fig3">Fig. 3</ce:cross-ref>, <ce:bold>D</ce:bold>, no matter whether there are substituents such as thienyl or methyl thienyl or no substituents, there was no additional interaction forced between compounds and the kinase. Generally, different substituents on the C-2 of the imidazole ring were well tolerated.</ce:para>
                     <ce:para id="p0065" view="all">Due to the lack of relatively potent selectivity over JAK1 kinase for the compound <ce:bold>6k</ce:bold>, more modifications were applied in these derivatives which were displayed in <ce:cross-ref id="crosref0235" refid="tbl3">Table 3</ce:cross-ref>. The sidechain of butylcyanide was preserved and heterocyclic aryl such as methyl furan, aminothiazole and methylthiophene along with alicyclic groups such as cyclopropyl, cyclobutyl and cyclopentyl were applied in the R<ce:inf loc="post">1</ce:inf> group to improve the selectivity of compounds to JAK1 kinase. From the data shown in <ce:cross-ref id="crosref0240" refid="tbl3">Table 3</ce:cross-ref>, we could see that this series of derivatives such as compound <ce:bold>6b</ce:bold>, <ce:bold>6d</ce:bold>, <ce:bold>9a</ce:bold>, <ce:bold>9b</ce:bold> and <ce:bold>9c</ce:bold> maintained the inhibitory activity against JAK2 kinase basically and the selectivity to JAK1 kinase was increased. Among them, compound <ce:bold>6d</ce:bold> performed best with the IC<ce:inf loc="post">50</ce:inf> 12 nM for JAK2 and 254 nM for JAK1 (JAK1/JAK2 selectivity>20 folds).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0050">Chemistry</ce:section-title>
                     <ce:para id="p0070" view="all">Compound <ce:bold>1a-d</ce:bold>, <ce:bold>2-3a</ce:bold>, <ce:bold>1e</ce:bold> were synthesized as described in <ce:cross-ref id="crosref0245" refid="sch1">Scheme 1</ce:cross-ref>
                        <ce:float-anchor refid="sch1"/></ce:float-anchor>. Generally, the reaction of tert-butyl-3-oxoazetidine-1-carboxylate with 2-diethoxyphosphorylacetonitrile under basic (NaH) condition led to the intermediate tert-butyl-3-(cyanomethylene) azetidine-1-carboxylate, which was then reacted with 4-nitropyrazole using DBU as a catalyst and then reduced under the condition of hydrogen palladium carbon to give target intermediate molecule <ce:bold>11</ce:bold> [<ce:cross-ref id="crosref0250" refid="bib17">17</ce:cross-ref>]. Intermediate <ce:bold>13</ce:bold> was obtained from reaction of 4-chloro-7-azaindole with benzenesulfonyl chloride under basic condition of TEA. Then, the key intermediate molecule <ce:bold>14</ce:bold> was afforded through nitration reaction under the condition of tetramethylammonium nitrate and TFAA [<ce:cross-ref id="crosref0255" refid="bib18">18</ce:cross-ref>]. The key intermediate <ce:bold>14</ce:bold> reacted with and <ce:bold>11</ce:bold> using K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf> as a basic at high temperature to produce molecule <ce:bold>15</ce:bold>, which then reduced under the condition of hydrogen palladium carbon to deliver intermediate <ce:bold>16</ce:bold>. Finally, target compounds <ce:bold>1a-d</ce:bold>, <ce:bold>2-3a</ce:bold>, <ce:bold>1e</ce:bold> were yielded through the rection with various aromatic aldehyde, deprotection of the Boc group, sulfonylation with different sulfonyl chloride and Bs-deprotection [<ce:cross-ref id="crosref0260" refid="bib19">19</ce:cross-ref>].</ce:para>
                     <ce:para id="p0075" view="all">Synthetic routes of the other three series of compounds were exhibited in <ce:cross-ref id="crosref0265" refid="sch2">Scheme 2</ce:cross-ref>
                        <ce:float-anchor refid="sch2"/></ce:float-anchor>. 4-nitropyrazole was applied for the starting material through the reduction and substitution reaction afforded the key intermediate <ce:bold>19</ce:bold>. Compound <ce:bold>2c</ce:bold> was obtained by reduction of intermediate <ce:bold>19</ce:bold>, cyclization with 2-thenaldehyde, substitution with 1-Boc-3-Iodoazetidine, Boc removal, sulfonylation with trifluoromethanesulfonyl chloride and deprotection of the benzenesulfonyl [<ce:cross-ref id="crosref0270" refid="bib20">20</ce:cross-ref>]. The synthetic route of derivatives <ce:bold>3-4c</ce:bold> were similar to that of compound <ce:bold>2c</ce:bold> through reduction, cyclization, substitution, <ce:italic>N</ce:italic>-alkylation and Bs-deprotection reaction to deliver target molecules <ce:bold>3c</ce:bold> and <ce:bold>4c</ce:bold>. The synthesis routes of the largest part of the compounds including <ce:bold>5-6a</ce:bold>, <ce:bold>5b-k</ce:bold>, <ce:bold>6-8k</ce:bold>, <ce:bold>6-7b</ce:bold>, <ce:bold>6-8d</ce:bold> and <ce:bold>9a-d</ce:bold> was similar to the synthesis of derivatives <ce:bold>3-4c</ce:bold>. This series of derivatives were obtained via reaction with virous aldehyde under the condition of Na<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">5</ce:inf> and DMF at 90 °C then with kinds of cyanogen halide and Bs-deprotection through the starting material intermediate <ce:bold>20</ce:bold> [<ce:cross-ref id="crosref0275" refid="bib13">13</ce:cross-ref>].</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0055">Biological evaluation</ce:section-title>
                     <ce:section id="sec2.3.1" view="all">
                        <ce:label>2.3.1</ce:label>
                        <ce:section-title id="sectitle0060">ADME and physicochemical properties of inhibitors</ce:section-title>
                        <ce:para id="p0080" view="all">Compounds <ce:bold>1a</ce:bold>, <ce:bold>1c</ce:bold>, <ce:bold>5h</ce:bold>, <ce:bold>6k</ce:bold>, <ce:bold>6b</ce:bold>, <ce:bold>6d</ce:bold> and <ce:bold>9c</ce:bold> were selected for further profiling on the basis of kinase potency and structural diversity considerations. Firstly, log D<ce:inf loc="post">
                              <ce:italic>7.2</ce:italic>
                           </ce:inf> were measured for these molecules and the results were displayed in <ce:cross-ref id="crosref0280" refid="tbl4">Table 4</ce:cross-ref>
                           <ce:float-anchor refid="tbl4"/></ce:float-anchor> [<ce:cross-ref id="crosref0285" refid="bib21">21</ce:cross-ref>]. This series of analogues along with <ce:bold>Baricitinib</ce:bold> exhibited a reasonable log of distribution coefficient which ranged from 0.24 to 2.42. In our initial screen process, compound <ce:bold>1a</ce:bold> possessed weak cytokine signaling cellular activity with the IC<ce:inf loc="post">50</ce:inf> (>10 μM) for JAK2 in TF1 cell despite its excellent kinase inhibition activity. Too large tPSA calculated by Chemdraw may be the cause of its poor cell viability and this value had been reduced in a reasonable range after our structural optimization. The solubility of these preferred compounds in aqueous buffer were also determined and most molecules displayed a comparable result with the FDA approved JAKs inhibitor <ce:bold>Baricitinib</ce:bold> especially compound <ce:bold>6k</ce:bold> which possessed 12 times the water solubility of <ce:bold>Baricitinib</ce:bold>. We also tested these compounds in rat liver microsomes to assess the propensity of the template toward degradation by phase I metabolism [<ce:cross-ref id="crosref0290" refid="bib22">22</ce:cross-ref>]. In rat liver microsomes, most molecules had a rapid clearance such as compound <ce:bold>1c</ce:bold>, <ce:bold>6b</ce:bold> and <ce:bold>6d</ce:bold> with a half-life of 27.72 min (apparent clearance of 45 mL/min/kg), 30.8 min (apparent clearance of 40.5 mL/min/kg) and 18.0 min (apparent clearance of 69.3 mL/min/kg). Gratifyingly, compound <ce:bold>6k</ce:bold> displayed a superior rat liver microsomes stability with a half-life of 433.13 min (apparent clearance of 2.88 mL/min/kg) which was compared favorably with <ce:bold>Baricitinib</ce:bold>.</ce:para>
                     </ce:section>
                     <ce:section id="sec2.3.2" view="all">
                        <ce:label>2.3.2</ce:label>
                        <ce:section-title id="sectitle0065">Cellular activity</ce:section-title>
                        <ce:para id="p0085" view="all">The cellular potency and selectivity of these preferred compounds for each individual kinase were characterized in a series of cytokine-stimulated cell-based assays because of the complexity of the cooperative property of JAK kinases. For instance, IL-4-induced STAT6 phosphorylation is mediated by JAK1 and JAK3 and GM-CSF-induced STAT5 phosphorylation is dependent on JAK2 [<ce:cross-ref id="crosref0295" refid="bib23">23</ce:cross-ref>]. As shown in <ce:cross-ref id="crosref0300" refid="tbl5">Table 5</ce:cross-ref>
                           <ce:float-anchor refid="tbl5"/></ce:float-anchor>, to assess JAK2 and JAK1-JAK3 signaling, we stimulated TF-1 and THP-1 cells via GM-CSF and IL-4 and measured the levels of phosphorylated STAT5 and STAT6. In these systems, compound <ce:bold>6k</ce:bold> inhibited the phosphorylation of STAT5 in JAK2 signaling with an IC<ce:inf loc="post">50</ce:inf> value of 269 nM and the phosphorylation of STAT6 in JAK1-JAK3 signaling with an IC<ce:inf loc="post">50</ce:inf> value of 10.69 μM. The data from these in vitro enzyme and cell-based assays indicated that <ce:bold>6k</ce:bold> inhibited JAK2 rather than JAK1 or JAK3.</ce:para>
                        <ce:para id="p0090" view="all">In order to verify the mechanism of compound <ce:bold>6k</ce:bold> in the JAK2-STAT signaling pathway, the phosphorylation levels of JAK2’s downstream substrate was evaluated. As shown in <ce:cross-ref id="crosref0305" refid="fig4">Fig. 4</ce:cross-ref>
                           <ce:float-anchor refid="fig4"/></ce:float-anchor>, the treatment of the TF1 cells with compound <ce:bold>6k</ce:bold> or <ce:bold>Baricitinib</ce:bold> led to the decrease of pSTAT5 (Y694) level. The pSTAT5 signal intensities decreased sharply at 0.3 μM in TF1 cells and also downregulated pSTAT5 in a dose-dependent manner from 0.3 to 10 μM. Overall, these results revealed that compound <ce:bold>6k</ce:bold> down-regulated the JAK2-STAT signaling pathway by inhibiting JAK2 kinase activity in TF1 cells.</ce:para>
                     </ce:section>
                     <ce:section id="sec2.3.3" view="all">
                        <ce:label>2.3.3</ce:label>
                        <ce:section-title id="sectitle0070">In vivo pharmacokinetics</ce:section-title>
                        <ce:para id="p0095" view="all">Compounds <ce:bold>6k</ce:bold> with potent JAK2 inhibitory activity and good JAK1, JAK3 and TYK2 selectivity as well as promising cellular potency was selected for further evaluation, and plasma concentration was determined after oral (PO, 20 mg/kg) and intravenous (IV, 5 mg/kg) administration in rats (<ce:cross-ref id="crosref0310" refid="tbl6">Table 6</ce:cross-ref>
                           <ce:float-anchor refid="tbl6"/></ce:float-anchor>) together with <ce:bold>Baricitinib</ce:bold>. Compound <ce:bold>6k</ce:bold> presented a moderate PK profile in rats, high maximum concentration (<ce:italic>C</ce:italic>
                           <ce:inf loc="post">max</ce:inf> = 885.62 μg/L) and good plasma duration (MRT = 2.10 h), leading to a high plasma exposure (AUC = 1507.67 μg<ce:inf loc="post">∗</ce:inf>h/L) after oral administration. Assessment of pharmacokinetic (PK) properties for compound <ce:bold>6k</ce:bold> in rats also showed good oral bioavailability (<ce:italic>F</ce:italic> = 38%) and the low clearance and high volume of distribution (38.33 L/kg) led to a suitable half-life of 1.9 h. In general, compound <ce:bold>6k</ce:bold> exhibited a comparable pharmacokinetic property to <ce:bold>Baricitinib</ce:bold>. Thus, compound <ce:bold>6k</ce:bold> could be selected for further evaluation in an in vivo experiment.</ce:para>
                     </ce:section>
                     <ce:section id="sec2.3.4" view="all">
                        <ce:label>2.3.4</ce:label>
                        <ce:section-title id="sectitle0075">In vivo pharmacodynamics</ce:section-title>
                        <ce:para id="p0100" view="all">To further assess the biological activity of compound <ce:bold>6k</ce:bold>, its ability to inhibit JAK2-mediated cytokine signaling was evaluated in vivo in a PD experiment in the mouse. As shown in <ce:cross-ref id="crosref0315" refid="fig5">Fig. 5</ce:cross-ref>
                           <ce:float-anchor refid="fig5"/></ce:float-anchor>, mice were pretreated with ascending oral doses of compound <ce:bold>6k</ce:bold> ranging from 3 to 50 mg/kg, followed by a 1 μg intraperitoneal (IP) injection of GM-CSF cytokine 30 min later. An additional 30 min after GM-CSF administration, concentrations of pSTAT3 and pSTAT5 were measured in snapfrozen spleens. As further demonstrated in <ce:cross-ref id="crosref0320" refid="fig5">Fig. 5</ce:cross-ref>, the decreasing pSTAT3 and pSTAT5 levels in the spleens of GM-CSF treated animals were achieved with ascending oral doses of compound <ce:bold>6k</ce:bold> in the mouse. Indeed, at a dose of 20 mg/kg compound <ce:bold>6k</ce:bold>, pSTAT3 and pSTAT5 expression was reduced to levels comparable to those of control animals untreated with GM-CSF, indicating that robust in vivo suppression of JAK2-mediated signaling was achieved.</ce:para>
                     </ce:section>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" role="conclusion" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0080">Conclusions</ce:section-title>
                  <ce:para id="p0105" view="all">In conclusion, we discovered compound <ce:bold>1a</ce:bold> as a promising lead for a small molecule targeting JAK2 kinase aimed at increasing cellular activity via pharmacophore merge strategy. SAR developed around the designed cycle moieties combined with structure-based design led to the discovery of <ce:bold>6k</ce:bold>, which possessed >18-fold selectivity over JAK1,3, TYK2 in enzyme assays. At the same time, the cell pathway inhibitory activity of the compound <ce:bold>6k</ce:bold> has been greatly improved due to the decrease in tPSA. Additionally, the excellent potency and oral PK properties of <ce:bold>6k</ce:bold> in rats enabled its use in multiple in vivo models for the evaluation of modulating JAK2 driven pharmacodynamic responses. To summarize, compound <ce:bold>6k</ce:bold> is a promising inhibitor of JAK2 for further development research for the treatment of MPNs.</ce:para>
               </ce:section>
               <ce:section id="sec4" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="sectitle0085">Experimental</ce:section-title>
                  <ce:section id="sec4.1" view="all">
                     <ce:label>4.1</ce:label>
                     <ce:section-title id="sectitle0090">Chemistry and chemical methods</ce:section-title>
                     <ce:para id="p0110" view="all">
                        <ce:bold>Chemical Methods.</ce:bold> All reagents and solvents purchased from commercial suppliers were used without further purification. <ce:sup loc="post">1</ce:sup>H NMR spectra were collected on a Bruker AVANCE 300 MHz spectrometer. Chemical shifts (<ce:italic>δ</ce:italic>) are reported in parts per million (ppm) from tetramethylsilane (TMS) using the residual solvent resonance. Multiplicities are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br s (broad singlet). HR-MS was recorded on Agilent technologies 6520 Accurate-Mass LC/MS Q-TOF instruments. The procedures outlined in this section are those employed for the reactions run at the largest scale. HPLC analysis was carried out on an Agilent 1260 infinity eluded with isocratic eluting mixed by solvent A (acetonitrile) and solvent B (methanol) at a flow rate of 1 mL/min and at λ = 254 nm.</ce:para>
                     <ce:para id="p0115" view="all">
                        <ce:bold>General synthetic procedure 1: substituted imidazole formation</ce:bold>
                     </ce:para>
                     <ce:para id="p0120" view="all">A solution of <ce:bold>16</ce:bold> or <ce:bold>20</ce:bold> (1.0 equiv) and Na<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">5</ce:inf> (5.0 equiv) in DMF were added aromatic aldehyde (2.0 equiv). The reaction was heated in an open single neck bottle at 90 °C for 12 h, cooled to room temperature, then water was added and aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum give the crude product, which was further purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1: 1) to give target product as a brown solid.</ce:para>
                     <ce:para id="p0125" view="all">
                        <ce:bold>General synthetic procedure 2: imidazole formation without substituted groups</ce:bold>
                     </ce:para>
                     <ce:para id="p0130" view="all">A mixture of <ce:bold>16</ce:bold> or <ce:bold>20</ce:bold> (1.0 equiv), triethyl orthoformate (2.5 equiv), and <ce:italic>p</ce:italic>-toluenesulfonic acid monohydrate (0.1 equiv) in toluene (20 mL) was heated at reflux for 24 h. After cooling, ethyl acetate was added and the mixture washed with saturated sodium hydrogen carbonate solution, water and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by silica gel column chromatography afforded target product as a light white solid.</ce:para>
                     <ce:para id="p0135" view="all">
                        <ce:bold>General synthetic procedure 3: TFA-Mediated Boc removal</ce:bold>
                     </ce:para>
                     <ce:para id="p0140" view="all">Boc-protected amine (1.0 equiv) was dissolved in a mixture of TFA (10.0 equiv)/DCM (1:1), and stirred at room temperature for 12 h. The mixture was concentrated under reduced pressure, triturated with diethyl ether, and filtered to give the desired product, which was directly used in the next step without further purification.</ce:para>
                     <ce:para id="p0145" view="all">
                        <ce:bold>General synthetic procedure 4: sulfamide formation</ce:bold>
                     </ce:para>
                     <ce:para id="p0150" view="all">A solution of sulfonyl chloride (1.5 equiv) in THF was added to the solution of heterocyclic secondary amine (1.0 equiv) and potassium carbonate (5.0 equiv). The reaction mixture was heated to reflux for 4 h. The completion of the reaction was checked with TLC. After cooling to room temperature, water was added and aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum give the crude product, which was further purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1: 3) to give target product as a brown solid.</ce:para>
                     <ce:para id="p0155" view="all">
                        <ce:bold>General synthetic procedure 5: deprotection of benzenesulfonyl</ce:bold>
                     </ce:para>
                     <ce:para id="p0160" view="all">A mixture of benzenesulfonyl protected product (1 equiv) and 1 M aqueous sodium hydroxide (5 equiv) in methanol/THF was stirred at room temperature for 10 h. The reaction mixture was concentrated under vacuum and the residue partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (DCM: MeOH = 30: 1) afforded target product as a light yellow solid.</ce:para>
                     <ce:para id="p0165" view="all">
                        <ce:bold>General synthetic procedure 6: N alkylation reaction on pyrazole</ce:bold>
                     </ce:para>
                     <ce:para id="p0170" view="all">A solution of bromide (1.5 equiv) in DMF was added to the solution of pyrazole analogues (1.0 equiv) and potassium carbonate (5.0 equiv). The reaction mixture was heated to 80 °C for 4 h. The completion of the reaction was checked with TLC. After cooling to room temperature, water was added and aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum give the crude product, which was further purified by silica gel column chromatography (ethyl acetate: petroleum ether = 1: 1) to give target product as a solid.</ce:para>
                     <ce:section id="sec4.1.1" view="all">
                        <ce:label>4.1.1</ce:label>
                        <ce:section-title id="sectitle0095">
                           <ce:italic>Tert</ce:italic>-butyl 3-(cyanomethylene) azetidine-1-carboxylate (<ce:bold>11</ce:bold>)</ce:section-title>
                        <ce:para id="p0175" view="all">2-Diethoxyphosphorylacetonitrile (5.7 g, 32.1 mmol) in THF (50 mL) was added to a stirred solution of NaH (1.2 g, 30.7 mmol) in THF (50 mL) at 0 °C. The mixture was stirred at ambient temperature for 1 h then <ce:italic>tert</ce:italic>-butyl 3-oxoazetidine-1-carboxylate (<ce:bold>10</ce:bold>; 5.0 g, 29.2 mmol) in THF was added at 0 °C in 1 h. The mixture was then stirred at ambient temperature for 16 h. The aqueous phase was extracted twice with EA. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum, the residue was dissolved in CH<ce:inf loc="post">3</ce:inf>CN (30 mL) and DBU (11.8 g, 77.4 mmol) together with 4-nitropyrazole (3.2g, 28.7 mmol) were added. The mixture was then stirred at ambient temperature for 16 h. Water was added and aqueous phase was extracted twice with EA. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum give the crude product, which was then dissolved in methanol and purged with argon, palladium on carbon (10% Pd content, 1.4 g, 1.3 mmol) was added, and the reaction mixture stirred under an atmosphere of hydrogen for 12 h. The solids were removed by filtration, washed with methanol and the filtrate concentrated under vacuum to afford 3.5 g (43% for three steps) of <ce:bold>11</ce:bold> as a clear oil.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.2" view="all">
                        <ce:label>4.1.2</ce:label>
                        <ce:section-title id="sectitle0100">4-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b] pyridine (<ce:bold>13</ce:bold>)</ce:section-title>
                        <ce:para id="p0180" view="all">A stirred suspension of 4-chloro-7-azaindole (<ce:bold>12</ce:bold>; 25.0 g, 163.8 mmol) in (DCM) 250 mL was treated with DMAP (2.0 g, 16.5 mmol), triethylamine (34.0 mL, 245.8 mmol), and benzenesulfonyl chloride (23.3 mL, 180.3 mmol) at ambient temperature. The mixture was left to stand overnight. After filtration, the filtrate was collected and concentrated under vacuum to give a brown solid. Trituration (MeOH) afforded 43.0 g (90%) of <ce:bold>13</ce:bold> as an ashen solid. <ce:sup loc="post">1</ce:sup>H NMR (300 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic>: 8.36 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 8.24 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.82 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.64 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.54 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 7.25 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 6.76 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H). HRMS (ESI): [M + H] <ce:sup loc="post">+</ce:sup> calcd for C<ce:inf loc="post">13</ce:inf>H<ce:inf loc="post">10</ce:inf>ClN<ce:inf loc="post">2</ce:inf>O<ce:inf loc="post">2</ce:inf>S, 293.0146; found, 293.0155.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.3" view="all">
                        <ce:label>4.1.3</ce:label>
                        <ce:section-title id="sectitle0105">4-Chloro-5-nitro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b] pyridine (<ce:bold>14</ce:bold>)</ce:section-title>
                        <ce:para id="p0185" view="all">Tetramethylammonium nitrate (28.0 g, 205.5 mmol) was added to a stirred solution of <ce:bold>3</ce:bold> (30.0 g, 102.7 mmol) in DCM (300 mL) at 25 °C. Trifluoroacetic anhydride (57.3 m0L, 410.8 mmol) was added while maintaining the reaction temperature below 30 °C. The mixture was then stirred at ambient temperature for 5 h. TLC indicated complete reaction. Saturated sodium bicarbonate was added, and the organic phase was separated. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried with sodium sulfate and concentrated under vacuum to give a yellow solid. Trituration (MeOH) afforded 25.9 g (75%) of <ce:bold>14</ce:bold> as a light yellow solid. <ce:sup loc="post">1</ce:sup>H NMR (300 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic>: 9.05 (s, 1H), 8.25 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 2H), 7.99 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.62–7.57 (m, 3H), 6.92 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H). HRMS (ESI): [M + H] <ce:sup loc="post">+</ce:sup> calcd for C<ce:inf loc="post">13</ce:inf>H<ce:inf loc="post">9</ce:inf>ClN<ce:inf loc="post">3</ce:inf>O<ce:inf loc="post">4</ce:inf>S, 337.9997; found, 338.0010.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.4" view="all">
                        <ce:label>4.1.4</ce:label>
                        <ce:section-title id="sectitle0110">
                           <ce:italic>Tert</ce:italic>-butyl 3-(cyanomethyl)-3-(4-((5-nitro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)amino)-1H-pyrazol-1-yl)azetidine-1-carboxylate (<ce:bold>15</ce:bold>)</ce:section-title>
                        <ce:para id="p0190" view="all">A mixture of <ce:bold>14</ce:bold> (3.5 g, 10.5 mmol), <ce:bold>11</ce:bold> (3.5 g, 12.6 mmol), and <ce:italic>N, N</ce:italic>-diisopropylethylamine (5.4 mL, 31.5 mmol) in THF was heated to reflux for 3 h. The cooled reaction mixture was concentrated under vacuum to afford a dark yellow residue. Trituration (MeOH) afforded 4.3 g (70%) of <ce:bold>15</ce:bold> as a yellow solid.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.5" view="all">
                        <ce:label>4.1.5</ce:label>
                        <ce:section-title id="sectitle0115">
                           <ce:italic>Tert</ce:italic>-butyl 3-(4-((5-amino-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)amino)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate (<ce:bold>16</ce:bold>)</ce:section-title>
                        <ce:para id="p0195" view="all">A solution of <ce:bold>15</ce:bold> (4.3 g, 7.4 mmol) in methanol was purged with argon, palladium on carbon (10% Pd content, 0.8 g, 0.74 mmol) added, and the reaction mixture stirred under an atmosphere of hydrogen for 12 h. The solids were removed by filtration, washed with methanol and the filtrate concentrated under vacuum to afford 4.0 g (98%) of <ce:bold>16</ce:bold> as a pink powder.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.6" view="all">
                        <ce:label>4.1.6</ce:label>
                        <ce:section-title id="sectitle0120">1H-pyrazol-4-amine (<ce:bold>18</ce:bold>)</ce:section-title>
                        <ce:para id="p0200" view="all">A solution of <ce:bold>17</ce:bold> (10.0 g, 88.5 mmol) in methanol was purged with argon, palladium on carbon (10% Pd content, 1.6 g, 1.5 mmol) added, and the reaction mixture stirred under an atmosphere of hydrogen for 12 h. The solids were removed by filtration, washed with methanol and the filtrate concentrated under vacuum to afford 7.3 g (99%) of <ce:bold>18</ce:bold> as a light white powder.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.7" view="all">
                        <ce:label>4.1.7</ce:label>
                        <ce:section-title id="sectitle0125">5-Nitro-1-(phenylsulfonyl)-N-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b] pyridin-4-amine (<ce:bold>19</ce:bold>)</ce:section-title>
                        <ce:para id="p0205" view="all">A mixture of <ce:bold>14</ce:bold> (23.7 g, 70.3 mmol), <ce:bold>18</ce:bold> (7.0 g, 84.3 mmol), and <ce:italic>N, N</ce:italic>-diisopropylethylamine (24.1 mL, 140.6 mmol) in THF (250 mL) was heated to reflux for 6 h. The cooled reaction mixture was concentrated under vacuum to afford a dark yellow residue. Trituration (MeOH) afforded 18.4 g (68%) of <ce:bold>19</ce:bold> as a dark yellow solid. HRMS (ESI): [M + H] <ce:sup loc="post">+</ce:sup> calcd for C<ce:inf loc="post">16</ce:inf>H<ce:inf loc="post">13</ce:inf>N<ce:inf loc="post">6</ce:inf>O<ce:inf loc="post">4</ce:inf>S, 385.0714; found, 385.0668.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.8" view="all">
                        <ce:label>4.1.8</ce:label>
                        <ce:section-title id="sectitle0130">1-(Phenylsulfonyl)-N4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-4,5-diamine (<ce:bold>20</ce:bold>)</ce:section-title>
                        <ce:para id="p0210" view="all">A solution of <ce:bold>19</ce:bold> (18.0 g, 46.9 mmol) in methanol was purged with argon, palladium on carbon (10% Pd content, 3.2 g, 3.0 mmol) added, and the reaction mixture stirred under an atmosphere of hydrogen for 12 h. The solids were removed by filtration, washed with methanol and the filtrate concentrated under vacuum to afford 14.9 g (90%) of <ce:bold>20</ce:bold> as a brown powder. HRMS (ESI): [M + H] <ce:sup loc="post">+</ce:sup> calcd for C<ce:inf loc="post">16</ce:inf>H<ce:inf loc="post">15</ce:inf>N<ce:inf loc="post">6</ce:inf>O<ce:inf loc="post">2</ce:inf>S, 355.0972; found, 355.0929.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.9" view="all">
                        <ce:label>4.1.9</ce:label>
                        <ce:section-title id="sectitle0135">2-(1-(Ethylsulfonyl)-3-(4-(2-(5-(hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1a</ce:bold>)</ce:section-title>
                        <ce:para id="p0215" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 5-hydroxymethylfurfural then ethyl sulfonyl chloride, and 0.2 g (22% for 4 steps) of <ce:bold>1a</ce:bold> was obtained as a light white solid. mp 187–192 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.94 (s, 1H), 8.90 (s, 1H), 8.69 (s, 1H), 8.14 (s, 1H), 7.37 (s, 1H), 6.41 (s, 2H), 5.95 (s, 1H), 5.43 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 4.62 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.47 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 4.34 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.78 (s, 2H), 3.32–3.25 (m, 2H), 1.28 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 4H) ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">23</ce:inf>H<ce:inf loc="post">23</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">4</ce:inf>S 507.1557, found 507.1549.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.10" view="all">
                        <ce:label>4.1.10</ce:label>
                        <ce:section-title id="sectitle0140">2-(1-(Ethylsulfonyl)-3-(4-(2-(5-methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1b</ce:bold>)</ce:section-title>
                        <ce:para id="p0220" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 5-methylthiophene-2-carboxaldehyde then ethyl sulfonyl chloride, and 0.1 (14% for 4 steps) g of <ce:bold>1b</ce:bold> was obtained as a gray solid. mp 191–197 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.89 (s, 1H), 8.92 (s, 1H), 8.66 (s, 1H), 8.16 (s, 1H), 7.36 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.06 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.78 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.93–5.91 (m, 1H), 4.61 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.35 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.79 (s, 2H), 3.32–3.25 (m, 2H), 2.48 (s, 2H), 1.28 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.29, 145.61, 143.37, 139.40, 136.18, 135.26, 133.88, 129.63, 129.13, 128.70, 126.84, 124.77, 119.69, 116.94, 104.54, 96.26, 58.77, 57.28, 43.95, 27.37, 15.24, 7.96 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">23</ce:inf>H<ce:inf loc="post">23</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf> 507.1380, found 507.1384.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.11" view="all">
                        <ce:label>4.1.11</ce:label>
                        <ce:section-title id="sectitle0145">2-(1-(Ethylsulfonyl)-3-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1c</ce:bold>)</ce:section-title>
                        <ce:para id="p0225" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 2-thenaldehyde then ethyl sulfonyl chloride, and 0.2 g of <ce:bold>1c</ce:bold> (18% for 4 steps) was obtained as a yellow solid. mp 183–188 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.94 (s, 1H), 8.68 (s, 1H), 8.18 (s, 1H), 7.72 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.36 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.23 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.10–7.07 (m, 1H), 5.94–5.92 (m, 2H), 4.61 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.35 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.79 (s, 2H), 3.32–3.25 (m, 2H), 1.30–1.25 (m, 4H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.19, 145.64, 139.41, 136.29, 135.39, 133.85, 132.17, 129.61, 129.11, 128.42, 124.80, 119.69, 116.95, 104.56, 58.81, 57.29, 43.93, 27.33, 7.95 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">22</ce:inf>H<ce:inf loc="post">21</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf> 493.1223, found 493.1233.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.12" view="all">
                        <ce:label>4.1.12</ce:label>
                        <ce:section-title id="sectitle0150">2-(1-(Ethylsulfonyl)-3-(4-(2-(5-methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1d</ce:bold>)</ce:section-title>
                        <ce:para id="p0230" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 5-methyl furfural then ethyl sulfonyl chloride, and 0.2 g of <ce:bold>1d</ce:bold> (11% for 4 steps) was obtained as a light yellow solid. mp 189–193 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.89 (s, 1H), 8.67 (s, 1H), 8.13 (s, 1H), 7.37 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.44 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.24 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.95 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.61 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.35 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.78 (s, 2H), 3.33–3.25 (m, 2H), 2.35 (s, 2H), 1.27 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 5H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 154.43, 145.72, 143.21, 142.75, 135.76, 135.60, 134.08, 128.65, 124.75, 119.89, 113.60, 108.62, 104.56, 60.25, 58.80, 57.20, 43.90, 26.99, 21.24, 14.55, 13.71, 7.96 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">23</ce:inf>H<ce:inf loc="post">23</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">3</ce:inf>S 491.1608, found 491.1609.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.13" view="all">
                        <ce:label>4.1.13</ce:label>
                        <ce:section-title id="sectitle0155">2-(3-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)-1-(propylsulfonyl)azetidin-3-yl)acetonitrile (<ce:bold>2a</ce:bold>)</ce:section-title>
                        <ce:para id="p0235" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 5-hydroxymethylfurfural then propyl sulfonyl chloride, and 0.3 g (25% for 4 steps) of <ce:bold>2a</ce:bold> was obtained as a light brown solid. mp 197–202 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.87 (s, 1H), 8.66 (s, 1H), 8.11 (s, 1H), 7.34 (s, 1H), 6.38 (s, 2H), 5.93 (s, 1H), 5.40 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 4.58 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.45 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 2H), 4.31 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.75 (s, 2H), 3.24 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 1.77–1.69 (m, 2H), 1.30–1.18 (m, 2H), 1.00 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.85, 145.73, 143.25, 143.07, 139.10, 135.78, 135.68, 134.04, 128.63, 124.75, 119.74, 117.03, 113.11, 109.22, 104.52, 96.44, 58.75, 57.15, 56.11, 50.29, 27.30, 16.89, 13.16 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">24</ce:inf>H<ce:inf loc="post">25</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">4</ce:inf>S 521.1714, found 521.1695.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.14" view="all">
                        <ce:label>4.1.14</ce:label>
                        <ce:section-title id="sectitle0160">2-(1-(Butylsulfonyl)-3-(4-(2-(5-(hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>3a</ce:bold>)</ce:section-title>
                        <ce:para id="p0240" view="all">Synthesized using the <ce:bold>procedure 1, 3, 4 and 5</ce:bold> using 5-hydroxymethylfurfural then butyl sulfonyl chloride, and 0.2 g (27% for 4 steps) of <ce:bold>3a</ce:bold> was obtained as a brown solid. mp 183–187 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.95 (s, 1H), 8.90 (s, 1H), 8.69 (s, 1H), 8.14 (s, 1H), 7.37 (s, 1H), 6.41 (s, 2H), 5.96 (s, 1H), 5.44 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 4.62 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.48 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 4.35 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.78 (s, 2H), 3.29 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.53 (s, 2H), 1.76–1.66 (m, 2H), 1.50–1.38 (m, 2H), 0.92 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.86, 145.75, 143.27, 143.09, 139.10, 135.80, 135.69, 134.05, 128.65, 124.76, 119.77, 117.06, 113.13, 109.23, 104.54, 96.46, 58.78, 57.16, 56.13, 48.45, 27.33, 25.08, 21.36, 13.94 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">25</ce:inf>H<ce:inf loc="post">27</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">4</ce:inf>S 535.1870, found 535.1870.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.15" view="all">
                        <ce:label>4.1.15</ce:label>
                        <ce:section-title id="sectitle0165">2-(Thiophen-2-yl)-1-(1-(1-((trifluoromethyl)sulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>2c</ce:bold>)</ce:section-title>
                        <ce:para id="p0245" view="all">Synthesized using the <ce:bold>procedure 1, 6, 3, 4 and 5</ce:bold> using 2-thenaldehyde, 1-Boc-3-iodoazetidine then trifluoromethanesulfonyl chloride, and 0.1 g (9% for 5 steps) of <ce:bold>2c</ce:bold> was obtained as a pink solid. mp 196–201 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.93 (s, 1H), 8.68 (s, 1H), 8.62 (s, 1H), 8.17 (s, 1H), 7.73 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.37 (s, 1H), 7.24 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.13 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 1H), 5.89 (s, 1H), 5.65 (s, 1H), 4.87 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 4.79 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.24, 145.73, 139.58, 136.43, 135.46, 133.93, 132.38, 130.73, 129.66, 128.50, 124.81, 120.51, 118.99, 104.62, 96.52, 64.50, 59.94, 49.83 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">15</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf> 494.0675, found 494.0665.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.16" view="all">
                        <ce:label>4.1.16</ce:label>
                        <ce:section-title id="sectitle0170">1,1,1-Trifluoro-N-(2-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)ethyl)methanesulfonamide (<ce:bold>3c</ce:bold>)</ce:section-title>
                        <ce:para id="p0250" view="all">Synthesized using the <ce:bold>procedure 1, 6, 4 and 5</ce:bold> using 2-thenaldehyde, 2-bromoethylamine hydrobromide then trifluoromethanesulfonyl chloride, and 0.1 g (17% for 4 steps) of <ce:bold>3c</ce:bold> was obtained as a yellow solid. mp 173–177 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 9.94 (s, 1H), 8.67 (s, 1H), 8.46 (s, 1H), 7.98 (s, 1H), 7.71 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.34 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.21 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.08 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 1H), 5.95 (s, 1H), 4.49 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.76 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.20, 145.59, 138.17, 136.43, 135.31, 133.84, 132.45, 130.36, 129.39, 128.37, 124.58, 122.32, 120.48, 118.23, 104.62, 96.56, 64.47, 51.96, 44.00 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">15</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf> 482.0675, found 482.0676.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.17" view="all">
                        <ce:label>4.1.17</ce:label>
                        <ce:section-title id="sectitle0175">N-(2-(4-(2-(thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)ethyl)propane-1-sulfonamide (<ce:bold>4c</ce:bold>)</ce:section-title>
                        <ce:para id="p0255" view="all">Synthesized using the <ce:bold>procedure 1, 6, 4 and 5</ce:bold> using 2-thenaldehyde, 2-bromoethylamine hydrobromide then propyl sulfonyl chloride, and 0.1 g (21% for 4 steps) of <ce:bold>4c</ce:bold> was obtained as a light brown solid. mp 199–204 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.90 (s, 1H), 8.66 (s, 1H), 8.42 (s, 1H), 7.94 (s, 1H), 7.71 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.40 (s, 1H), 7.33 (s, 1H), 7.22 (s, 1H), 7.11 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 1H), 5.94 (s, 1H), 4.42 (s, 2H), 3.53 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.08 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 1.75–1.67 (m, 2H), 0.99 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.23, 145.61, 137.90, 136.44, 135.33, 133.85, 132.43, 130.24, 129.37, 128.46, 124.61, 118.27, 104.63, 96.60, 53.19, 52.43, 42.85, 17.35, 13.14 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">22</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf>S<ce:inf loc="post">2</ce:inf> 456.1271, found 456.1268.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.18" view="all">
                        <ce:label>4.1.18</ce:label>
                        <ce:section-title id="sectitle0180">2-(1-(Ethylsulfonyl)-3-(4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile (<ce:bold>1e</ce:bold>)</ce:section-title>
                        <ce:para id="p0260" view="all">Synthesized using the <ce:bold>procedure 2, 3, 4 and 5</ce:bold> using ethyl sulfonyl chloride, and 0.2 g (33% for 4 steps) of <ce:bold>1e</ce:bold> was obtained as a light white solid. mp 225–230 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.96 (s, 1H), 8.87 (s, 1H), 8.70 (s, 1H), 8.36 (s, 1H), 8.21 (s, 1H), 7.43 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.34 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.58 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 4.32 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 3.75 (s, 2H), 3.33–3.26 (m, 2H), 1.29 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 4H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 145.62, 142.86, 137.08, 136.05, 135.04, 133.08, 126.19, 124.52, 120.40, 117.12, 104.40, 97.02, 70.39, 64.50, 58.89, 56.94, 43.91, 27.22, 7.92 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">19</ce:inf>N<ce:inf loc="post">8</ce:inf>O<ce:inf loc="post">2</ce:inf>S 411.1346, found 411.1351.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.19" view="all">
                        <ce:label>4.1.19</ce:label>
                        <ce:section-title id="sectitle0185">3-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5a</ce:bold>)</ce:section-title>
                        <ce:para id="p0265" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-hydroxymethylfurfural then 3-bromopropionitrile, and 0.2 g (10% for 3 steps) of <ce:bold>5a</ce:bold> was obtained as a light yellow solid. mp 210–215 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.89 (s, 1H), 8.66 (s, 1H), 8.50 (s, 1H), 7.96 (s, 1H), 7.35 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.39 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.32 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.96 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.42 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 4.61 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 4.48 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.26 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.78, 157.47, 145.67, 143.23, 138.19, 135.90, 135.62, 134.01, 131.03, 127.33, 124.62, 123.63, 119.93, 118.80, 118.63, 104.56, 56.10, 19.18 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf> 374.1360, found 374.1362.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.20" view="all">
                        <ce:label>4.1.20</ce:label>
                        <ce:section-title id="sectitle0190">2-(4-(2-(5-(Hydroxymethyl)furan-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)acetonitrile (<ce:bold>6a</ce:bold>)</ce:section-title>
                        <ce:para id="p0270" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-hydroxymethylfurfural then bromoacetonitrile, and 0.1 g (16% for 3 steps) of <ce:bold>6a</ce:bold> was obtained as a dark brown solid. mp 216–219 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.89 (s, 1H), 8.67 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 8.42 (s, 1H), 7.93 (s, 1H), 7.39 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.43 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.35 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.02 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.43 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 5.33 (s, 1H), 4.49 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.80 (s, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 169.13, 157.79, 145.66, 143.25, 138.08, 135.95, 133.97, 131.01, 124.72, 118.97, 112.96, 109.20, 104.62, 96.44, 56.10, 52.96 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">14</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf> 360.1203, found 360.1683.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.21" view="all">
                        <ce:label>4.1.21</ce:label>
                        <ce:section-title id="sectitle0195">3-(4-(2-(5-Methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5b</ce:bold>)</ce:section-title>
                        <ce:para id="p0275" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methyl furfural then 3-bromopropionitrile, and 0.1 g (22% for 3 steps) of <ce:bold>5b</ce:bold> was obtained as a yellow solid. mp 215–221 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.88 (s, 1H), 8.65 (s, 1H), 8.49 (s, 1H), 7.95 (s, 1H), 7.34 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.32 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 6.21 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.95 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.61 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.26 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) 2.36 (s, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 154.37, 145.63, 143.32, 142.66, 138.23, 135.85, 135.51, 134.01, 129.74, 124.61, 118.80, 118.74, 113.49, 108.52, 104.57, 96.45, 48.04, 19.19, 13.71 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf>O 358.1411, found 358.1425.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.22" view="all">
                        <ce:label>4.1.22</ce:label>
                        <ce:section-title id="sectitle0200">3-(4-(2-(3-Hydroxyphenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5c</ce:bold>)</ce:section-title>
                        <ce:para id="p0280" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 3-hydroxybenzaldehyde then 3-bromopropionitrile, and 0.2 g (16% for 3 steps) of <ce:bold>5c</ce:bold> was obtained as a gray solid. mp 247–250 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.87 (s, 1H), 9.66 (s, 1H), 8.69 (s, 1H), 8.41 (s, 1H), 7.86 (s, 1H), 7.34 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.26 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.19 (t, <ce:italic>J</ce:italic> = 9.0 Hz, 1H), 7.07 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.87–6.83 (m, 1H), 6.00 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.56 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.21 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.65, 150.93, 145.56, 138.25, 136.49, 135.68, 133.84, 131.18, 129.86, 129.55, 124.45, 119.89, 119.64, 118.73, 117.04, 116.29, 104.76, 96.65, 47.97, 19.17 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf>O 370.1411, found 370.1425.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.23" view="all">
                        <ce:label>4.1.23</ce:label>
                        <ce:section-title id="sectitle0205">3-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5d</ce:bold>)</ce:section-title>
                        <ce:para id="p0285" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methylthiophene-2-carboxaldehyde then 3-bromopropionitrile, and 0.1 g (17% for 3 steps) of <ce:bold>5d</ce:bold> was obtained as a light yellow solid. mp 210–216 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.86 (s, 1H), 8.64 (s, 1H), 8.52 (s, 1H), 7.98 (s, 1H), 7.33 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.03 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.78 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.92 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.62 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.27 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.47 (s, 3H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.32, 145.59, 143.22, 138.52, 136.31, 135.24, 133.88, 130.18, 129.84, 128.52, 126.81, 124.60, 118.77, 118.67, 104.58, 96.35, 48.09, 19.26, 15.27 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf>S 374.1182, found 374.1195.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.24" view="all">
                        <ce:label>4.1.24</ce:label>
                        <ce:section-title id="sectitle0210">3-(4-(2-(2-Chlorophenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5e</ce:bold>)</ce:section-title>
                        <ce:para id="p0290" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 2-chlorobenzaldehyde then 3-bromopropionitrile, and 0.1 g (21% for 3 steps) of <ce:bold>5e</ce:bold> was obtained as a light green solid. mp 186–191 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.93 (s, 1H), 8.72 (s, 1H), 8.29 (s, 1H), 7.70 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.55 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 2H), 7.44–7.52 (m, 1H), 7.39 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.16 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.46 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) 3.12 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 149.44, 145.60, 137.55, 135.83, 134.93, 134.02, 133.74, 133.22, 132.17, 129.88, 129.80, 128.90, 127.47, 124.63, 118.62, 118.27, 104.56, 96.73, 47.82, 19.04 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20-</ce:inf>H<ce:inf loc="post">15</ce:inf>ClN<ce:inf loc="post">7</ce:inf> 388.1072, found 388.1102.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.25" view="all">
                        <ce:label>4.1.25</ce:label>
                        <ce:section-title id="sectitle0215">3-(4-(2-(4-(Methylsulfonyl)phenyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5f</ce:bold>)</ce:section-title>
                        <ce:para id="p0295" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 4-methylsulphonyl benzaldehyde then 3-bromopropionitrile, and 0.1 g (31% for 3 steps) of <ce:bold>5f</ce:bold> was obtained as a dark yellow solid. mp 198–203 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.97 (s, 1H), 8.77 (s, 1H), 8.49 (s, 1H), 8.03–7.96 (m, 4H), 7.92 (s, 1H), 7.39 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.04 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.59 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 3.28 (s, 3H), 3.23 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 149.14, 145.68, 141.54, 138.28, 136.68, 136.08, 134.74, 134.00, 129.95, 129.86, 127.54, 124.72, 119.15, 118.75, 104.68, 96.79, 48.03, 43.79, 19.29 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">7</ce:inf>O<ce:inf loc="post">2</ce:inf>S 432.1237, found 432.1241.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.26" view="all">
                        <ce:label>4.1.26</ce:label>
                        <ce:section-title id="sectitle0220">3-(4-(2-(Trifluoromethyl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5g</ce:bold>)</ce:section-title>
                        <ce:para id="p0300" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using trifluoroacetaldehyde then 3-bromopropionitrile, and 0.2 g (33% for 3 steps) of <ce:bold>5g</ce:bold> was obtained as a white solid. mp 218–222 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 12.18 (s, 1H), 8.84 (s, 1H), 8.56 (s, 1H), 8.04 (s, 1H), 7.45 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.05 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.61 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.25 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.31, 139.10, 138.59, 138.09, 137.05, 136.31, 132.02, 129.84, 125.29, 120.89, 118.68, 117.30, 116.51, 104.31, 97.01, 48.05, 19.10 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">15</ce:inf>H<ce:inf loc="post">11</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">7</ce:inf> 346.1023, found 346.1049.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.27" view="all">
                        <ce:label>4.1.27</ce:label>
                        <ce:section-title id="sectitle0225">3-(4-(2-(Thiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5h</ce:bold>)</ce:section-title>
                        <ce:para id="p0305" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 2-thenaldehyde then 3-bromopropionitrile, and 0.2 g (22% for 3 steps) of <ce:bold>5h</ce:bold> was obtained as a light yellow solid. mp 221–226 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.94 (s, 1H), 8.69 (s, 1H), 8.57 (s, 1H), 8.04 (s, 1H), 7.74 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 7.37 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.22 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.10 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 1H), 5.96 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.65 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.30 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.22, 145.67, 138.58, 136.44, 135.42, 133.90, 132.46, 130.23, 129.51, 128.30, 124.67, 120.51, 118.75, 104.62, 96.43, 64.50, 48.12, 19.29 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">14</ce:inf>N<ce:inf loc="post">7</ce:inf>S 360.1026, found 360.1033.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.28" view="all">
                        <ce:label>4.1.28</ce:label>
                        <ce:section-title id="sectitle0230">3-(4-(2-(Thiazol-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5i</ce:bold>)</ce:section-title>
                        <ce:para id="p0310" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 2-thiazolecarboxaldehyde then 3-bromopropionitrile, and 0.2 g (31% for 3 steps) of <ce:bold>5i</ce:bold> was obtained as a yellow solid. mp 247–250 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 12.04 (s, 1H), 8.76 (s, 1H), 8.44 (s, 1H), 7.95–7.91 (m, 3H), 7.38 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.04 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.59 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.25 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.89, 145.93, 144.50, 138.49, 136.63, 136.15, 135.26, 133.75, 132.31, 129.71, 124.78, 123.35, 120.51, 118.88, 114.62, 104.62, 97.09, 70.39, 64.50, 61.55, 52.70, 49.75, 47.93, 19.20 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">13</ce:inf>N<ce:inf loc="post">8</ce:inf>S 361.0978, found 361.2340.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.29" view="all">
                        <ce:label>4.1.29</ce:label>
                        <ce:section-title id="sectitle0235">3-(4-(2-(Thiazol-5-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5j</ce:bold>)</ce:section-title>
                        <ce:para id="p0315" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using thiazole-5-carboxaldehyde then 3-bromopropionitrile, and 0.2 g (19% for 3 steps) of <ce:bold>5j</ce:bold> was obtained as a dark yellow solid. mp 227–231 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.98 (s, 1H), 9.20 (s, 1H), 8.70 (s, 1H), 8.56 (s, 1H), 8.01 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 7.37 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.97 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.64 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.27 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 156.69, 145.70, 144.30, 143.13, 138.53, 136.36, 135.59, 134.08, 130.36, 128.12, 124.81, 118.82, 118.08, 104.55, 96.50, 48.18, 19.26 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">13</ce:inf>N<ce:inf loc="post">8</ce:inf>S 361.0978, found 361.2341.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.30" view="all">
                        <ce:label>4.1.30</ce:label>
                        <ce:section-title id="sectitle0240">3-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)propanenitrile (<ce:bold>5k</ce:bold>)</ce:section-title>
                        <ce:para id="p0320" view="all">Synthesized using the <ce:bold>procedure 2, 6 and 5</ce:bold> using 3-bromopropionitrile, and 0.1 g (15% for 3 steps) of <ce:bold>5k</ce:bold> was obtained as a light white solid. mp 258–262 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.94 (s, 1H), 8.68 (s, 1H), 8.51 (s, 1H), 8.32 (s, 1H), 8.04 (s, 1H), 7.42 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.36 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 1H), 4.58 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.23 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.67, 150.90, 145.57, 138.27, 136.51, 135.69, 133.84, 131.18, 129.89, 129.57, 124.49, 119.93, 119.65, 118.74, 117.08, 116.31, 104.78, 96.67, 47.98, 19.18 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">14</ce:inf>H<ce:inf loc="post">12</ce:inf>N<ce:inf loc="post">7</ce:inf> 278.1149, found 278.1955.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.31" view="all">
                        <ce:label>4.1.31</ce:label>
                        <ce:section-title id="sectitle0245">4-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6k</ce:bold>)</ce:section-title>
                        <ce:para id="p0325" view="all">Synthesized using the <ce:bold>procedure 2, 6 and 5</ce:bold> using 4-bromobutyronitrile, and 0.1 g (31% for 3 steps) of <ce:bold>6k</ce:bold> was obtained as a white solid. mp 197–200 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.67 (s, 1H), 8.44 (s, 1H), 8.28 (s, 1H), 7.98 (s, 1H), 7.42 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.31 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.37 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.62 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.27–2.18 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 145.58, 142.92, 136.06, 135.56, 135.11, 133.05, 127.12, 124.43, 120.47, 119.25, 104.45, 96.98, 51.09, 26.24, 14.35 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">15</ce:inf>H<ce:inf loc="post">14</ce:inf>N<ce:inf loc="post">7</ce:inf> 292.1305, found 292.1314.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.32" view="all">
                        <ce:label>4.1.32</ce:label>
                        <ce:section-title id="sectitle0250">5-(4-(Imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)pentanenitrile (<ce:bold>7k</ce:bold>)</ce:section-title>
                        <ce:para id="p0330" view="all">Synthesized using the <ce:bold>procedure 2, 6 and 5</ce:bold> using 5-bromovaleronitrile, and 0.1 g (13% for 3 steps) of <ce:bold>7k</ce:bold> was obtained as a gray solid. mp 203–207 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.68 (s, 1H), 8.43 (s, 1H), 8.31 (s, 1H), 7.97 (s, 1H), 7.42 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.26 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.33 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.63 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.05–1.95 (m, 2H), 1.68–1.58 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 145.55, 142.94, 136.06, 135.40, 135.09, 133.14, 127.01, 124.42, 120.98, 118.98, 104.45, 96.80, 51.50, 29.32, 22.51, 16.21 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">16</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf> 306.1462, found 306.1468.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.33" view="all">
                        <ce:label>4.1.33</ce:label>
                        <ce:section-title id="sectitle0255">1-(1-(4,4,4-Trifluorobutyl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>8k</ce:bold>)</ce:section-title>
                        <ce:para id="p0335" view="all">Synthesized using the <ce:bold>procedure 2, 6 and 5</ce:bold> using 1-bromo-4,4,4-trifluorobutane, and 0.1 g (16% for 3 steps) of <ce:bold>8k</ce:bold> was obtained as a light yellow solid. mp 176–179 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.96 (s, 1H), 8.68 (s, 1H), 8.46 (s, 1H), 8.32 (s, 1H), 7.99 (s, 1H), 7.43 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.26 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.38 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.44–2.30 (m, 2H), 2.19–2.10 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 145.67, 143.09, 136.17, 135.75, 135.23, 133.22, 132.31, 129.89, 127.30, 124.56, 123.46, 120.51, 119.24, 114.62, 107.14, 104.55, 96.86, 70.39, 64.50, 61.55, 52.70, 51.09, 49.75, 30.50, 23.26 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">15</ce:inf>H<ce:inf loc="post">14</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">6</ce:inf> 335.1227, found 335.2531.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.34" view="all">
                        <ce:label>4.1.34</ce:label>
                        <ce:section-title id="sectitle0260">4-(4-(2-(5-Methylfuran-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6b</ce:bold>)</ce:section-title>
                        <ce:para id="p0340" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methyl furfural then 4-bromobutyronitrile, and 0.2 g (21% for 3 steps) of <ce:bold>6b</ce:bold> was obtained as a white solid. mp 201–206 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.93 (s, 1H), 8.66 (s, 1H), 8.44 (s, 1H), 7.93 (s, 1H), 7.38 (s, 1H), 6.35 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 6.26 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.88 (s, 1H), 4.41 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.64 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.31 (s, 3H), 2.28–2.22 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 154.23, 145.67, 143.30, 142.83, 137.64, 135.86, 135.58, 134.07, 129.42, 124.66, 120.37, 118.74, 113.43, 108.56, 104.59, 96.30, 51.14, 26.31, 14.29, 13.73 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">7</ce:inf>O 372.1567, found 372.2493.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.35" view="all">
                        <ce:label>4.1.35</ce:label>
                        <ce:section-title id="sectitle0265">4-(4-(2-(2-Aminothiazol-5-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>7b</ce:bold>)</ce:section-title>
                        <ce:para id="p0345" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 2-aminothiazole-5-carboxaldehyde then 4-bromobutyronitrile, and 0.2 g (19% for 3 steps) of <ce:bold>7b</ce:bold> was obtained as a dark brown solid. mp 219–225 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.84 (s, 1H), 8.58 (s, 1H), 8.45 (s, 1H), 7.96 (s, 1H), 7.53 (s, 1H), 7.34 (s, 1H), 7.00 (s, 1H), 5.81 (s, 1H), 4.41 (s, 2H), 2.63 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 2.26 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 170.74, 145.80, 145.53, 140.56, 137.94, 136.13, 134.81, 134.12, 129.80, 124.62, 120.35, 118.56, 114.53, 104.51, 96.01, 51.18, 26.33, 14.28 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">9</ce:inf>S 390.1244, found 390.2187.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.36" view="all">
                        <ce:label>4.1.36</ce:label>
                        <ce:section-title id="sectitle0270">4-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>6d</ce:bold>)</ce:section-title>
                        <ce:para id="p0350" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methylthiophene-2-carboxaldehyde then 4-bromobutyronitrile, and 0.2 g (24% for 3 steps) of <ce:bold>6d</ce:bold> was obtained as a yellow solid. mp 221–227 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.90 (s, 1H), 8.65 (s, 1H), 8.46 (s, 1H), 7.96 (s, 1H), 7.36 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.06 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 6.82 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.84 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.41 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.63 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.48 (s, 3H), 2.31–2.21 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.34, 145.62, 143.14, 137.98, 136.33, 135.31, 133.93, 129.70, 128.60, 126.77, 124.66, 120.34, 118.66, 104.62, 96.17, 60.22, 51.20, 26.34, 21.19, 15.26, 14.52, 14.26 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">7</ce:inf>S 388.1339, found 388.2289.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.37" view="all">
                        <ce:label>4.1.37</ce:label>
                        <ce:section-title id="sectitle0275">2-(5-Methylthiophen-2-yl)-1-(1-(4,4,4-trifluorobutyl)-1H-pyrazol-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (<ce:bold>7d</ce:bold>)</ce:section-title>
                        <ce:para id="p0355" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methylthiophene-2-carboxaldehyde then 1-bromo-4,4,4-trifluorobutane, and 0.2 g (26% for 3 steps) of <ce:bold>7d</ce:bold> was obtained as a yellow solid. mp 199–206 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.90 (s, 1H), 8.64 (s, 1H), 8.45 (s, 1H), 7.96 (s, 1H), 7.35 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.09 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.81 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.80 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.42 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.46 (s, 3H), 2.40–2.27 (m, 2H), 2.20–2.10 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.36, 145.60, 143.16, 138.06, 136.32, 135.33, 133.94, 129.95, 129.78, 128.59, 126.63, 126.04, 124.62, 118.55, 104.60, 95.97, 51.10, 30.57, 30.19, 23.29, 15.17 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">18</ce:inf>F<ce:inf loc="post">3</ce:inf>N<ce:inf loc="post">6</ce:inf>S 431.1260, found 431.2250.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.38" view="all">
                        <ce:label>4.1.38</ce:label>
                        <ce:section-title id="sectitle0280">5-(4-(2-(5-Methylthiophen-2-yl)imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)pentanenitrile (<ce:bold>8d</ce:bold>)</ce:section-title>
                        <ce:para id="p0360" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using 5-methylthiophene-2-carboxaldehyde then 5-bromovaleronitrile, and 0.2 g (31% for 3 steps) of <ce:bold>8d</ce:bold> was obtained as a yellow solid. mp 208–214 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.91 (s, 1H), 8.64 (s, 1H), 8.43 (s, 1H), 7.94 (s, 1H), 7.35 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 7.05 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 1H), 6.83 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.81 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.37 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.65 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.48 (s, 3H), 2.06–1.97 (m, 2H), 1.68–1.59 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 146.36, 145.60, 143.21, 137.81, 136.38, 135.32, 133.93, 129.88, 129.78, 128.50, 126.76, 124.70, 120.98, 118.37, 104.62, 96.05, 51.65, 29.42, 22.52, 16.21, 15.32 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">21</ce:inf>H<ce:inf loc="post">20</ce:inf>N<ce:inf loc="post">7</ce:inf>S 402.1495, found 402.2456.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.39" view="all">
                        <ce:label>4.1.39</ce:label>
                        <ce:section-title id="sectitle0285">4-(4-(2-Methylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9a</ce:bold>)</ce:section-title>
                        <ce:para id="p0365" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using acetaldehyde then 4-bromobutyronitrile, and 0.2 g (18% for 3 steps) of <ce:bold>9a</ce:bold> was obtained as a white solid. mp 197–203 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.81 (s, 1H), 8.54 (s, 1H), 8.40 (s, 1H), 7.93 (s, 1H), 7.35 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 6.02 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.38 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.62 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.51 (s, 3H), 2.28–2.19 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 150.67, 145.39, 136.87, 134.86, 133.71, 128.49, 124.30, 120.37, 118.49, 104.50, 96.15, 51.14, 26.18, 14.33, 14.09 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">16</ce:inf>H<ce:inf loc="post">16</ce:inf>N<ce:inf loc="post">7</ce:inf> 306.1462, found 306.1478.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.40" view="all">
                        <ce:label>4.1.40</ce:label>
                        <ce:section-title id="sectitle0290">4-(4-(2-Cyclopropylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9b</ce:bold>)</ce:section-title>
                        <ce:para id="p0370" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using cyclopropanecarboxaldehyde then 4-bromobutyronitrile, and 0.2 g (34% for 3 steps) of <ce:bold>9b</ce:bold> was obtained as a white solid. mp 205–209 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.71 (s, 1H), 8.43 (s, 1H), 8.37 (s, 1H), 7.88 (s, 1H), 7.28 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.94 (d, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.32 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.55 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 2H), 2.22–2.13 (m, 2H), 1.98–1.91 (m, 1H), 1.03–0.98 (m, 4H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 155.63, 145.32, 137.16, 135.03, 134.77, 133.48, 128.80, 124.31, 120.38, 118.20, 104.46, 96.15, 51.15, 26.21, 14.34, 9.27, 7.85 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">18</ce:inf>H<ce:inf loc="post">18</ce:inf>N<ce:inf loc="post">7</ce:inf> 332.1618, found 332.1610.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.41" view="all">
                        <ce:label>4.1.41</ce:label>
                        <ce:section-title id="sectitle0295">4-(4-(2-Cyclobutylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9c</ce:bold>)</ce:section-title>
                        <ce:para id="p0375" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using cyclobutanecarboxaldehyde then 4-bromobutyronitrile, and 0.2 g (27% for 3 steps) of <ce:bold>9c</ce:bold> was obtained as a light yellow solid. mp 211–217 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.80 (s, 1H), 8.60 (s, 1H), 8.33 (s, 1H), 7.85 (s, 1H), 7.33 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 5.95 (t, <ce:italic>J</ce:italic> = 3.0 Hz, 1H), 4.37 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.75–3.64 (m, 1H), 2.63–2.53 (m, 2H), 2.52–2.43 (m, 2H), 2.27–2.18 (m, 4H), 2.06–1.83 (m, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 156.70, 145.42, 137.05, 135.20, 133.71, 128.65, 124.28, 120.35, 118.20, 104.57, 96.18, 51.12, 32.02, 27.56, 26.24, 18.45, 14.32 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">19</ce:inf>H<ce:inf loc="post">20</ce:inf>N<ce:inf loc="post">7</ce:inf> 346.1775, found 346.1805.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.42" view="all">
                        <ce:label>4.1.42</ce:label>
                        <ce:section-title id="sectitle0300">4-(4-(2-Cyclopentylimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)-1H-pyrazol-1-yl)butanenitrile (<ce:bold>9d</ce:bold>)</ce:section-title>
                        <ce:para id="p0380" view="all">Synthesized using the <ce:bold>procedure 1, 6 and 5</ce:bold> using cyclopentanecarbaldehyde then 4-bromobutyronitrile, and 0.2 g (29% for 3 steps) of <ce:bold>9d</ce:bold> was obtained as a light yellow solid. mp 227–232 °C. <ce:sup loc="post">1</ce:sup>HNMR(300 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>): <ce:italic>δ</ce:italic> = 11.81 (s, 1H), 8.56 (s, 1H), 8.41 (s, 1H), 7.90 (s, 1H), 7.32 (s, 1H), 5.89 (s, 1H), 4.38 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 3.31–3.18 (m, 1H), 2.62 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 2.26 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 2H), 1.94 (t, <ce:italic>J</ce:italic> = 6.0 Hz, 4H), 1.78 (s, 2H), 1.62 (d, <ce:italic>J</ce:italic> = 6.0 Hz, 2H) ppm; <ce:sup loc="post">13</ce:sup>C NMR (75 MHz, DMSO‑<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 157.87, 145.32, 137.40, 135.34, 135.02, 133.49, 129.04, 124.28, 120.36, 118.30, 104.55, 96.03, 51.11, 36.62, 32.29, 26.20, 25.81, 14.28 ppm; HRMS (ESI): <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> [M+H]<ce:sup loc="post">+</ce:sup>.Calcd for C<ce:inf loc="post">20</ce:inf>H<ce:inf loc="post">22</ce:inf>N<ce:inf loc="post">7</ce:inf> 360.1931, found 360.1935.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.2" view="all">
                     <ce:label>4.2</ce:label>
                     <ce:section-title id="sectitle0305">Biologic assays</ce:section-title>
                     <ce:section id="sec4.2.1" view="all">
                        <ce:label>4.2.1</ce:label>
                        <ce:section-title id="sectitle0310">Enzyme assay</ce:section-title>
                        <ce:para id="p0385" view="all">Recombinant kinases of human JAK enzymes were purchased from Carna Biosciences Inc. (JAK1: 08–144; JAK2: 08–045; JAK3: 08–046; TYK2: 08–147), and Kinase substrate22, 30 and Kinase JAK1 peptide were from GL Inc. (Kinase substrate22: 112393; Kinase substrate30: 117885; Kinase JAK1 peptide: 758318). The 250 nL samples of test compounds and controls solubilized in 100% DMSO were added to a 384-well polypropylene plate using a noncontact acoustic dispenser. Kinase assays were carried out at room temperature in a 15 μL reaction buffer containing 20 mM HEPES, pH 7.4, 1 mM ATP, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween 20, and 1 mM DTT. The assays were initiated by the addition of enzyme. The assays were stopped with 30 μL of a buffer containing 180 mM HEPES, pH 7.4, 20 mM EDTA, 0.2% Coating Reagent, resulting in a final concentration of 10 mM EDTA, 0.1% Coating Reagent, and 100 mM HEPES, pH 7.4. The conversion% were read by Caliper EZ Reader.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.2" view="all">
                        <ce:label>4.2.2</ce:label>
                        <ce:section-title id="sectitle0315">Cellular assays</ce:section-title>
                        <ce:para id="p0390" view="all">The activities of compounds were determined in cell-based assays that are designed to measure JAK-dependent STAT phosphorylation. TF-1 cells are cultured in RPMI 1640 + 10% FBS+2 ng/mL Recombinant Human Protein GM-CSF medium. Cells are maintained in log phase before the assay. Compounds were serially diluted in DMSO and incubated for 2 h at 37 °C with TF-1 cells in 384-well microtiter plates in RPMI-1640 at a final cell density of 40,000 cells per well. freshly prepared GM-CSF (final conc. 100 ng/ml) were then added at the final concentrations indicated to the microtiter plates containing the TF-1 cells and compounds and the plates were incubated for 10 min at 37 °C. Cells are lysed by adding 4 μl lysis buffer and shaking for 30 min at room temperature. Add 4 μL/well of premixed antibody solutions prepared in the detection buffer. Cover the plate with a plate sealer. Incubate overnight at room temperature. Read plate (HTRF protocol) on Envision (plate reader). THP-1 cells are cultured in RPMI 1640 + 10% FBS+0.05 mM 2-mercaptoethanol medium. Cells are maintained in log phase before the assay. Cell pellets are collected and re-suspended in serum free and phenol free RPMI1640 medium. 40,000 cells/well (10 μl) are seeded in each well of 384-well plate. Compounds were serially diluted in DMSO and incubated for 2 h at 37 °C with THP-1 cells. Stimulate cells with freshly prepared IL-4 (final conc. 200 ng/ml), incubate for 10 min at 37 °C. Cells are lysed by adding 4 μl lysis buffer and shaking for 30 min at room temperature. Add 4 μL/well of premixed antibody solutions prepared in the detection buffer. Cover the plate with a plate sealer. Incubate overnight at room temperature. Read plate (HTRF protocol) on Envision (plate reader).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.3" view="all">
                        <ce:label>4.2.3</ce:label>
                        <ce:section-title id="sectitle0320">Microsomal metabolism</ce:section-title>
                        <ce:para id="p0395" view="all">The liver is the main organ of drug metabolism in the body. Subcellular fractions such as liver microsomes are useful in vitro models of hepatic clearance as they contain many of the drug metabolising enzymes found in the liver. Microsomes are easy to prepare and can be stored for long periods of time. They are easily adaptable to high throughput screens which enable large numbers of compounds to be screened rapidly and inexpensively. The metabolic stability is conducted in microsomes at time-gradient (5, 10, 20, 30, 60, 120 min). Microsomes (0.8 mg/mL) are incubated with the test compounds (1 μM) at 37 °C in the presence of the co-factor, NADPH, which initiates the reaction. After the incubation period, the reaction is terminated by the addition of Acetonitrile. Following centrifugation, the amount of parent compound in the supernatant is quantified by HPLC-MS/MS. The percentage of metabolism is calculated by comparing the peak area of the parent compound versus zero time point control.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.4" view="all">
                        <ce:label>4.2.4</ce:label>
                        <ce:section-title id="sectitle0325">JAK2-STAT pathway assay</ce:section-title>
                        <ce:para id="p0400" view="all">TF-1 cells were cultured in RPMI-1640 with 10% FBS + 2 ng/ml GM-CSF and incubated at 37 °C in a 5% CO<ce:inf loc="post">2</ce:inf> incubator. TF-1 cells were plated at density of 6 × 10<ce:sup loc="post">6</ce:sup> cells/well in a 6-well plate. After 24 h cultivation, the cells were treated with different concentrations of compounds and further cultured for 3 h. Then, cells were collected and lysed. Proteins were resolved by SDS-polyacrylamide gel electrophoresis, transferred to a PVDF membrane. Membrane was blocked in 5% non-fat dried milk in Tris-buffered saline (pH7.4) containing 0.1% Tween 20 (TBST) for 0.5 h and subsequently incubated with primary antibodies diluted in TBST at 4 °C overnight. Membranes were then probed with horseradish Peroxidase-conjugated secondary antibodies and developed using enhanced chemiluminescence (ECL) reagent. Band intensities were measured using ImageJ software program. The antibodies used in these experiments are pSTAT5 (Y694), β-actin antibodies.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.5" view="all">
                        <ce:label>4.2.5</ce:label>
                        <ce:section-title id="sectitle0330">Pharmacokinetic in rats</ce:section-title>
                        <ce:para id="p0405" view="all">The pharmacokinetics of test compounds were evaluated following intravenous injection (IV) or oral administration (PO) of solution at doses of 1–20 mg/kg in Lewis rats. Compounds were dissolved in 70/20/10 Normal Saline/PEG400/DMSO. Blood samples for IV or PO dose groups were collected prior to administration (Predose) and at 0.03, 0.08, 0.17, 0.33, 0.5, 1, 2, 4, 6, 8, 12 and 24 h post dose. The vehicle used for IV and PO dose groups was a combination of PEG400 with citrate buffer (pH5.0) or PEG400 with DMSO/Normal Saline. Plasma concentrations were quantitated using a non-validated LC/MS/MS method. PK parameters were determined by non-compartmental methods using WinNonlin (version 8.0).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.6" view="all">
                        <ce:label>4.2.6</ce:label>
                        <ce:section-title id="sectitle0335">Pharmacodynamics in mice</ce:section-title>
                        <ce:para id="p0410" view="all">C57 mice were orally administered Normal Saline, or ascending doses (10–50 mg/kg) of compound <ce:bold>6k</ce:bold> formulated in DMSO/PEG400/Normal Saline = 10:20:70 in 200 μL volume at t = 0. 30 min later, mice were stimulated intraperitoneally with 1 μg recombinant mouse GM-CSF in 10 μL saline. 30 min after GM-CSF administration, animals were sacrificed and snap frozen spleen samples were collected for analysis of concentrations of pSTAT3 and pSTAT5, respectively. Spleen homogenates were thawed on ice, and their total protein concentration was measured by the ELISA method (Jianglai Biological Technology Co. LTD; JL13517, JL50768) per the manufacturer’s protocol.</ce:para>
                     </ce:section>
                  </ce:section>
               </ce:section>
            </ce:sections>
            <ce:conflict-of-interest id="coi0010" view="all">
               <ce:section-title id="sectitle0340">Declaration of competing interest</ce:section-title>
               <ce:para id="p0415" view="all">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</ce:para>
            </ce:conflict-of-interest>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0345">Acknowledgments</ce:section-title>
               <ce:para id="p0420" view="all">We gratefully acknowledge financial support for the <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100001809" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">National Natural Science Foundation of China</ce:grant-sponsor> (no. <ce:grant-number refid="gs1">21672260</ce:grant-number>), the financial support of the <ce:grant-sponsor id="gs2" sponsor-id="https://doi.org/10.13039/501100004608" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">National Natural Science Foundation of Jiangsu Province of China</ce:grant-sponsor> (no. <ce:grant-number refid="gs2">BK20170743</ce:grant-number> and <ce:grant-number refid="gs2">BK20171393</ce:grant-number>), a <ce:grant-sponsor id="gs3" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">National Innovation and Entrepreneurship Training Program For College Students</ce:grant-sponsor> (<ce:grant-number refid="gs3">201910316030S</ce:grant-number>) the <ce:grant-sponsor id="gs4" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">‘Double FirstClass’ University Project</ce:grant-sponsor> (<ce:grant-number refid="gs4">CPU2018GY07</ce:grant-number>), and the <ce:grant-sponsor id="gs5" sponsor-id="https://doi.org/10.13039/501100011198" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">State Key Laboratory of Drug Research</ce:grant-sponsor> (<ce:grant-number refid="gs5">SIMM1903KF-03</ce:grant-number>) and <ce:grant-sponsor id="gs6" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor" xlink:type="simple">Postgraduate Research & Practice Innovation Program of Jiangsu Province</ce:grant-sponsor> (<ce:grant-number refid="gs6">KYCX18_0770</ce:grant-number>).</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec1" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0350">Supplementary data</ce:section-title>
                  <ce:para id="p0425" view="all">The following is the Supplementary data to this article:<ce:display>
                        <ce:e-component id="mmc1">
                           <ce:label>Multimedia component 1</ce:label>
                           <ce:alt-text id="alttext0015" role="short">Multimedia component 1</ce:alt-text>
                           <ce:link locator="mmc1" xlink:href="pii:S0223523421002439/mmc1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" xlink:type="simple"/></ce:link>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
               <ce:section id="appsec2" view="compact-standard">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0355">Supplementary data</ce:section-title>
                  <ce:para id="p0430" view="all">Supplementary data to this article can be found online at <ce:inter-ref id="intref0010" xlink:href="https://doi.org/10.1016/j.ejmech.2021.113394" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2021.113394</ce:inter-ref>.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0360">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Daniel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Attilio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Robert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Jürgen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.B.</ce:given-name>
                                 <ce:surname>Michael</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Michelle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.B.</ce:given-name>
                                 <ce:surname>Clara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Mario</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.V.</ce:given-name>
                                 <ce:surname>James</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Blood</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>127</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2391</sb:first-page>
                              <sb:last-page>2406</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1515/jtim-2017-0002</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0030">A. A. Daniel, O. Attilio, H. Robert, T. Jurgen, J. B. Michael, M. Le B. Michelle, D. B. Clara, C. Mario, W. V. James, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood. 127 (2016) 2391-2406, https://doi.org/10.1515/jtim-2017-0002.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Legare</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.G.</ce:given-name>
                                 <ce:surname>Gilliland</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Myelodysplastic syndrome</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Opin. Hematol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>1995</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>283</sb:first-page>
                              <sb:last-page>292</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1097/00062752-199502040-00008</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0035">R. D. Legare, D. G. Gilliland, Myelodysplastic syndrome, Curr Opin Hematol. 2 (1995) 283-292, https://doi.org/10.1097/00062752-199502040-00008.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Monali</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Syed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Xin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.V.</ce:given-name>
                                 <ce:surname>Kent</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Novel immunotherapies for hematological malignancies</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Mol. Pharmacol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>264</sb:first-page>
                              <sb:last-page>271</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.2174/1874467208666150716121253</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0040">V. Monali, R. Syed, L. Xin, E. V. Kent, Z. Hong, Novel immunotherapies for hematological malignancies, Curr. Mol. Pharmacol. 9(2016)264-271, https://doi.org/10.2174/1874467208666150716121253.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Vesna</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Natasa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Tatjana</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Sonja</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Milica</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Srp. Arh. Celok. Lek.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>138</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>614</sb:first-page>
                              <sb:last-page>618</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.2298/SARH1010614S</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0045">S. Vesna, T. Natasa, K. Tatjana, P. Sonja, C. Milica, JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation, Srp Arh Celok Lek. 138 (2010) 614-618, https://doi.org/10.2298/SARH1010614S.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.L.</ce:given-name>
                                 <ce:surname>Emily</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Susan</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Ruxolitinib: a new treatment for myelofibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin. J. Oncol. Nurs.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>312</sb:first-page>
                              <sb:last-page>318</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1188/13.CJON.312-318</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0050">W. L. Emily, M. S. Susan, Ruxolitinib: a new treatment for myelofibrosis, Clin. J. Oncol. Nurs. 17 (2013) 312-318, https://doi.org/10.1188/13.CJON.312-318.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>William</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.-H.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Blanchard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Poulsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.L.</ce:given-name>
                                 <ce:surname>Teo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Nagaraj</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Tan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Williams</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.T.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.C.</ce:given-name>
                                 <ce:surname>Goh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.C.</ce:given-name>
                                 <ce:surname>Ong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.K.</ce:given-name>
                                 <ce:surname>Goh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jayaraman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Pasha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ethirajulu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Wood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.W.</ce:given-name>
                                 <ce:surname>Dymock</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14, 19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4638</sb:first-page>
                              <sb:last-page>4658</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm200326p</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0055">A. D. William, A. C.-H. Lee, S. Blanchard, A. Poulsen, E. L. Teo, H. Nagaraj, E. Tan, D. Chen, M. Williams, E. T. Sun, K. C. Goh, W. C. Ong, S. K. Goh, S. Hart, R. Jayaraman, M. K. Pasha, K. Ethirajulu, J. M. Wood, B. W. Dymock, Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14, 19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma, J. Med. Chem. 54 (2011) 4638-4658, https://doi.org/10.1021/jm200326p.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref7">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pardoll</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs in cancer inflammation and immunity: a leading role for STAT3</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Canc.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>798</sb:first-page>
                              <sb:last-page>809</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/nrc2734</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0060">H. Yu, D. Pardoll, R. Jove, STATs in cancer inflammation and immunity: a leading role for STAT3, Nat. Rev. Cancer. 9 (2009) 798-809, https://doi.org/10.1038/nrc2734.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Taoka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Otte</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Spencer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.J.</ce:given-name>
                                 <ce:surname>Dinsmore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Altman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Chan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rosenstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sharma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.P.</ce:given-name>
                                 <ce:surname>Su</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Szewczak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zugay-Murphy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.G.</ce:given-name>
                                 <ce:surname>Marshall</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Young</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7334</sb:first-page>
                              <sb:last-page>7349</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm200909u</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0065">J. Lim, B. Taoka, R. D. Otte, K. Spencer, C. J. Dinsmore, M. D. Altman, G. Chan, C. Rosenstein, S. Sharma, H. P. Su, A. A. Szewczak, L. Xu, H. Yin, J. Zugay-Murphy, C. G. Marshall, J. R. Young, Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders, J. Med. Chem. 54 (2011) 7334-7349, https://doi.org/10.1021/jm200909u.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Perner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Perner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ernst</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.H.</ce:given-name>
                                 <ce:surname>Heidel</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cells</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>854</sb:first-page>
                              <sb:last-page>872</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.3390/cells8080854</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0070">F. Perner, C. Perner, T. Ernst, F. H. Heidel, Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation, Cells. 8 (2019) 854-872, https://doi.org/10.3390/cells8080854.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Mascarenhas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hoffman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin. Canc. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3008</sb:first-page>
                              <sb:last-page>3014</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1158/1078-0432.CCR-11-3145</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0075">J. Mascarenhas, R. Hoffman, Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis, Clin. Cancer Res. 18 (2012) 3008-3014, https://doi.org/10.1158/1078-0432.CCR-11-3145.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.B.</ce:given-name>
                                 <ce:surname>Hannah</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fedratinib: first approval</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>79</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1719</sb:first-page>
                              <sb:last-page>1725</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1007/s40265-019-01205-x</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0080">A. B. Hannah, Fedratinib: First Approval, Drugs. 79 (2019) 1719-1725, https://doi.org/10.1007/s40265-019-01205-x.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.M.</ce:given-name>
                                 <ce:surname>Schroeder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Hart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Inghrim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Grebinski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Tokarski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.V.</ce:given-name>
                                 <ce:surname>Lorenzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>You</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Mcdevitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Penhallow</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Vuppugalla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Gu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Iyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>Lombardo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.L.</ce:given-name>
                                 <ce:surname>Trainor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ruepp</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lippy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Blat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Sack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Khan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Stefanski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sleczka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Mathur</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Wong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.N.</ce:given-name>
                                 <ce:surname>Arunachalam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Pragalathan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Narayanan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.C.</ce:given-name>
                                 <ce:surname>Nanjundaswamy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Kuppusamy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.V.</ce:given-name>
                                 <ce:surname>Purandare</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of a highly selective JAK2 inhibitor, BMS-911543, for the treatment of myeloproliferative neoplasms</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>850</sb:first-page>
                              <sb:last-page>855</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acsmedchemlett.5b00226</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0085">H. Wan, G. M. Schroeder, A. C. Hart, J. Inghrim, J. Grebinski, J. S. Tokarski, M. V. Lorenzi, D. You, T. Mcdevitt, B. Penhallow, R. Vuppugalla, Y. Zhang, X. Gu, R. Iyer, L. J. Lombardo, G. L. Trainor, S. Ruepp, J. Lippy, Y. Blat, J. S. Sack, J. A. Khan, K. Stefanski, B. Sleczka, A. Mathur, J. Sun, M. K. Wong, D. Wu, P. Li, A. Gupta, P. N. Arunachalam, B. Pragalathan, S. Narayanan, K.C. Nanjundaswamy, P. Kuppusamy, A. V. Purandare, Discovery of a highly selective JAK2 inhibitor, BMS-911543, for the treatment of myeloproliferative neoplasms, ACS Med. Chem. Lett. 6 (2015) 850−855, https://doi.org/10.1021/acsmedchemlett.5b00226.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Hart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.M.</ce:given-name>
                                 <ce:surname>Schroeder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Grebinski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Inghrim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kempson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Pitts</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Tokarski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Sack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Khan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lippy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.V.</ce:given-name>
                                 <ce:surname>Lorenzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>You</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>McDevitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Vuppugalla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>Lombardo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.L.</ce:given-name>
                                 <ce:surname>Trainor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.V.</ce:given-name>
                                 <ce:surname>Purandare</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Structure-Based design of selective janus kinase 2 imidazo[4,5-d]pyrrolo[2,3-b]pyridine inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>845</sb:first-page>
                              <sb:last-page>849</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acsmedchemlett.5b00225</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0090">A. C. Hart, G. M. Schroeder, H. Wan, J. Grebinski, J. Inghrim, J. Kempson, J. Guo, W. J. Pitts, J. S. Tokarski, J. S. Sack, J. A. Khan, J. Lippy, M. V. Lorenzi, D. You, T. McDevitt, R. Vuppugalla, Y. Zhang, L. J. Lombardo, G. L. Trainor, A. V. Purandare, Structure-Based design of selective janus kinase 2 imidazo[4,5-d]pyrrolo[2,3-b]pyridine inhibitors, ACS Med. Chem. Lett. 6 (2015) 845−849, https://doi.org/10.1021/acsmedchemlett.5b00225.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Hurley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.I.</ce:given-name>
                                 <ce:surname>Ward</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bergeron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Barrett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Balazs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>Blair</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bull</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Chakravarty</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Crackett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Deshmukh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>DeVoss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Dragovich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Eigenbrot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ellwood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gaines</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ghilardi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gradl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gribling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Hamman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Harstad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Hewitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Kenny</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.T.</ce:given-name>
                                 <ce:surname>Koehler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bir Kohli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Labadie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.P.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Liao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Liimatta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Mendonca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Narukulla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pulk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Reeve</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Savage</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Shia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Steffek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ubhayakar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>van Abbema</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Aliagas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Avitabile-Woo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Kulagowski</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>56</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4764</sb:first-page>
                              <sb:last-page>4785</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm4004895</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0095">M. Zak, C. A. Hurley, S. I. Ward, P. Bergeron, K. Barrett, M. Balazs, W. S. Blair, R. Bull, P. Chakravarty, C. Chang, P. Crackett, G. Deshmukh, J. DeVoss, P. S. Dragovich, C. Eigenbrot, C. Ellwood, S. Gaines, N. Ghilardi, P. Gibbons, S. Gradl, P. Gribling, C. Hamman, E. Harstad, P. Hewitt, A. Johnson, T. Johnson, J. R. Kenny, M. F. T. Koehler, P. Bir Kohli, S. Labadie, W. P. Lee, J. Liao, M. Liimatta, R. Mendonca, R. Narukulla, R. Pulk, A. Reeve, S. Savage, S. Shia, M. Steffek, S. Ubhayakar, A. van Abbema, I. Aliagas, B. Avitabile-Woo, Y. Xiao, J. Yang, J. J. Kulagowski, Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2, J. Med. Chem. 56 (2013) 4764-4785, https://doi.org/10.1021/jm4004895.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>James</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.F.</ce:given-name>
                                 <ce:surname>Mark</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Jean-Baptiste</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery and development of janus kinase (JAK) inhibitors for inflammatory diseases</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>57</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5023</sb:first-page>
                              <sb:last-page>5038</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm401490p</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0100">D. C. James, E. F. Mark, T. Jean-Baptiste, Discovery and development of janus kinase (JAK) inhibitors for inflammatory diseases, J. Med. Chem. 57 (2014) 5023−5038, https://doi.org/10.1021/jm401490p.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ioannidis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Lamb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Almeida</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Block</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Davies</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Peng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Su</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Hoffmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rivard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Howard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Pollard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Read</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Alimzhanov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Bebernitz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Bell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Huszar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zinda</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl) ethyl]-N4-(5-methyl-1H-pyrazol-3-yl) pyrimidine-2,4-diamine (Azd1480) as a novel inhibitor of the jak/stat pathway</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>262</sb:first-page>
                              <sb:last-page>276</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm1011319</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0105">S. Ioannidis, M. L. Lamb, T. Wang, L. Almeida, M. H. Block, A. M. Davies, B. Peng, M. Su, H. Zhang, E. Hoffmann, C. Rivard, I. Green, T. Howard, H. Pollard, J. Read, M. Alimzhanov, G. Bebernitz, K. Bell, M. Ye, D. Huszar, M. Zinda, Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl) ethyl]-N4-(5-methyl-1H-pyrazol-3-yl) pyrimidine-2,4-diamine (Azd1480) as a novel inhibitor of the jak/stat pathway, J Med Chem. 54 (2011) 262-276, https://doi.org/10.1021/jm1011319.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Swapna</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Raphaël</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Stephanie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.D.</ce:given-name>
                                 <ce:surname>Girdhar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Lori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Arthur</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Amy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Melissa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Albane</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Amanda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.C.</ce:given-name>
                                 <ce:surname>Artur</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Julian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Ana</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Vicky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Matthew</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Jonathan</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of potent N-ethylurea pyrazole derivatives as dual inhibitors of trypanosoma brucei and trypanosoma cruzi</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2020</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>278</sb:first-page>
                              <sb:last-page>285</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acsmedchemlett.9b00218</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0110">V. Swapna, R. Raphael, R. Stephanie, S. D. Girdhar, F. Lori, T. Arthur, J. Amy, S. Melissa, K. Albane, E. Amanda, T. C. Artur, S. Julian, R. Ana, M. A. Vicky, J. P. Matthew, B. B. Jonathan, Discovery of potent N-ethylurea pyrazole derivatives as dual inhibitors of trypanosoma brucei and trypanosoma cruzi, ACS Med. Chem. Lett. 11 (2020) 278-285, https://doi.org/10.1021/acsmedchemlett.9b00218.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Mendonca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Balazs</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Barrett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bergeron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>Blair</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Deshmukh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>DeVoss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Dragovich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Eigenbrot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ghilardi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gradl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Hamman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.J.</ce:given-name>
                                 <ce:surname>Hanan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Harstad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.R.</ce:given-name>
                                 <ce:surname>Hewitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Hurley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Jin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Kenny</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.F.T.</ce:given-name>
                                 <ce:surname>Koehler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bir Kohli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Kulagowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Labadie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Liao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Liimatta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Lupardus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Maxey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Murray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pulk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rodriguez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Savage</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Shia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Steffek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ubhayakar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ultsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>van Abbema</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.I.</ce:given-name>
                                 <ce:surname>Ward</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6176</sb:first-page>
                              <sb:last-page>6193</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm300628c</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0115">M. Zak, R. Mendonca, M. Balazs, K. Barrett, P. Bergeron, W. S. Blair, C. Chang, G. Deshmukh, J. DeVoss, P. S. Dragovich, C. Eigenbrot, N. Ghilardi, P. Gibbons, S. Gradl, C. Hamman, E. J. Hanan, E. Harstad, P. R. Hewitt, C. A. Hurley, T. Jin, A. Johnson, T. Johnson, J. R. Kenny, M. F. T. Koehler, P. Bir Kohli, J. J. Kulagowski, S. Labadie, J. Liao, M. Liimatta, Z. Lin, P. J. Lupardus, R. J. Maxey, J. M. Murray, R. Pulk, M. Rodriguez, S. Savage, S. Shia, M. Steffek, S. Ubhayakar, M. Ultsch, A. van Abbema, S. I. Ward, L. Xiao, Y. Xiao, Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2, J. Med. Chem. 55 (2012) 6176−6193, https://doi.org/10.1021/jm300628c.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Kulagowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Blair</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Bull</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Deshmukh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.J.</ce:given-name>
                                 <ce:surname>Dyke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Eigenbrot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ghilardi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.K.</ce:given-name>
                                 <ce:surname>Harrison</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.R.</ce:given-name>
                                 <ce:surname>Hewitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Liimatta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Hurley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Kenny</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bir Kohli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Maxey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Mendonca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Mortara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Murray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Narukulla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Shia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Steffek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ubhayakar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ultsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>van Abbema</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.I.</ce:given-name>
                                 <ce:surname>Ward</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Waszkowycz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zak</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5901</sb:first-page>
                              <sb:last-page>5921</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm300438j</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0120">J. J. Kulagowski, W. Blair, R. J. Bull, C. Chang, G. Deshmukh, H. J. Dyke, C. Eigenbrot, N. Ghilardi, P. Gibbons, T. K. Harrison, P. R. Hewitt, M. Liimatta, C. A. Hurley, A. Johnson, T. Johnson, J. R. Kenny, P. Bir Kohli, R. J. Maxey, R. Mendonca, K. Mortara, J. Murray, R. Narukulla, S. Shia, M. Steffek, S. Ubhayakar, M. Ultsch, A. van Abbema, S. I. Ward, B. Waszkowycz, M. Zak, Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors, J. Med. Chem. 55 (2012) 5901−5921, https://doi.org/10.1021/jm300438j.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Shin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Nam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Choo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Benzimidazole derivatives as potent JAK1-selective inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>58</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7596</sb:first-page>
                              <sb:last-page>7602</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acs.jmedchem.5b01263</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0125">M. K. Kim, H. Shin, K. Park, H. Kim, J. Park, K. Kim, J. Nam, H. Choo, Y. Chong, Benzimidazole derivatives as potent JAK1-selective inhibitors, J. Med. Chem. 58 (2015) 7596−7602, https://doi.org/10.1021/acs.jmedchem.5b01263.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ritzen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Sørensen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.N.</ce:given-name>
                                 <ce:surname>Dack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.R.</ce:given-name>
                                 <ce:surname>Greve</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Jerre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Carnerup</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.A.</ce:given-name>
                                 <ce:surname>Rytved</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Bagger-Bahnsen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fragment-Based discovery of 6-arylindazole JAK inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>641</sb:first-page>
                              <sb:last-page>646</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acsmedchemlett.6b00087</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0130">A. Ritzen, M. D. Soerensen, K. N. Dack, D. R. Greve, A. Jerre, M. A. Carnerup, K. A. Rytved, J. Bagger-Bahnsen, Fragment-Based discovery of 6-arylindazole JAK inhibitors, ACS Med. Chem. Lett. 7 (2016) 641−646, https://doi.org/10.1021/acsmedchemlett.6b00087.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.G.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Mustafa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.C.</ce:given-name>
                                 <ce:surname>Tan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Poulsen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.M.</ce:given-name>
                                 <ce:surname>Ramanujulu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Chong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.Y.</ce:given-name>
                                 <ce:surname>Yen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.W.</ce:given-name>
                                 <ce:surname>Dymock</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design and synthesis of janus kinase 2 (JAK2) and histone deacetlyase (HDAC) bispecific inhibitors based on pacritinib and evidence of dual pathway inhibition in hematological cell lines</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>59</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>8233</sb:first-page>
                              <sb:last-page>8262</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/acs.jmedchem.6b00157</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0135">E. G. Yang, N. Mustafa, E. C. Tan, A. Poulsen, P. M. Ramanujulu, W. J. Chong, J. J. Y. Yen, B. W. Dymock, Design and synthesis of janus kinase 2 (JAK2) and histone deacetlyase (HDAC) bispecific inhibitors based on pacritinib and evidence of dual pathway inhibition in hematological cell lines, J. Med. Chem. 59 (2016) 8233−8262, https://doi.org/10.1021/acs.jmedchem.6b00157.</ce:source-text>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Shubhasree</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Ann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Massimo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sarfaraz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Daniella</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>JAK–STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>77</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>521</sb:first-page>
                              <sb:last-page>546</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1007/s40265-017-0736-y</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <ce:source-text id="srct0140">B. Shubhasree, B. Ann, G. Massimo, H. Sarfaraz, M. S. Daniella, JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects, Drugs. 77 (2017) 521-546, https://doi.org/10.1007/s40265-017-0736-y.</ce:source-text>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>